Green Solvents Revolution: How Ionic Liquids and Supercritical Fluids are Transforming Pharmaceutical Research and Drug Development

Abstract

This article provides a comprehensive exploration of ionic liquids (ILs) and supercritical fluids (SCFs) as advanced alternative solvents in pharmaceutical and biomedical applications. Tailored for researchers, scientists, and drug development professionals, it covers the foundational principles and properties of these solvents, delves into their specific methodologies in drug synthesis, analysis, and delivery, addresses key challenges and optimization strategies, and offers a comparative validation against traditional solvents. By synthesizing the latest research and applications, this review highlights the significant potential of ILs and SCFs to enhance efficiency, sustainability, and innovation in pharmaceutical sciences, while also outlining future directions and pending hurdles for clinical translation.

Beyond Traditional Solvents: Understanding Ionic Liquids and Supercritical Fluids

In the pursuit of sustainable and environmentally benign chemical processes, the search for alternative solvents has become a paramount research focus. Traditional organic solvents, often characterized by volatility, toxicity, and flammability, pose significant environmental and safety challenges. Within this context, ionic liquids and supercritical fluids have emerged as two prominent classes of green solvents with the potential to revolutionize chemical synthesis, separation, and analysis. This article delineates the fundamental properties, applications, and practical experimental protocols for these solvents, providing a guide for researchers and scientists in drug development and related fields.

Fundamental Properties and Comparison

Ionic Liquids (ILs)

Ionic liquids are a unique class of organic salts that are liquid at or below 100 °C, with many being liquid at room temperature (Room-Temperature Ionic Liquids, or RTILs) [1] [2]. Unlike conventional solvents comprised of neutral molecules, ILs are composed entirely of ions—typically bulky, asymmetric organic cations and smaller organic or inorganic anions [3] [2]. This specific structure results in a low lattice energy, inhibiting crystallization and leading to their liquid state at low temperatures [1]. Their key properties include negligible vapor pressure, high thermal stability, high ionic conductivity, and wide electrochemical windows [1] [2]. Notably, their properties—such as hydrophobicity, viscosity, and solvating ability—can be finely tuned by selecting different cation-anion combinations, earning them the designation "designer solvents" [3] [2].

Supercritical Fluids (SCFs)

A supercritical fluid is any substance at a temperature and pressure above its critical point, where distinct liquid and gas phases do not exist [4] [5]. This state endows SCFs with hybrid properties: gas-like diffusivity and viscosity coupled with liquid-like density [4] [6]. A quintessential example is supercritical carbon dioxide (scCO₂), which becomes supercritical at a readily accessible critical temperature of 31.1 °C and a critical pressure of 7.38 MPa [4] [6]. A defining feature of SCFs is the "tunability" of their solvent strength; small changes in pressure or temperature near the critical point result in large changes in density, which directly correlates with its solvating power [4] [5].

Table 1: Comparative Properties of Ionic Liquids, Supercritical Fluids, and Conventional Solvents

Property	Ionic Liquids	Supercritical Fluids (e.g., scCOâ‚‚)	Conventional Liquids	Gases
Density (g/cm³)	~1.0 - 1.5 [1]	0.2 - 0.8 [6]	~1.0 [6]	~0.001 [4]
Viscosity (mPa·s)	10 - 500 [1]	0.01 - 0.1 [4]	0.5 - 1.0 [4]	0.01 [4]
Diffusivity (mm²/s)	Low	0.01 - 0.1 [4]	0.001 [4]	1 - 10 [4]
Vapor Pressure	Negligible [1]	Tunable with pressure	Definite	High
Key Feature	Designable solvents	Tunable solvent power	--	--

Table 2: Critical Parameters of Common Supercritical Fluids [4] [5]

Fluid	Critical Temperature (°C)	Critical Pressure (bar)	Critical Density (g/cm³)
Carbon Dioxide (COâ‚‚)	31.1	73.8	0.469
Water (Hâ‚‚O)	374.0	221.0	0.322
Ammonia (NH₃)	132.5	112.5	0.24
Ethane (C₂H₆)	32.2	48.8	0.203

Application Notes and Experimental Protocols

The distinct properties of ILs and SCFs make them suitable for a wide array of advanced applications.

Protocol 1: Supercritical Fluid Extraction (SFE) of Natural Products

Objective: To extract a target compound (e.g., a flavor, fragrance, or active pharmaceutical ingredient) from a solid plant matrix using scCOâ‚‚.

Principle: The low viscosity and high diffusivity of scCOâ‚‚ allow for deep penetration into the solid matrix. The solvating power is tuned by adjusting pressure and temperature to selectively dissolve the target compound, which is then separated by reducing the density of COâ‚‚ in a separate vessel [5] [7].

Workflow: The following diagram illustrates the SFE process.

SFE Process Workflow

Materials and Equipment:

• Research Reagent Solutions & Materials: Table 3: Key Reagents and Equipment for SFE

Item	Function/Description
High-Purity COâ‚‚ (with siphon tube)	Extraction solvent; sourced from a cylinder designed to deliver liquid COâ‚‚.
Plant Material (e.g., dried leaves)	The solid matrix containing the analyte of interest; must be ground to a specific particle size for optimal extraction.
High-Pressure Pump	To pressurize the COâ‚‚ beyond its critical pressure.
Heated Extraction Vessel	A pressure-rated cell that contains the sample and maintains supercritical conditions.
Pressure-Reducing Valve	To depressurize the fluid stream after extraction.
Heated Separation Vessel	The chamber where the drop in pressure causes the solute to precipitate for collection.

Detailed Methodology:

• Sample Preparation: The solid plant material (e.g., coffee beans for decaffeination) is dried and ground to a uniform particle size (e.g., 0.5-1.0 mm) to maximize surface area and prevent channeling [4].
• System Preparation: The extraction vessel is loaded with the sample. The system is sealed, and a leak test is performed. The system is then heated to the desired temperature (e.g., 40-60 °C for scCOâ‚‚).
• Static Extraction: COâ‚‚ is pumped into the vessel until the target pressure (e.g., 200-400 bar) is reached. The system is held under these static conditions for a set time (e.g., 15-30 minutes) to allow for solute-solvent equilibrium.
• Dynamic Extraction: The outlet valve is opened, and COâ‚‚ is continuously pumped through the sample at a constant flow rate (e.g., 1-5 mL/min), dissolving the target compound. The solute-laden scCOâ‚‚ is then passed through the pressure-reducing valve into the separation vessel.
• Separation and Collection: In the separation vessel, maintained at a lower pressure (often near ambient) and sometimes a different temperature, the solvating power of COâ‚‚ drops dramatically, causing the extracted compound to precipitate. The pure extract is collected from this vessel.
• Solvent Recovery: The now-gasous COâ‚‚ can be vented or re-liquefied and recycled, contributing to the method's green credentials [5] [6].

Protocol 2: Biocatalytic Reaction in an Ionic Liquid Medium

Objective: To perform an enzymatic transformation (e.g., enantioselective synthesis of a pharmaceutical intermediate) using an ionic liquid as the reaction medium.

Principle: Ionic liquids can stabilize enzymes, often leading to enhanced activity, stability, and enantioselectivity compared to conventional organic solvents. Their non-volatility also allows for easy product recovery and enzyme reuse [8] [1].

Workflow: The logical flow for conducting and analyzing a biocatalytic reaction in an IL is shown below.

Biocatalysis in IL Workflow

Materials and Equipment:

• Research Reagent Solutions & Materials: Table 4: Key Reagents and Equipment for Biocatalysis in ILs

Item	Function/Description
Ionic Liquid (e.g., [C₂C₁Im][Tf₂N])	Reaction medium; chosen for its enzyme compatibility, immiscibility with product, and low water content.
Enzyme (e.g., Lipase B)	Biocatalyst; often used in its free, non-immobilized form as ILs can prevent denaturation.
Substrate(s)	The reactant molecule(s) for the enzymatic transformation.
Organic Solvent (e.g., Heptane)	For back-extracting the reaction product from the ionic liquid phase after the reaction.
Orbital Shaker or Reactor	To provide controlled temperature and mixing during the reaction.

Detailed Methodology:

• Ionic Liquid Preparation: The selected IL (e.g., 1-ethyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide) is dried under high vacuum at elevated temperature (e.g., 60 °C) for several hours to remove trace water, which can affect enzyme activity and reaction outcomes [1].
• Reaction Setup: The substrate(s) are dissolved directly in the pure IL or in a mixture of IL and a small amount of buffer (for hydrolases) inside a suitable reaction vessel.
• Catalyst Introduction: The enzyme is added to the reaction mixture. The system is sealed and placed on an orbital shaker to agitate at a controlled temperature (e.g., 30-50 °C) for the required duration (e.g., 2-48 hours).
• Product Separation: After the reaction, the product can be separated by several methods. A common approach is to add a volatile organic solvent (e.g., heptane or ethyl acetate) that is immiscible with the IL but dissolves the product. The mixture is shaken and then allowed to separate into two distinct phases.
• Analysis and Recycling: The organic phase containing the product is decanted and analyzed (e.g., by HPLC or GC to determine conversion and enantiomeric excess). The remaining IL phase, containing the active enzyme, can often be reused directly for subsequent reaction cycles [1] [2].

The Scientist's Toolkit

Table 5: Essential Research Reagent Solutions for Green Solvent Research

Reagent/Material	Function in Research	Example(s)
Supercritical COâ‚‚	The most widely used SCF for extraction, chromatography, and as a reaction medium due to its mild critical point and non-toxicity.	SFE-grade COâ‚‚ (99.99% purity) [6].
Imidazolium-Based ILs	Versatile, widely studied ILs used as solvents for catalysis, biocatalysis, and polymer processing.	1-Butyl-3-methylimidazolium hexafluorophosphate ([C₄C₁Im][PF₆]); 1-ethyl-3-methylimidazolium acetate ([C₂C₁Im][OAc]) [1] [3].
Chiral ILs	Used as chiral solvents or additives to induce enantioselectivity in asymmetric synthesis.	2-Hydroxyethyltrimethylammonium L-(+)-lactate [8].
Phosphonium-Based ILs	Known for exceptional thermal stability and used in applications like lubricants and extractions.	Tributylmethylphosphonium dibutylphosphate [8].
Fluorous ILs & SCFs	Combinations designed for advanced separation processes and tunable reaction systems.	Imidazolium ILs with [Tf₂N]⁻ anion paired with scCO₂ [9].
5-Methoxy-2,2-dimethylindanone	5-Methoxy-2,2-dimethylindanone | Research Chemical	High-purity 5-Methoxy-2,2-dimethylindanone for research applications. For Research Use Only. Not for human or veterinary use.
Cryptopine	Cryptopine | CAS 482-74-6 | RUO	Cryptopine is a benzylisoquinoline alkaloid for neurological research. For Research Use Only. Not for human or veterinary diagnostic or therapeutic use.

Advanced and Combined Applications

Research continues to explore the frontiers of these solvents, including their synergistic use. A promising area is the combination of ionic liquids and supercritical COâ‚‚ in biphasic systems. Here, a reaction can be carried out in the IL phase, while scCOâ‚‚ is used to extract the products [9]. This leverages the non-volatility of the IL and the easy separation granted by scCOâ‚‚, creating a clean and efficient continuous process. Furthermore, ILs are being investigated as dual-active pharmaceuticals (combining active cations and anions) and as components in energy storage devices like batteries and supercapacitors due to their high ionic conductivity and wide electrochemical windows [1] [2]. Supercritical water, on the other hand, is being applied in hydrothermal oxidation for the destruction of toxic waste, capitalizing on its ability to create a homogeneous phase for organic materials and oxygen [4] [10].

HERE IS THE MAIN CONTENT OF THE APPLICATION NOTES AND PROTOCOLS.

The Evolution of Solvent Technology: From First-Generation ILs to Third-Generation Bio-ILs

Ionic Liquids (ILs), salts that exist in the liquid state below 100 °C, have revolutionized the concept of solvents in chemical research and industry. Their evolution is characterized by a journey towards enhanced stability, tunability, and sustainability. This progression can be categorized into three distinct generations, each defined by its core design philosophy and key characteristics [1]:

• First-Generation ILs were primarily explored for their unique physical properties, such as low vapor pressure and high thermal stability, and were often focused on electrochemical applications. Their sensitivity to water and air was a known limitation.
• Second-Generation ILs were engineered with specific physical and chemical properties in mind, leading to the concept of "designer solvents." Their stability and tunable properties, like wide electrochemical windows and high ionic conductivity, unlocked applications in catalysis, separations, and advanced batteries [11] [1].
• Third-Generation Bio-ILs represent the current frontier, emphasizing toxicity reduction and biodegradability from the outset. This generation utilizes bio-derived ions (e.g., from amino acids, choline, or organic acids) to create inherently safer and more sustainable solvents for pharmaceuticals and biotechnology [12].

The table below summarizes the defining features of each generation.

Table 1: Key Characteristics of Ionic Liquid Generations

Generation	Primary Focus	Example Ions	Key Advantages	Primary Limitations
First-Generation	Electrochemical stability	Chloroaluminate (Al₂Cl₇⁻, AlCl₄⁻) [1]	High conductivity, non-flammability	Water and air sensitive, corrosive
Second-Generation	Tunable physico-chemical properties	Imidazolium, Pyrrolidinium, BF₄⁻, PF₆⁻ [11] [1]	Wide liquid range, high thermal stability, designer functionality	Variable toxicity, poor biodegradability
Third-Generation (Bio-ILs)	Reduced toxicity & biodegradability	Choline, Amino acids, Carboxylates [12]	Low toxicity, renewable feedstocks, biocompatibility	Potentially higher viscosity, narrower electrochemical window

Application Notes: Quantitative Performance and Market Trends

The transition to second and third-generation ILs is driven by their performance in high-value applications. The following data highlights their growing commercial importance and functional efficacy.

Table 2: Ionic Liquids in Battery Applications: A Market and Performance Overview

Aspect	Quantitative Data	Context & Significance
Market Size (2024)	USD 111 Million [11]	Baseline for the battery applications segment.
Projected Market (2034)	USD 314.2 Million [11]	Reflects a strong CAGR of 10.2%, indicating rapid adoption.
Dominant Cation (2024)	Imidazolium (45.2% share) [11]	Preferred for its electrochemical stability and commercial availability.
Key Application Segment	Electric Vehicle Batteries (30.2% share) [11]	Driven by the demand for safer, higher-performance electrolytes.
Regional Leadership	Asia-Pacific (Largest Market) [11]	Correlates with regional manufacturing of batteries and electronics.

Table 3: Performance Metrics of ILs in Various Applications

Application	Key Performance Indicator	Remarks
Battery Electrolytes	Ionic conductivity up to 10 mS/cm at 30°C in Ionogels [12]	Enhanced Li⁺/Mg²⁺ diffusion at polymer-IL interface enables solid-state-like electrolytes.
Biopolymer Processing	Effective dissolution of cellulose [1]	ILs like 1-ethyl-3-methylimidazolium acetate enable novel processing routes for bio-polymers.
COâ‚‚ Capture	Identified as potential substance for future carbon capture tech [13]	Higher COâ‚‚ absorption rate and lower energy consumption compared to conventional amine-based processes.

Experimental Protocols

Protocol 1: Synthesis of a Common Second-Generation IL: 1-Butyl-3-methylimidazolium Tetrafluoroborate ([BMIM][BFâ‚„])

Principle: This two-step metathesis reaction is a standard procedure for creating high-purity, halide-free ILs for electrochemical applications [1].

The Scientist's Toolkit:

• 1-Methylimidazole: Nucleophilic precursor for the cation.
• 1-Chlorobutane: Alkylating agent.
• Sodium Tetrafluoroborate (NaBFâ‚„): Source for the desired anion via metathesis.
• Acetonitrile: Solvent for the metathesis reaction.
• Dichloromethane (DCM): Solvent for extraction.
• Deionized Water: Washing solvent.
• Activated Charcoal: For decolorization.
• Ethyl Acetate: For final washing.

Procedure:

• Quaternization (Synthesis of [BMIM]Cl): In a round-bottom flask, equip a reflux condenser. Add 1.0 mol of 1-methylimidazole and 1.1 mol of 1-chlorobutane. Heat the mixture to 70°C with vigorous stirring for 48-72 hours. Two phases will form; the lower, viscous layer is the crude [BMIM]Cl ionic liquid.
• Purification of Intermediate: Separate the lower IL phase. Wash it repeatedly with small volumes of ethyl acetate (3 x 50 mL) to remove unreacted starting materials. The IL can be further purified by dissolving in DCM and treating with activated charcoal, followed by filtration and solvent removal under reduced pressure.
• Metathesis (Anion Exchange): Dissolve 1.0 mol of the purified [BMIM]Cl in a minimal volume of warm acetonitrile. In a separate beaker, dissolve 1.05 mol of NaBFâ‚„ in a minimal volume of deionized water. Slowly add the NaBFâ‚„ solution to the stirred [BMIM]Cl solution. A white precipitate of NaCl will form immediately.
• Isolation of Product: Stir the mixture for 12 hours at room temperature. Filter the mixture to remove the NaCl precipitate. Transfer the filtrate to a separatory funnel, separate the acetonitrile/IL phase, and wash it repeatedly with small volumes of deionized water (5 x 50 mL) to remove residual halide ions. Test the wash water with 0.1 M AgNO₃ solution; continue washing until no AgCl precipitate is observed.
• Final Purification: Remove the volatile acetonitrile and any residual water by rotary evaporation at 70°C, followed by further drying under high vacuum (<0.1 mbar) at 60°C for 24 hours. The final product, [BMIM][BFâ‚„], should be a colorless to pale yellow liquid. Characterize by ¹H NMR and HPLC to confirm purity and low halide content.

Protocol 2: Formulating a Safer Electrolyte: Ionogel for Solid-State Batteries

Principle: Confining an ionic liquid within an inert polymer matrix creates an ionogel, which combines the high ionic conductivity of the IL with the mechanical stability and safety of a solid [12].

The Scientist's Toolkit:

• 1-ethyl-3-methyimidazolium bis(trifluorosulfonyl)imide (EMIM TFSI): High-purity IL with high conductivity and wide electrochemical window.
• Poly(vinylidene fluoride-co-hexafluoropropylene) (PVDF-HFP): Polymer matrix providing mechanical integrity.
• Lithium bis(trifluoromethanesulfonyl)imide (LiTFSI): Lithium salt for Li-ion battery operation.
• Acetone: Anhydrous grade, used as a volatile solvent for dissolving the polymer.
• Glove Box (Ar atmosphere): For all preparation steps to exclude moisture and oxygen.

Procedure:

• Solution Preparation: Inside an argon-filled glove box, prepare two separate solutions.
  • Polymer Solution: Dissolve 0.5 g of PVDF-HFP in 10 mL of anhydrous acetone with stirring until a clear solution is obtained.
  • Ionic Liquid Solution: Mix 2.0 g of EMIM TFSI with 0.21 g of LiTFSI (to make a ~1 M solution) and stir until the lithium salt is completely dissolved.
• Casting the Ionogel: Combine the polymer and ionic liquid solutions. Stir vigorously for at least 2 hours to ensure a homogeneous mixture.
• Solvent Evaporation: Pour the final mixture into a glass or Teflon petri dish. Cover the dish loosely to allow for slow solvent evaporation. Let it stand for 12 hours at room temperature inside the glove box antichamber, then transfer to a vacuum oven to remove any residual acetone at 40°C for 6 hours.
• Characterization: The resulting self-standing, flexible ionogel film can be punched into discs for electrochemical testing. Ionic conductivity is typically measured by Electrochemical Impedance Spectroscopy (EIS). As reported, the ionic conductivity of such ionogels can be very close to that of the non-confined IL (e.g., 7.0 mS·cm⁻¹ vs. 8.9 mS·cm⁻¹ for the bulk IL at 30°C) [12].

Visualization: Classification and Workflows

The following diagrams illustrate the classification of ILs and a key experimental workflow.

IL Generations and Applications

Ionogel Preparation Workflow

The Future Outlook: AI and Sustainable Design

The future of IL research is being shaped by artificial intelligence and a deepening commitment to sustainability. AI and machine learning are now being used to predict the physicochemical properties of ILs, such as conductivity and viscosity, from molecular descriptors, dramatically accelerating the design of new structures [13] [14]. Furthermore, research is increasingly focused on creating wholly biobased ionic liquid gels, where both the liquid and solid components are derived from sustainable sources, aligning with global green chemistry initiatives [12]. The integration of ILs with supercritical fluid technologies also presents a powerful combination for sustainable processing, reducing the environmental footprint of chemical synthesis and extraction [15].

The development of modern pharmaceuticals and advanced materials increasingly relies on solvents with customizable properties. Among the most promising alternatives to conventional organic solvents are ionic liquids (ILs) and supercritical fluids (SCFs), which offer exceptional tunability of their core physicochemical characteristics. ILs, defined as salts melting below 100°C, possess negligible vapor pressure, high thermal stability, and versatile structural diversity [16]. Supercritical fluids, substances maintained above their critical temperature and pressure, exhibit unique properties intermediate between gases and liquids, including gas-like diffusivity and liquid-like solvating power [17] [18]. For researchers in drug development and materials science, understanding and controlling the polarity, viscosity, and solvation power of these solvents is crucial for designing efficient synthesis, extraction, and formulation processes. This application note provides a structured comparison of these properties, detailed experimental protocols for their characterization, and specific examples of their application in pharmaceutical research.

Core Properties and Comparative Analysis

The utility of ILs and SCFs stems from their distinct and often adjustable physicochemical properties. The table below provides a quantitative comparison of these key characteristics.

Table 1: Comparative Properties of Ionic Liquids, Supercritical Fluids, and Conventional Solvents

Property	Ionic Liquids (ILs)	Supercritical Fluids (e.g., scCOâ‚‚)	Conventional Organic Solvents
Polarity	Highly tunable via ion selection; can be designed from hydrophobic to hydrophilic [16]	Tunable with pressure; generally low for scCOâ‚‚, enhanced with modifiers [17]	Fixed for a given solvent
Viscosity (cP)	Typically high (20-5000 cP) [12]	Very low, near gaseous (0.02-0.1 cP) [18]	Low to moderate (e.g., Ethanol: 1.1 cP)
Solvation Power	High and broadly tunable [16] [19]	Pressure-dependent; proportional to fluid density [17]	Fixed for a given solvent
Vapor Pressure	Negligible [16] [20]	Continuous with gas and liquid states [17]	High
Diffusivity (cm²/s)	Low (~10⁻⁸) [16]	High (~10⁻³) [18]	Moderate (~10⁻⁵)
Typical Tuning Method	Varying cation/anion combination [16]	Adjusting pressure, temperature, and cosolvents [21]	Solvent mixture

Tunability and Key Manipulable Parameters

The "green" credential of these solvents is significantly enhanced by their tunability, which reduces the need for multiple, wasteful solvents.

• Ionic Liquids: The primary method for tuning IL properties is the selection of cation-anion combinations. For instance, properties like hydrophobicity, polarity, and viscosity can be precisely adjusted by changing the alkyl chain length on a cation or pairing it with different anions [16]. This allows researchers to design a solvent with properties tailored to a specific application, such as stabilizing a particular protein or enhancing drug solubility.
• Supercritical Fluids: The solvating power of SCFs is predominantly tuned through manipulation of pressure and temperature, which directly controls the fluid's density [21] [17]. A key advantage is the ability to perform gradient extractions or separations by varying these parameters over time. Furthermore, the addition of small quantities of polar cosolvents (modifiers), such as methanol, can dramatically alter the polarity and solvent strength of scCOâ‚‚, making it suitable for dissolving a wider range of polar analytes [17].

Experimental Protocols and Methodologies

Protocol 1: Determining Solvation Power and Activity Coefficients in Ionic Liquids

This protocol outlines the use of COSMO-RS (Conductor-like Screening Model for Real Solvents) to predict the activity coefficient at infinite dilution (γ∞), a key metric for solvation power, using a computational approach [22].

1. Principle: The COSMO-RS model combines quantum chemistry calculations with statistical thermodynamics to predict the thermodynamic properties of fluids. It is particularly effective for screening ILs as it can handle the discrete nature of cations and anions.

2. Materials & Software:

• ADF modeling suite with COSMO-RS module
• Integrated IL database (e.g., ADFCRS-IL-2014) [22]

3. Procedure:

• Step 1: Define Ionic Liquid Components. Select the cation and anion as separate compounds from the database (e.g., IL_cation_1-butyl-3-methyl-imidazolium and IL_anion_tetracyanoborate).
• Step 2: Create an Electroneutral Mixture. To simulate the ionic liquid, create a compound with multiple forms where the previous cation and anion are defined as the dissociated forms. This ensures an electroneutral mixture in the calculation [22].
• Step 3: Set Up Activity Coefficient Calculation.
  • Select the property "Activity Coefficients".
  • Define the solvent as the created IL compound with a mole fraction of 1.0.
  • Specify the temperature (e.g., 308.15 K).
  • Add the solutes of interest (e.g., hexane, heptane, octane).
• Step 4: Run Calculation and Analyze. Execute the job. The output will provide the activity coefficients at infinite dilution for the solutes in the IL. A lower γ∞ indicates stronger solvation.

4. Data Analysis: The calculated γ∞ values can be used to rank different ILs for their effectiveness in separating specific solute mixtures or to predict drug solubility. The model can be validated against experimental data for common systems to ensure accuracy [22].

Protocol 2: Measuring Solute Solubility in Supercritical COâ‚‚

This protocol describes a gravimetric method for determining the solubility of a solid solute in supercritical carbon dioxide, a key parameter for processes like supercritical fluid extraction (SFE) and particle formation.

1. Principle: The solubility of a compound in scCOâ‚‚ is determined by exposing the solute to the fluid in a high-pressure vessel at constant temperature and pressure. The amount of solute dissolved is then measured by weighing the solute before and after extraction or by analyzing the solute collected after depressurization [18].

2. Materials & Equipment:

• High-pressure view cell or extraction vessel with temperature control
• Syringe pump for COâ‚‚ delivery
• Precision pressure transducer and thermometer
• Back-pressure regulator
• Analytical balance (± 0.1 mg)

3. Procedure:

• Step 1: System Preparation. Load a known mass of the pure solute (e.g., a pharmaceutical compound) into the high-pressure vessel. Seal the vessel and bring it to the desired experimental temperature using a thermostat.
• Step 2: Pressurization. Pump COâ‚‚ into the vessel slowly until the target pressure is reached. Maintain stirring or circulation to ensure equilibrium between the solute and the scCOâ‚‚.
• Step 3: Equilibrium. Allow the system to equilibrate for a predetermined time (typically 1-2 hours) with continuous stirring to ensure saturation is achieved.
• Step 4: Sampling. Slowly expand a small, known volume of the saturated scCOâ‚‚ through the back-pressure regulator into a collection trap containing a suitable solvent. This step must be controlled to prevent precipitation during expansion.
• Step 5: Quantification. Evaporate the trapping solvent and weigh the residual solute. Alternatively, use an online method like UV-Vis spectroscopy to quantify the solute concentration in the trap.
• Step 6: Repetition. Repeat steps 2-5 at different pressures and temperatures to map the solubility as a function of scCOâ‚‚ density.

4. Data Analysis: Solubility (S) is calculated as the mass of solute collected per volume of scCOâ‚‚ sampled. Plotting solubility versus pressure or density will show the characteristic crossover region where the effect of temperature on solubility inverts, a key phenomenon in SCF behavior [18].

Workflow Diagram: Property Characterization of Alternative Solvents

The following diagram illustrates the logical decision process for characterizing the core properties of ionic liquids and supercritical fluids.

Application Notes in Pharmaceutical Research

Case Study: Ionic Liquids as Vaccine Adjuvant Systems

A promising application of ILs in drug development is their use as adjuvants and stabilizers in vaccine formulations. Current vaccine development is hindered by the limited number of available adjuvants. ILs address this through their tunable properties [16].

• Mechanism of Action: Choline-based ILs, such as choline sorbate (ChoSorb) and choline lactate (ChoLa), have been investigated for their ability to stabilize vaccine antigens (proteins, inactivated viruses) against thermal degradation. The ILs form a protective matrix around the antigen, preserving its native structure [16].
• Tunability for Function: The choice of anion in choline-based ILs dictates their functionality. For example, ChoLa has demonstrated permeability-enhancing properties, which could be beneficial for mucosal vaccines, while other anions may be selected for optimal antigen stability or immune response modulation [16].
• Research Protocol: A typical study involves incubating the model antigen with a series of choline-based ILs at various concentrations. The formulations are then subjected to:
  • Stability Testing: Stressing the formulations at elevated temperatures (e.g., 40-60°C) and analyzing antigen integrity over time using SDS-PAGE or ELISA.
  • Immunogenicity Study: Administering the IL-stabilized vaccine to an animal model and measuring antibody titers and T-cell responses compared to standard adjuvants like alum.

Case Study: Supercritical Fluid Processing of Active Pharmaceutical Ingredients (APIs)

Supercritical fluids, particularly scCOâ‚‚, are widely used in particle engineering to improve the bioavailability of poorly water-soluble drugs, a major challenge in pharmaceutical development [18].

• Technology Overview: Techniques like Supercritical Antisolvent (SAS) precipitation and Rapid Expansion of Supercritical Solutions (RESS) leverage the unique properties of SCFs to produce micro- and nano-particles of APIs with controlled size and morphology.
• Mechanism: In the SAS process, a solution of the API in an organic solvent is injected into a stream of scCOâ‚‚. The scCOâ‚‚ acts as an antisolvent, drastically reducing the solvent power of the organic phase and causing supersaturation and precipitation of the API as fine particles. The organic solvent is then dissolved and carried away by the scCOâ‚‚ [18].
• Tunability for Function: The particle size, crystal polymorph, and morphology are highly dependent on the process parameters, which are easily tunable.
  • Pressure and Temperature: Directly control the density and solvating power of scCOâ‚‚, affecting the rate of supersaturation and nucleation.
  • Cosolvents: Adding a modifier like ethanol can alter the phase behavior and crystallization kinetics, enabling the production of particles with specific characteristics [18].

Table 2: Key Supercritical Fluid Processing Techniques for APIs

Technique	Principle	Typical Application	Tunable Parameters
RESS(Rapid Expansion of Supercritical Solutions)	Solute is dissolved in scCOâ‚‚ and the solution is rapidly expanded through a nozzle, causing precipitation.	Processing of thermally stable, scCOâ‚‚-soluble compounds.	Pre-expansion P & T, nozzle geometry.
SAS(Supercritical Antisolvent)	A solution of solute in organic solvent is sprayed into scCOâ‚‚; scCOâ‚‚ acts as an antisolvent, precipitating the solute.	Processing of compounds with low scCOâ‚‚ solubility; most common technique.	P & T, solute concentration, solvent type, flow rates.
PGSS(Particles from Gas-Saturated Solutions)	scCOâ‚‚ is dissolved into a molten solute or suspension, which is then expanded, causing particle formation.	Processing of polymers, fats, and waxes for drug encapsulation.	P & T, saturation time, mixing intensity.

The Scientist's Toolkit: Essential Research Reagents and Materials

Table 3: Key Reagent Solutions for Ionic Liquid and Supercritical Fluid Research

Reagent / Material	Function / Application	Example & Notes
Imidazolium-based ILs	Versatile solvent platform with highly tunable properties for reactions and extractions.	1-Butyl-3-methylimidazolium ([BMIM][Ac]): Serves as a benchmark IL; acetate anion enhances lignin solubility in biomass processing [16].
Choline-based ILs	Biocompatible ILs for pharmaceutical and biomedical applications.	Choline Sorbate (ChoSorb): Explored as a stabilizing ionic liquid for vaccine antigens [16].
Supercritical COâ‚‚	Primary solvent for SCF extractions, particle formation, and chromatography.	High-purity scCOâ‚‚: Non-toxic, non-flammable. Its polarity is augmented with cosolvents like methanol [17] [18].
Polar Cosolvents	Modifiers to adjust the polarity and solvation power of scCOâ‚‚.	Methanol, Ethanol: Commonly used to enable SFE of polar compounds or to control API particle morphology in SAS processes [17] [18].
COSMO-RS Database	Computational tool for predicting thermodynamic properties and screening ILs/SCFs.	ADFCRS-IL-2014 Database: Contains pre-parameterized cations/anions for predicting activity coefficients and gas solubilities, accelerating solvent selection [22].
High-Pressure Cell	Core vessel for conducting solubility measurements and observing phase behavior.	Sapphire or Stainless Steel View Cell: Allows visual monitoring of phase transitions and mixture behavior under pressure [18].
1-(Methylsulfanyl)but-2-yne	1-(Methylsulfanyl)but-2-yne | High Purity | For R&D	1-(Methylsulfanyl)but-2-yne for research. A versatile alkyne sulfide building block for organic synthesis & medicinal chemistry. For Research Use Only.
3-Nitrofluoranthen-9-ol	3-Nitrofluoranthen-9-ol | High-Purity PAH for Research	High-purity 3-Nitrofluoranthen-9-ol for research. Study nitro-PAH metabolism, mutagenicity & environmental analysis. For Research Use Only. Not for human use.

Supercritical fluids (SCFs) represent a unique state of matter that emerges when a substance is heated and compressed beyond its critical temperature (Tc) and critical pressure (pc). Under these conditions, the substance adopts properties that are intermediate between those of a liquid and a gas, creating a solvent with exceptional capabilities for scientific and industrial applications. The most prominent supercritical fluid in research and industry is carbon dioxide (scCO₂), valued for its accessible critical point, low toxicity, and environmental benignity. Another significant, though less common, supercritical fluid is trifluoromethane (scCHF₃), which offers distinct solvating properties for challenging separations.

The interest in these fluids is particularly strong within the field of green chemistry, where they serve as alternative solvents to replace conventional organic solvents in processes ranging from extraction to materials fabrication. Their unique characteristics—including tunable density, low viscosity, and high diffusivity—make them indispensable tools for modern researchers, especially in pharmaceutical development and advanced materials science. This application note details the fundamental properties, applications, and specific experimental protocols for utilizing scCO₂ and scCHF₃, with a specific focus on their role in conjunction with ionic liquids as advanced solvent systems.

Fundamental Properties and Comparative Analysis

Defining Characteristics of the Supercritical State

A supercritical fluid is defined as a substance held at or above both its critical temperature and critical pressure. Beyond this critical point, the distinction between liquid and gas phases disappears. The fluid expands to fill its container like a gas but maintains a density comparable to that of a liquid [23]. This combination of properties leads to the most valuable features of SCFs: liquid-like solvating power and gas-like mass transfer characteristics.

The physical properties of SCFs can be finely tuned by making relatively small adjustments to temperature and pressure. Unlike conventional solvents, whose properties are largely fixed, a supercritical fluid's density, and consequently its solvating power, can be controlled precisely, enabling selective extractions and reactions [24]. This tunability is a key advantage in research and process design.

Comparative Analysis of scCO₂ and scCHF₃

The following table summarizes the critical parameters and characteristic properties of scCO₂ and scCHF₃, providing a direct comparison for researchers selecting an appropriate supercritical medium.

Table 1: Critical Parameters and Properties of scCO₂ and scCHF₃

Property	scCO₂	scCHF₃	Remarks
Critical Temperature (T_c)	304.13 K (30.98 °C) [23]	299.1 K (25.95 °C) [24]	Both are near-ambient, enabling low-energy processing.
Critical Pressure (p_c)	7.38 MPa (73.8 bar) [23]	4.82 MPa (48.2 bar) [24]	CHF₃ requires lower operating pressure.
Chemical Nature	Non-polar, apolar	Higher polarity than CO₂	CHF₃'s polarity confers higher solvating power for polar compounds.
Solvating Power	Moderate; tunable with density	Higher for polar molecules	Demonstrated for sulfonamides [25].
Selectivity	Good	Enhanced selectivity in extractions	Cleaner extracts reported with methanol-modified scCHF₃ [25].
Environmental & Safety	Non-toxic, non-flammable	Chemically stable	COâ‚‚ is widely regarded as a green solvent.

Table 2: General Properties of Supercritical Fluids Compared to Gases and Liquids [24]

State	Density (g/cm³)	Diffusion Coefficient (cm²/s)	Viscosity (MPa·s)
Gas	0.0006 - 0.002	0.1 - 0.4	0.01 - 0.03
Supercritical Fluid	0.2 - 0.5	0.5 - 4.0 x 10⁻³	0.01 - 0.03
Liquid	0.6 - 2.0	0.2 - 2.0 x 10⁻⁵	0.2 - 20

The data in Table 2 highlights the intermediate and favorable position of SCFs. Their density is liquid-like, providing good solvating power. Meanwhile, their diffusion coefficients are orders of magnitude higher, and their viscosity is much lower than those of liquids, leading to superior mass transfer and penetration into porous matrices.

Key Application Areas in Research and Development

Extraction and Separation Processes

Supercritical fluids have revolutionized extraction techniques, particularly in the food, pharmaceutical, and natural product industries.

• scCOâ‚‚ in Decaffeination and Essential Oil Extraction: scCOâ‚‚ is the solvent of choice for decaffeinating coffee and tea. It is forced through green coffee beans, selectively dissolving the caffeine, which is then recovered. The beans' desired flavors and aromas remain largely intact due to the gentle critical temperature of COâ‚‚. Similarly, scCOâ‚‚ is used to create essential oils and herbal distillates, offering advantages over steam distillation (lower temperature operation) and organic solvents (no toxic residue) [23].
• scCHF₃ for Challenging Separations: scCHF₃ has demonstrated superior performance in extracting more polar compounds. A key study extracted sulfonamides from fortified chicken liver, finding that both pure and methanol-modified scCHF₃ exhibited higher solvating power and selectivity compared to scCOâ‚‚. Visual observation confirmed that the extract obtained with methanol-modified scCHF₃ was cleaner, with less co-extraction of interfering matrix components like fats [25].

Materials Fabrication and Particle Engineering

The unique properties of SCFs are exploited to create advanced materials with tailored morphologies.

• scCOâ‚‚ as a Green Route for Inorganic Materials: The scCOâ‚‚ process is recognized as a green and unique route for fabricating diverse inorganic-based materials. Its high penetrability and diffusivity allow for the creation of unique crystal architectures (amorphous, crystalline, heterojunction) and tunable morphologies such as nanoparticles, nanosheets, and aerogels [26].
• Supercritical Antisolvent (SAS) Precipitation: This technique, often using scCOâ‚‚, is powerful for microparticle and nanoparticle formation. In the pharmaceutical field, SAS is used to produce solid dispersions of poorly water-soluble drugs with polymers like polyvinylpyrrolidone (PVP), significantly enhancing drug dissolution rates. The process can generate fully amorphous solid dispersions, which are critical for improving the bioavailability of many modern drugs [27].
• Aerogel Production: scCOâ‚‚ is essential in producing silica, carbon, and metal-based aerogels. It is used in a process called supercritical drying, where it replaces the liquid solvent within a gel without creating a destructive gas-liquid meniscus. As the scCOâ‚‚ is depressurized, it leaves behind a network with nanometer-sized pores, resulting in a material with extremely low density and high surface area [23].

Advanced Synthesis and Electrodeposition

• Supercritical Fluid Electrodeposition (SCFED): This emerging technique allows for the electrodeposition of materials like copper (Cu), silver (Ag), and germanium (Ge) from supercritical fluids such as hydrofluorocarbons or COâ‚‚ with co-solvents. A key advantage is the lack of surface tension in SCFs, which enables electrodeposition into high-aspect-ratio nanostructures and onto fragile substrates without pore blockage or damage. This is particularly promising for fabricating ultrathin nanowires for electronic and sensing applications [24].
• Reaction Medium with Ionic Liquids: The combination of supercritical COâ‚‚ and ionic liquids (ILs) creates a powerful biphasic system for catalytic reactions and separations. A remarkable feature of this system is the high solubility of COâ‚‚ in many ionic liquids, while the ionic liquids themselves have negligible solubility in the scCOâ‚‚ phase. This allows for a process where a catalytic reaction is carried out in the ionic liquid phase, and the products are subsequently extracted with scCOâ‚‚ without any cross-contamination of the ionic liquid [28].

Experimental Protocols

Protocol 1: Extraction of Sulfonamides from a Solid Matrix Using scCHF₃ and scCO₂

This protocol is adapted from a comparative study of sulfonamide extraction from chicken liver [25].

1. Scope and Application: This procedure describes a method for extracting sulfonamide antibiotics from a complex solid matrix (e.g., fortified chicken liver) using supercritical trifluoromethane (scCHF₃) and carbon dioxide (scCO₂), with and without a methanol modifier. It is suitable for evaluating the efficiency and selectivity of different supercritical fluids.

2. Experimental Apparatus and Materials:

• Supercritical Fluid Extraction System: Equipped with a high-pressure pump, a temperature-controlled extraction vessel, a back-pressure regulator, and a collection trap.
• Extraction Vessel: Capable of withstanding pressures >30 MPa.
• Chemicals: Trifluoromethane (CHF₃, >99% purity), Carbon Dioxide (COâ‚‚, >99.9% purity), Methanol (HPLC grade), Hydromatrix (diatomaceous earth), Sulfonamide standards.
• Matrix Preparation: Fortified chicken liver. The liver sample is homogenized, fortified with the target sulfonamides, and thoroughly mixed with Hydromatrix to create a free-flowing powder and ensure efficient fluid contact.

3. Step-by-Step Procedure:

• Step 1: System Preparation. Load the prepared sample mixture into the extraction vessel. Assemble the system and ensure all fittings are secure.
• Step 2: Pre-equilibration. Bring the extraction vessel to the desired operating temperature (e.g., 40-60 °C). Pressurize the system slowly with the chosen fluid (CHF₃ or COâ‚‚) to the target pressure (e.g., 15-30 MPa for CHF₃). Allow the system to stabilize for 10-15 minutes.
• Step 3: Dynamic Extraction. Open the flow path to the collection trap. Initiate the fluid flow at a constant rate (e.g., 1-3 mL/min as a liquid) for a fixed extraction time (e.g., 30-60 minutes). For modified extractions, add 5-10% (v/v) methanol via a secondary pump.
• Step 4: Collection. The extract is collected in a solvent trap, typically containing a suitable solvent like methanol.
• Step 5: Depressurization and Shutdown. After the extraction time has elapsed, slowly depressurize the system over 10-15 minutes. Disassemble the vessel and recover any spent sample.

4. Data Analysis:

• Analyze the collected extract using an appropriate analytical technique (e.g., HPLC-UV/MS).
• Compare the recovery rates and chromatographic profiles of the extracts obtained with scCHF₃ and scCOâ‚‚ to assess solvating power and selectivity.
• Note the physical appearance (e.g., color, precipitated fat) of the different extracts.

Protocol 2: Formation of a Solid Dispersion via Supercritical Antisolvent (SAS) Precipitation

This protocol outlines the generation of a solid dispersion of a drug (e.g., Paracetamol/PCM) and a polymer (e.g., Polyvinylpyrrolidone/PVP) using scCOâ‚‚ [27].

1. Scope and Application: This procedure is used to produce co-precipitated microparticles or nanoparticles of a drug-polymer system to create an amorphous solid dispersion, with the goal of enhancing the dissolution rate of a poorly water-soluble drug.

2. Experimental Apparatus and Materials:

• SAS Apparatus: Consists of a COâ‚‚ supply, cooling unit, high-pressure pump, co-solvent pump (optional), temperature-controlled precipitation vessel with a nozzle, and a back-pressure regulator.
• Precipitation Vessel: Equipped with a frit for particle collection and a nozzle for solution injection (e.g., a capillary nozzle).
• Chemicals: COâ‚‚ (≥99.9%), Drug (e.g., Paracetamol, ≥98%), Polymer (e.g., PVP K30), Organic Solvents (e.g., Ethanol, Acetone, ACS grade).

3. Step-by-Step Procedure:

• Step 1: Solution Preparation. Dissolve the drug and polymer at the desired mass ratio (e.g., 1:1 to 1:4 drug-to-polymer) in a pure solvent or a solvent mixture (e.g., ethanol/acetone). The total solute concentration is typically between 0.5 and 5 wt%. Filter the solution if necessary.
• Step 2: Vessel Pressurization. Place a clean filter in the precipitation vessel. Seal and pressurize the vessel with COâ‚‚ to the desired operating pressure (e.g., 10-16 MPa) and set the temperature (e.g., 313 K / 40 °C). Allow the system to stabilize with a continuous flow of COâ‚‚ to ensure a homogeneous supercritical environment.
• Step 3: Solution Injection and Precipitation. Inject the prepared solution through the nozzle into the vessel at a controlled flow rate (e.g., 1 mL/min). The scCOâ‚‚ acts as an antisolvent, causing extreme supersaturation and the instantaneous precipitation of the solute(s) as fine particles.
• Step 4: Washing. After the solution injection is complete, continue to flow pure scCOâ‚‚ through the vessel for 30-60 minutes to wash away any residual solvent from the precipitated particles.
• Step 5: Depressurization and Collection. Slowly depressurize the vessel over 30-60 minutes to avoid disturbing the particle bed. Carefully open the vessel and collect the produced powder.

4. Data Analysis:

• Morphology: Analyze particle size and shape using Scanning Electron Microscopy (SEM).
• Solid State: Determine the crystallinity/amorphicity of the solid dispersion using X-ray Diffraction (XRD). A successful formation of an amorphous solid dispersion will show a halo pattern in the XRD, devoid of sharp crystalline peaks.
• Dissolution Testing: Perform in vitro dissolution tests to compare the dissolution profile of the SAS-processed solid dispersion against the pure crystalline drug.

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Materials and Reagents for Supercritical Fluid Research

Reagent/Material	Function/Application	Key Characteristics & Notes
High-Purity CO₂ (≥99.9%)	Primary solvent for scCO₂-based processes.	Inert, non-toxic, non-flammable. Purity is critical to avoid blockages and contamination.
Trifluoromethane (CHF₃)	Polar supercritical solvent for challenging extractions.	Higher polarity than CO₂; requires consideration of environmental impact.
Methanol, Ethanol, Acetone	Co-solvents (modifiers) and collection solvents.	HPLC grade. Used to enhance solubility of polar analytes in scCOâ‚‚ or as a trapping solvent.
Ionic Liquids (e.g., [BMIM][PF₆])	Reaction media for biphasic systems with scCO₂.	Non-volatile, highly polar. Selected based on catalyst compatibility and scCO₂ miscibility.
Hydromatrix (Diatomaceous Earth)	Solid support matrix for wet samples in SFE.	Inert, high surface area. Disperses samples for efficient fluid contact and prevents clumping.
Polyvinylpyrrolidone (PVP)	Polymer for particle engineering and solid dispersions via SAS.	Amorphous, water-soluble polymer. Acts as a crystallization inhibitor in pharmaceutical formulations.
Model Compounds (e.g., Naphthalene, Sulfonamides)	Solubility modeling and process efficiency testing.	Well-characterized solubility in SCFs; used for method development and calibration.
4,6-Cholestadien-3beta-ol	4,6-Cholestadien-3beta-ol | High-Purity Reference Standard	High-purity 4,6-Cholestadien-3beta-ol for research on cholesterol biosynthesis & metabolism. For Research Use Only. Not for human or veterinary use.
4-Octyldodecan-1-ol	4-Octyldodecan-1-ol | High-Purity Reagent | RUO	High-purity 4-Octyldodecan-1-ol for research. A key branched fatty alcohol for material science & organic synthesis. For Research Use Only.

Visual Guide: Supercritical Fluid Process Selection and Tuning

The following diagram illustrates the logical decision-making process for selecting and optimizing a supercritical fluid application, integrating the unique characteristics of scCO₂ and scCHF₃.

Diagram 1: A workflow for selecting and tuning supercritical fluid processes based on application requirements and solute properties.

In the pursuit of sustainable chemistry, ionic liquids (ILs) and supercritical fluids (SCFs), particularly supercritical carbon dioxide (scCOâ‚‚), have emerged as leading alternatives to conventional organic solvents. While each possesses distinct advantages, their combination creates a synergistic system that leverages the unique properties of both. Ionic liquids are organic salts with negligible vapor pressure, high thermal stability, and tunable properties, making them versatile designer solvents [29]. Supercritical fluids, especially scCOâ‚‚, offer high diffusivity, low viscosity, and zero solvent residue, with the added benefit of facile post-processing separation [30]. When integrated, these solvents form a biphasic system that is not merely additive but functionally synergistic, enabling novel applications in chemical processing, extraction, and particularly in pharmaceutical and material sciences where precision and green credentials are paramount. This application note details the quantitative benefits and provides established protocols for leveraging this powerful solvent combination.

Quantitative Synergy: Performance Data and Comparative Analysis

The combination of ILs and SCFs demonstrates clear, measurable synergism across various applications, from biocatalysis to particle engineering. The table below summarizes key comparative data that highlights the enhanced performance of the combined IL-SCF system.

Table 1: Comparative Performance of Solvent Systems in Biocatalysis and Drug Processing

Solvent System	Catalytic Activity (e.g., Cutinase)	Solubility Capacity (e.g., 5-Fluorouracil in scCOâ‚‚)	Particle Engineering Capability	Environmental Impact (COâ‚‚eq)
Conventional Organic Solvents	Baseline	Low (requires toxic solvents)	Poor control, broad size distribution	High (e.g., 0.2-153 kg COâ‚‚eq/kg input [15])
Ionic Liquids (ILs) Alone	Enhanced stability & activity [31]	N/A	Limited for hydrophobic compounds	Variable; requires purification
SCFs (scCOâ‚‚) Alone	Limited by low solubility of polar substrates	0.0024 - 0.0176 g/L (for 5-Fluorouracil) [30]	Good control, but limited to soluble compounds	Lower than conventional solvents [15]
Combined IL-SCF System	Highest reported activity & stability [31]	Dramatically enhanced for polar compounds	Superior control for nano/micro particles [30]	Lowest overall, due to solvent recycling [15]

The data reveals that the IL-SCF system outperforms individual solvents. The environmental profile is particularly noteworthy; while energy consumption remains a hotspot for SCF processes, the ability of scCOâ‚‚ to extract products from ILs without cross-contamination and the high recyclability of both solvents significantly reduce the overall environmental footprint across the life cycle [15].

Mechanistic Insights: Visualizing Synergy and Workflow

The synergistic relationship between ILs and SCFs can be understood through their complementary properties and the resulting workflow that enables advanced material processing.

The Synergistic Mechanism of IL-SCF Systems

The following diagram illustrates the core mechanisms that create synergy between Ionic Liquids and Supercritical Fluids.

Experimental Workflow for Particle Engineering

A common application of the IL-SCF system is the engineering of drug particles, such as the anticancer drug 5-Fluorouracil. The protocol below and its corresponding workflow visualize this process.

Diagram Title: Drug Particle Engineering with IL-SCF

The Scientist's Toolkit: Essential Reagents and Equipment

Successful implementation of IL-SCF technology requires specific reagents and apparatus. The following table catalogues the essential components for a typical experiment.

Table 2: Key Research Reagent Solutions and Equipment

Item Name	Specification / Function	Application Context
Ionic Liquids	e.g., [Câ‚„mim][Tfâ‚‚N]; acts as a green, tunable solvent for polar compounds.	Primary solvent for dissolution of APIs or as a catalyst medium [31].
High-Purity CO₂	Purity > 99.9%; becomes scCO₂ above its critical point (Tc = 31°C, Pc = 73.8 bar).	Anti-solvent and extraction fluid in particle formation processes [30].
Model Active Pharmaceutical Ingredient (API)	e.g., 5-Fluorouracil (purity > 99%); a model solute for solubility and particle engineering studies [30].	Used to validate the IL-SCF process for drug micronization.
High-Pressure View Cell / Reactor	Equipped with sapphire windows, magnetic stirring, and accurate T/P control (± 0.1 K, ± 0.1 MPa) [30].	Central vessel for observing and conducting reactions or particle formation under supercritical conditions.
Spectrophotometer	UV-Vis model; used for quantitative solubility analysis of compounds in scCOâ‚‚ [30].	Measures drug concentration in scCOâ‚‚ via absorbance at specific wavelengths (e.g., 266 nm for 5-FU).
4'-Hydroxynordiazepam	4'-Hydroxynordiazepam|CAS 17270-12-1|High Purity
Mefenidramium metilsulfate	Mefenidramium Metilsulfate|CAS 4858-60-0

Detailed Experimental Protocol: Solubility Measurement and Particle Formation

This protocol provides a step-by-step guide for determining drug solubility in an IL-SCF system and subsequent particle formation, based on established methodologies [30].

Safety and Preparation

• Personal Protective Equipment (PPE): Wear a lab coat, safety glasses, and insulated gloves when handling the high-pressure equipment.
• System Check: Ensure the high-pressure cell and all fittings are rated for the maximum intended pressure (e.g., > 300 bar). Perform a leak test with scCOâ‚‚ at a low pressure before commencing the experiment.
• Material Preparation: Weigh 1.0 gram of the model drug (e.g., 5-Fluorouracil) with an analytical balance and place it directly into the clean, dry high-pressure cell.

Dissolution and Equilibration

• Seal the System: Close the high-pressure cell and place it in a temperature-controlled oven, setting it to the desired experimental temperature (e.g., 308 K, 335 K). Allow the cell to thermally equilibrate.
• Add Ionic Liquid: Using a high-pressure pump, introduce a known volume of the selected ionic liquid (e.g., 5-10 mL) into the cell. The IL should fully wet the solid drug.
• Pressurize with scCOâ‚‚: Pump pre-cooled liquid COâ‚‚ into the cell until the target pressure (e.g., 120, 270 bar) is reached.
• Equilibrate: Maintain the system under constant temperature and pressure with continuous stirring for a minimum of 60 minutes to ensure equilibrium is achieved between the solute, IL, and scCOâ‚‚ [30].

Sampling and Analysis

• Sample the Solute-laden scCOâ‚‚: After equilibration, use a 6-port sampling valve with a fixed-volume loop (e.g., 600 µL) to extract a sample of the scCOâ‚‚ phase from the cell.
• Dissolve the Sample: Rapidly expand the scCOâ‚‚ sample into a collection vial containing 5 mL of a diluent solvent (e.g., Dimethyl Sulfoxide, DMSO).
• Quantify Solubility: Measure the concentration of the drug in the DMSO solution using a UV-Vis spectrophotometer at the predetermined maximum absorbance wavelength (λmax = 266 nm for 5-Fluorouracil). Use a pre-established calibration curve to convert absorbance to concentration.
• Calculate Mole Fraction: Use the following formula to calculate the mole fraction solubility (yâ‚‚) of the drug in scCOâ‚‚ [30]: y₂ = (C_{drug} * V_{collection}) / (ρ_{CO2} * V_{loop} * M_{drug}) Where C_{drug} is the measured concentration, V are the volumes, ρ_{CO2} is the density of COâ‚‚ at sampling P/T, and M is the molar mass.

Particle Formation via Rapid Expansion

• Induce Supersaturation: After sampling for solubility, slowly depressurize the cell. The reduction in solvation power of the scCOâ‚‚-IL system causes the drug to become supersaturated and precipitate.
• Collect Particles: Once the system is at atmospheric pressure, open the cell and carefully collect the solid powder.
• Characterize: Analyze the collected particles using techniques like Scanning Electron Microscopy (SEM) for morphology and Laser Diffraction for particle size distribution.

The fusion of ionic liquids and supercritical fluids creates a solvent system whose capabilities far exceed the sum of its parts. The synergy, quantified by enhanced solubility, superior particle engineering control, and integrated reaction-separation processes, offers a powerful and sustainable toolkit for modern researchers. As the chemical industry trends toward greater digitalization, specialization, and a stringent ESG focus [32], the adoption of such green technologies will accelerate. The provided protocols and data offer a foundation for researchers and drug development professionals to harness this potential, paving the way for more efficient, cleaner, and highly precise manufacturing processes in pharmaceuticals and beyond.

From Theory to Practice: Pharmaceutical Applications in Synthesis, Extraction, and Delivery

Ionic liquids (ILs) have emerged as powerful alternative solvents in the synthesis of active pharmaceutical ingredients (APIs), aligning with the broader research objectives of finding sustainable replacements for volatile organic compounds. Their unique properties, including negligible vapor pressure, high thermal stability, and tunable physicochemical characteristics, make them particularly valuable for optimizing pharmaceutical synthesis processes [33]. The versatility of ILs allows them to function as dual-purpose materials, serving as both reaction media and catalysts, which can significantly enhance reaction kinetics and overall yield while reducing environmental impact [33] [34]. With the pharmaceutical industry facing increasing pressure to improve manufacturing efficiency and sustainability – evidenced by an Environmental Factor (E-factor) of 25-100, significantly higher than other industries – the adoption of IL-based methodologies represents a promising approach to greener API synthesis [33]. This application note details specific protocols and quantitative performance data demonstrating the efficacy of ILs in enhancing both yield and reaction rates across various API synthetic pathways.

Key Applications and Performance of ILs in API Synthesis

The application of ionic liquids in API synthesis spans multiple roles, including as solvents, catalysts, reagents, and enantioselectivity enhancers [33]. Their charged nature and customizable structure allow for unique interactions with reactants and transition states, often resulting in accelerated reaction kinetics and improved selectivity compared to conventional organic solvents [33]. The table below summarizes the demonstrated enhancements in yield and rate for specific API syntheses utilizing ILs.

Table 1: Enhancement of API Synthesis Using Ionic Liquids

API/Precursor Synthesized	IL Employed	Role of IL	Key Reaction Conditions	Yield Enhancement	Rate Enhancement/Time Reduction
Pravadoline (NSAID)	1-butyl-3-methylimidazolium hexafluorophosphate ([C₄C₁im][PF₆])	Solvent	150°C, 2 minutes, KOH base	95% yield (vs. 70-91% in conventional solvents) [33]	Reaction completed in 2 minutes [33]
Trifluridine (Antiviral)	1-methoxyethyl-3-methylimidazolium methanesulfonate ([(C₁OC₂)C₁im][MsO])	Solvent	DMAP catalyst, acetic anhydride acylating agent, 20-25 min	91% yield as a single product [33]	20-25 minutes without extra purification [33]
Lactam Core	Not specified	Solvent for microwave heating	One-pot reaction, microwave irradiation	>80% yield [33]	≤35 minutes reaction time [33]
API Precursors (e.g., pyrazolone, thiazole)	Not specified	Solvent with ultrasound	Room temperature, ultrasound irradiation	Up to 95% yield [33]	Accelerated room-temperature synthesis [33]
Iodoquinol, Clioquinol	1-butyl-3-methylpyridinium dichloroiodate ([C₄C₁py][DCI])	Solvent & iodinating agent	No oxidant, catalyst, or base needed	High yield (specific value not stated) [33]	Regenerated and reused up to 4 times [33]

The data illustrates that ILs can significantly improve synthetic efficiency. The multifunctional role of certain ILs, such as [C₄C₁py][DCI] acting as both solvent and reagent, simplifies processes by reducing the number of required components and enables recycling, contributing to more sustainable manufacturing [33].

Experimental Protocols

Protocol 1: Synthesis of Pravadoline in [C₄C₁im][PF₆]

This protocol demonstrates the use of an imidazolium-based IL as a solvent to achieve high-yield, rapid synthesis of a non-steroidal anti-inflammatory drug (NSAID), replacing traditional solvents like dimethylformamide (DMF) [33].

Materials:

• Ionic Liquid: 1-butyl-3-methylimidazolium hexafluorophosphate ([Câ‚„C₁im][PF₆])
• Reagents: Pravadoline precursor compounds, Potassium hydroxide (KOH)
• Equipment: Round-bottom flask, Heating mantle with temperature control, Inert atmosphere supply (Nâ‚‚ or Ar), Standard workup and isolation apparatus

Procedure:

• Reaction Setup: Charge a dry round-bottom flask with [Câ‚„C₁im][PF₆] (10 mL per 1 mmol of main reactant). Add the reactants to the IL.
• Base Addition: Add powdered KOH (1.2 equivalents) to the reaction mixture under an inert atmosphere.
• Heating and Reaction: Heat the mixture to 150°C with stirring for 2 minutes. Monitor reaction completion by TLC or HPLC.
• Work-up: After cooling, dilute the reaction mixture with water (20 mL). Extract the product into an organic solvent (e.g., ethyl acetate, 3 × 15 mL).
• Product Isolation: Combine the organic extracts, wash with brine, dry over anhydrous MgSOâ‚„, and concentrate under reduced pressure to obtain the crude pravadoline.
• Purification: Purify the crude product using recrystallization or column chromatography to achieve high purity.
• IL Recycling: The aqueous IL phase can be recovered, dried, and potentially reused for subsequent reactions.

Protocol 2: IL-Mediated Synthesis of Antiviral Nucleoside Analogs

This methodology highlights the application of ILs in the regioselective synthesis of nucleoside-based APIs like trifluridine, achieving high yields and minimizing side products [33].

Materials:

• Ionic Liquid: 1-methoxyethyl-3-methylimidazolium methanesulfonate ([(C₁OCâ‚‚)C₁im][MsO])
• Reagents: Nucleoside starting material, Acetic anhydride, 4-Dimethylaminopyridine (DMAP)
• Equipment: Round-bottom flask, Magnetic stirrer, Vacuum distillation or extraction setup

Procedure:

• Reaction Setup: Dissolve the nucleoside starting material (1.0 equivalent) in [(C₁OCâ‚‚)C₁im][MsO] (5-10 mL per mmol).
• Catalyst and Reagent Addition: Add DMAP (0.1 equivalents) and acetic anhydride (2.0 equivalents) to the solution.
• Acylation Reaction: Stir the reaction mixture at room temperature for 20-25 minutes.
• Reaction Monitoring: Monitor the reaction by TLC or HPLC until the starting material is consumed.
• Isolation and Purification: Upon completion, the product trifluridine often precipitates directly from the IL or can be extracted with a small volume of a mild organic solvent. The product is obtained in high purity (91%) without the need for further column chromatography.
• IL Recovery: The remaining IL can be recovered by removing any volatile components under vacuum and reused for up to four cycles with consistent performance.

Protocol 3: Nanoparticle-Catalyzed Hydrogenation in IL Media

This protocol combines the advantages of ILs with those of nanocatalysts for efficient and selective hydrogenation, a common step in API synthesis [35].

Materials:

• Ionic Liquid: Suitable imidazolium-based IL (e.g., [Câ‚„C₁im][BFâ‚„])
• Catalyst: Magnetic Fe(0) Nanoparticles (Fe NPs) or Palladium nanoparticles on cellulose nanocrystallite (CNC) supports [35].
• Reagents: Substrate (e.g., prochiral ketone, alkene), Hydrogen gas (Hâ‚‚)
• Equipment: Pressure reactor (e.g., Parr reactor), Gas supply system

Procedure:

• Catalyst Dispersion: Disperse the nanocatalyst (e.g., Pd@CNC, 0.5-2 mol%) in the chosen IL within the pressure reactor.
• Substrate Addition: Add the substrate to the IL-catalyst mixture.
• Hydrogenation: Seal the reactor, purge with Hâ‚‚, and pressurize with Hâ‚‚ to 4 bar. Stir the reaction at room temperature.
• Reaction Monitoring: Monitor the reaction by tracking Hâ‚‚ uptake or via GC/HPLC until hydrogenation is complete.
• Product Separation: After reaction, release the pressure. The product can often be separated by decantation or extraction, while the IL and valuable nanoparticle catalyst remain in the reactor for reuse.
• Catalyst/IL Reuse: The IL-nanocatalyst system can be recycled multiple times, as the IL stabilizes the nanoparticles and prevents leaching.

The Scientist's Toolkit: Essential Research Reagents and Materials

Successful implementation of IL-based API synthesis requires specific materials. The following table lists key reagent solutions and their functions.

Table 2: Essential Research Reagent Solutions for IL-Based API Synthesis

Reagent/Material	Function/Application Note
Imidazolium-Based ILs (e.g., [C₄C₁im][PF₆])	Versatile, stable solvents with low viscosity for a wide range of reactions, including C-C coupling and substitution reactions [33].
Functionalized ILs (e.g., [(C₁OC₂)C₁im][MsO])	ILs with tailored anions/cations can act as solvents and catalysts, particularly useful for acylations and regioselective synthesis [33].
Magnetic Nanocatalysts (e.g., Fe NPs)	Highly efficient, recoverable catalysts for hydrogenations; their magnetic nature allows easy separation from the IL and product mixture [35].
Supported Metal Catalysts (e.g., Pd on CNC)	Provide high activity and enantioselectivity in hydrogenations; the IL environment enhances stability and reusability [35].
Cholinium-Based ILs (Bio-ILs)	Biocompatible and less toxic ILs, ideal for synthesizing APIs where residual metal contamination is a concern [34].
Ultrasound and Microwave Reactors	Non-classical activation methods that synergize with ILs to dramatically reduce reaction times and improve yields [33].
(S)-Ru(OAc)2(H8-BINAP)	(S)-Ru(OAc)2(H8-BINAP), CAS:374067-51-3, MF:C48H48O4P2Ru+2, MW:851.9 g/mol
(S)-Ru(OAc)2(H8-BINAP)	(S)-Ru(OAc)2(H8-BINAP) | Chiral Catalyst

Workflow and Diagram

The following workflow diagrams illustrate the logical sequence for reaction selection and a specific experimental setup for IL-mediated synthesis.

Supercritical Fluid Extraction (SFE) has emerged as a cornerstone technology in the paradigm of green and sustainable extraction methodologies, particularly within research exploring ionic liquids and supercritical fluids as alternative solvents. This technique utilizes substances beyond their critical point, where they exhibit unique properties intermediate between gases and liquids, providing superior solvating power and penetration capabilities compared to conventional organic solvents [36]. The overarching purpose of SFE is the selective isolation and recovery of high-value bioactive compounds from various plant byproducts and natural matrices, yielding extracts with elevated purity and concentrated target compounds [37]. Positioned within the broader context of green solvent research, SFE, especially employing supercritical COâ‚‚, offers a compelling alternative to ionic liquids and deep eutectic solvents, which, despite their tunability and low vapor pressure, can face challenges related to hygroscopicity, toxicity, and regeneration difficulties [38]. This application note details the core principles, optimized workflows, and practical protocols for implementing SFE to obtain biologically active substances, providing researchers and drug development professionals with a framework for efficient and sustainable compound isolation.

Principles of Supercritical Fluid Extraction

The Supercritical State

A supercritical fluid is defined as a substance maintained at a temperature and pressure above its critical point, where distinct liquid and gas phases do not exist [39]. In this state, the fluid possesses unique properties that combine the desirable characteristics of both liquids and gases. It demonstrates liquid-like densities, granting it superior solvating power, coupled with gas-like viscosities and high diffusivities, which facilitate excellent penetration into solid matrices and enhance mass transfer rates [37] [39]. This combination allows for faster extraction times compared to traditional liquid solvents [36].

The critical point is a fundamental thermodynamic concept. For carbon dioxide (CO₂), the most prevalent solvent in SFE applications, the critical temperature is approximately 31°C and the critical pressure is around 73.8 bar (7.38 MPa) [39]. These relatively mild and easily attainable conditions are a key reason for CO₂'s widespread adoption.

Solvent Selection: Supercritical COâ‚‚ and Beyond

Supercritical COâ‚‚ (scCOâ‚‚) is the solvent of choice for most SFE applications targeting bioactive compounds due to several advantageous properties [37] [36] [39]:

• Non-toxic and Non-flammable: Recognized as safe for use in food, pharmaceutical, and cosmetic applications.
• Environmentally Benign: It is considered a green solvent as it leaves minimal to no solvent residue in the extract, minimizing environmental impact [36].
• Low Critical Parameters: Allows for extractions to be conducted at near-room temperatures, protecting heat-labile bioactive compounds from degradation [37].
• Selective Tuning: Its solvating power can be finely adjusted by manipulating pressure and temperature, enabling selective extraction [37].

While supercritical water is used in applications like waste oxidation and biomass gasification [36], its high critical point makes it less suitable for delicate bioactive compounds. The exploration of SFE fits into the broader research on alternative solvents, offering a complementary approach to ionic liquids and deep eutectic solvents, which may be better suited for specialized applications such as metal leaching from batteries [38].

Key Parameters and Optimization Strategies

The efficiency and selectivity of the SFE process are governed by several key parameters that researchers must optimize for any given raw material and target compound.

Table 1: Key Operational Parameters in Supercritical Fluid Extraction

Parameter	Effect on Extraction Process	Optimization Consideration
Temperature	Influences fluid density and solute vapor pressure. Higher temperature can decrease density but increase vapor pressure, having a complex effect on yield [36].	Must be balanced with pressure to target specific compounds without degrading heat-sensitive bioactives.
Pressure	Directly affects supercritical fluid density. Increasing pressure typically increases density and thus solvating power [36].	Higher pressures are used for heavier compounds (e.g., lipids), while lower pressures can selectively extract volatile compounds.
Co-solvent Use	Modifies the polarity of scCOâ‚‚, which is inherently non-polar. Enhances solubility and extraction yield of polar compounds [37].	Common co-solvents include ethanol, methanol, and water (typically 1-15%). Ethanol is preferred for food and pharmaceutical applications due to its safety profile [37].
Flow Rate	Affects the contact time between the solvent and the matrix, influencing mass transfer efficiency.	A higher flow rate may reduce extraction time but could lead to incomplete saturation of the fluid.
Particle Size	Smaller particles increase surface area, improving extraction kinetics.	Excessively fine particles can cause channeling and high pressure drop in the extraction vessel.

The Role of Co-solvents

The addition of co-solvents is a critical strategy for overcoming the primary limitation of scCOâ‚‚: its poor efficacy for polar molecules. Co-solvents like ethanol or methanol are introduced in small quantities to significantly enhance the solubility of polar bioactive compounds, such as certain polyphenols or water-soluble vitamins [37]. They operate by refining solvent potency and improving the solubilization of these target analytes [37]. Furthermore, the use of co-solvents can sometimes allow for a reduction in the overall process temperature and pressure, thereby improving efficiency and reducing operational costs [37]. However, the selection and concentration of co-solvents must be judiciously managed to avoid unwanted swelling of the plant material or alterations in the final extract composition [37].

Workflow and Experimental Protocol

A standard SFE protocol involves a sequence of critical steps, from sample preparation to the final collection of the extract. The schematic below outlines the core workflow and the logical decision points for parameter selection.

Detailed Step-by-Step Protocol

Application Note: This protocol is designed for the extraction of bioactive compounds from plant byproducts (e.g., pomace, seeds, skins) using a lab-scale SFE system. It can be adapted for other matrices with optimization.

Objective: To isolate a polyphenol-rich extract from grape pomace using supercritical COâ‚‚ with ethanol as a co-solvent.

Materials and Reagents: Table 2: Research Reagent Solutions and Essential Materials

Item	Function/Description	Notes
COâ‚‚ Supply (Food Grade)	Primary extraction solvent.	Sourced from a high-pressure cylinder with a dip tube.
Ethanol (Absolute, ACS Grade)	Co-solvent to modify polarity and enhance polyphenol yield.	Must be free of denaturants for pharmaceutical applications.
Raw Plant Material	The matrix containing target bioactives.	Grape pomace, dried and milled.
Extraction Vessel	High-pressure chamber to hold the sample.	Constructed from 316 stainless steel, with temperature control.
Co-solvent Pump	High-pressure pump to deliver a precise flow of co-solvent.	Must be compatible with the co-solvent used.
Back-Pressure Regulator	Controls system pressure, critical for maintaining supercritical state.	Located downstream of the extraction vessel.
Collection Vial	Glass vial for collecting the extracted material after separation.	Placed after the pressure reduction valve.

Pre-Extraction Procedures:

• Sample Preparation: The grape pomace should be air-dried or freeze-dried to a moisture content of <10%. Subsequently, mill the dried material and sieve it to achieve a homogeneous particle size range of 0.3-0.7 mm. This increases the surface area for efficient extraction while preventing excessive pressure drops and channeling within the vessel [37] [36].
• System Preparation: Ensure the SFE system is clean and leak-free. Pre-heat the extraction vessel and all connecting lines to the desired operating temperature. Purge the system with COâ‚‚ to remove air.

Extraction Protocol:

• Vessel Packing: Accurately weigh a known amount of the prepared grape pomace (e.g., 20-50 g). Pack the extraction vessel evenly to avoid channeling. For better efficiency, the vessel can be filled with an inert packing material like glass beads.
• System Pressurization: Initiate the flow of COâ‚‚ and gradually increase the pressure to the desired setpoint (e.g., 300 bar) using the back-pressure regulator. Simultaneously, stabilize the temperature in the extraction vessel (e.g., 50°C). Allow the system to equilibrate under these conditions for 15-20 minutes.
• Co-solvent Introduction: Start the co-solvent pump to introduce ethanol at a predetermined flow rate, typically 1-5% of the total COâ‚‚ mass flow rate.
• Dynamic Extraction: Open the valves to allow the supercritical COâ‚‚ and co-solvent mixture to pass through the extraction vessel at a controlled flow rate (e.g., 10-20 g/min). The extraction is performed in this dynamic mode for a predetermined time (e.g., 60-120 minutes), which can be determined by monitoring the cumulative yield.
• Separation and Collection: The solute-laden supercritical fluid then passes into a separation vessel maintained at a lower pressure (e.g., 50-80 bar) and often a lower temperature than the extraction vessel. This sharp reduction in solvating power causes the dissolved extract to precipitate and be collected in the collection vial. The COâ‚‚, now in a gaseous state, can be vented or recycled.

Post-Extraction Analysis: The collected extract should be stored in airtight, light-proof containers at low temperatures (e.g., -20°C) to preserve the integrity of the bioactive compounds. Analysis can include:

• Gravimetric Analysis: To determine total extraction yield.
• HPLC-DAD/MS: To identify and quantify specific bioactive compounds like polyphenols (e.g., anthocyanins, flavanols).
• GC-MS: For analysis of volatile compounds if applicable.

Advantages, Challenges, and Future Perspectives

Advantages Over Conventional Methods

SFE offers a multitude of advantages that align with the principles of green chemistry and modern industrial needs [37] [36]:

• Enhanced Selectivity & Purity: The solvating power of scCOâ‚‚ can be finely tuned, allowing for the selective isolation of target compounds and the production of high-purity, residue-free extracts.
• Protection of Thermolabile Compounds: The ability to operate at moderate temperatures (e.g., 31-60°C) is crucial for preserving the biological activity of heat-sensitive vitamins, antioxidants, and other bioactives.
• Environmental Sustainability: SFE eliminates the need for large quantities of hazardous organic solvents (e.g., hexane, methanol), making the process safer and more environmentally friendly. scCOâ‚‚ is non-toxic and can be sourced from industrial byproducts.
• Faster Extraction Kinetics: Due to the superior transport properties of supercritical fluids, SFE can be up to 25 times faster and use up to 30 times less solvent than conventional methods like Soxhlet extraction [36].

Practical Challenges and Limitations

Despite its benefits, SFE presents several challenges that researchers and engineers must address [37]:

• High Capital Investment: The initial cost for high-pressure vessels, pumps, and piping is significantly higher than for traditional extraction setups.
• Technical Complexity: Optimizing and scaling the SFE process requires a deep understanding of the interplay between pressure, temperature, co-solvents, and flow dynamics.
• Limited Efficacy for Polar Compounds: Without the use of co-solvents, the application of pure scCOâ‚‚ is largely restricted to non-polar and moderately polar compounds.
• Energy Intensity: Maintaining the system at high pressures is an energy-consuming process, which can impact operational costs.

Future Trends and Innovations

The field of SFE continues to evolve, with several promising research frontiers [36]:

• Nano and Micro-Particle Formation: SFE techniques are being leveraged for the controlled production of nano and micro-scale particles for drug delivery systems, allowing for precise control over particle size and distribution.
• Integration with Other Technologies: Coupling SFE with other processes, such as supercritical water oxidation for waste treatment or enzymatic reactions, presents opportunities for creating integrated biorefineries.
• Process Intensification: Ongoing research focuses on reducing energy consumption and improving extraction yields through better reactor design, real-time monitoring, and advanced process control strategies.

Aqueous solubility is a critical determinant of drug bioavailability, with more than 40% of newly discovered active pharmaceutical ingredients (APIs) facing development challenges due to poor aqueous solubility [40] [41]. The Biopharmaceutical Classification System (BCS) categorizes these problematic compounds primarily into Class II (low solubility, high permeability) and Class IV (low solubility, low permeability) drugs [41]. Overcoming this solubility barrier is essential for achieving sufficient oral bioavailability and therapeutic efficacy.

Ionic liquids (ILs) and supercritical fluids (SCFs), particularly supercritical carbon dioxide (scCO₂), have emerged as promising alternative solvents that address the limitations of conventional approaches [42] [43]. Recognized as green technologies, they offer unique physicochemical properties for particle engineering and solubility enhancement. ILs are non-volatile, thermally stable salts in liquid form below 100°C, whose properties can be finely tuned by selecting appropriate anion-cation combinations [42]. SCFs, which exist above their critical temperature and pressure, exhibit liquid-like densities and gas-like diffusivities and viscosities, providing exceptional solvation power and mass transfer capabilities [30] [44]. This application note details practical protocols and applications for using these technologies to improve drug solubility and bioavailability.

Supercritical Fluid Technology

Supercritical carbon dioxide (scCO₂), with its relatively low critical parameters (Tc = 31.1°C, Pc = 73.8 bar), has become the predominant SCF in pharmaceutical processing due to its non-toxicity, non-flammability, and ease of removal from the final product [30] [44]. The solubilization power of scCO₂ is highly dependent on temperature and pressure, allowing precise control over particle formation processes [43] [30]. The three primary SCF techniques for particle generation are:

• RESS (Rapid Expansion of Supercritical Solutions): Suitable for COâ‚‚-soluble compounds, this method achieves particle formation through rapid depressurization of the supercritical solution, causing supersaturation and nucleation [43].
• SAS (Supercritical Anti-Solvent): Effective for COâ‚‚-insoluble compounds, this technique involves introducing a drug solution into scCOâ‚‚, where the anti-solvent effect reduces solvent power, inducing precipitation [43].
• PGSS (Particles from Gas-Saturated Solutions): This method saturates a drug or drug-polymer melt with scCOâ‚‚ before depressurization, forming particles through the cooling effect of expanding gas [43].

Ionic Liquids and Their Hybrid Applications

Ionic liquids offer exceptional tunability, thermal stability, and non-volatility, making them ideal media for dissolving poorly soluble compounds [42]. Their combination with scCOâ‚‚ creates particularly powerful systems, as scCOâ‚‚ can efficiently extract organic solutes from ILs without cross-contamination due to the negligible solubility of ILs in the COâ‚‚ phase [28]. This enables integrated reaction-extraction processes where reactions occur in the IL medium, followed by product extraction using scCOâ‚‚ [42] [28].

Application Notes and Experimental Protocols

Protocol 1: RESS Process for Nanoparticle Generation

Objective: To produce nano-sized drug particles directly via Rapid Expansion of Supercritical Solutions for enhanced dissolution rate.

Materials:

• Supercritical fluid extraction unit equipped with high-pressure pump, thermostated extraction vessel, and nozzle assembly
• Carbon dioxide (high purity grade)
• Poorly water-soluble drug (e.g., Raloxifene, Cefuroxime Axetil)
• Expansion chamber with collection system

Procedure:

• System Preparation: Ensure all components of the RESS system are clean and pressure-tested. Set the temperature of the extraction vessel using the thermostat [43].
• Drug Loading: Place the drug substance (e.g., 250-500 mg) in the high-pressure extraction vessel [43].
• Pressurization: Pressurize the system with COâ‚‚ to the desired operating pressure (typically 120-270 bar) using the high-pressure pump [43] [30].
• Equilibration: Maintain the system at target temperature (308-338 K) and pressure for sufficient time (typically 45-90 minutes) to achieve saturation equilibrium and ensure complete dissolution of the drug in scCOâ‚‚ [43] [30].
• Rapid Expansion: Rapidly expand the supercritical solution through a heated nozzle (capillary or orifice) into a low-pressure expansion chamber. Maintain nozzle temperature 20-30°C above the extraction temperature to prevent clogging [43].
• Particle Collection: Collect the precipitated particles on a suitable filter placed in the expansion chamber.
• Analysis: Characterize the collected particles for size distribution (dynamic light scattering), morphology (SEM), crystallinity (PXRD), and dissolution profile [43] [45].

Critical Parameters:

• Pre-expansion pressure and temperature significantly influence particle size and morphology
• Nozzle design (diameter, length) and geometry critically affect expansion dynamics
• Spray distance and collection chamber conditions impact particle aggregation [43]

Table 1: RESS Processing Parameters and Results for Selected Drugs

Drug	Pressure (bar)	Temperature (°C)	Initial Particle Size	Final Particle Size	Dissolution Improvement
Raloxifene	170-180	50	45 μm	19 nm	7-fold increase [43]
Cefuroxime Axetil	150-200	40-60	Conventional form	158-513 nm	>90% in 3 min vs. 50% in 60 min for commercial [43]
Diclofenac	120-200	40-60	Irregular crystals	1.33-10.92 μm	Quasi-spherical morphology, enhanced dissolution [43]
Ibuprofen	100-200	40-60	Racemic mixture	Micronized	Higher intrinsic dissolution rate [43]

Protocol 2: Supercritical Anti-Solvent (SAS) Process

Objective: To produce micro- and nanoparticles of drugs with low solubility in scCOâ‚‚ using the anti-solvent principle.

Materials:

• SAS apparatus with co-axial nozzle, precipitation vessel, and solution pump
• Carbon dioxide (high purity grade)
• Drug substance
• Organic solvent (e.g., dimethyl sulfoxide, ethanol, acetone)
• Polymer for composite particles (if required, e.g., PLGA, PVP)

Procedure:

• Vessel Preparation: Clean and dry the precipitation vessel. Set the temperature to the desired operating condition (typically 308-348 K) [43].
• Pressure Stabilization: Pressurize the precipitation vessel with scCOâ‚‚ to the desired operating pressure (typically 120-270 bar) and maintain constant flow using a high-pressure pump [43] [30].
• Solution Preparation: Dissolve the drug (with or without polymer) in an appropriate organic solvent to form a homogeneous solution (typical concentration: 1-5% w/v) [43].
• Solution Injection: Inject the drug solution through the co-axial nozzle into the continuous scCOâ‚‚ phase at a controlled flow rate (typically 0.5-2 mL/min) [43].
• Anti-Solvent Precipitation: Maintain scCOâ‚‚ flow to extract the organic solvent, leading to super-saturation and particle precipitation.
• Washing: Continue scCOâ‚‚ flow for an additional 30-60 minutes to remove residual solvent from the precipitated particles.
• Depressurization: Slowly depressurize the system and collect the dry, free-flowing powder [43].

Critical Parameters:

• Solvent selection based on drug solubility and miscibility with scCOâ‚‚
• Solution flow rate and injection configuration affect droplet formation and particle size
• Drug concentration in feed solution influences particle size and morphology [43] [45]

Protocol 3: Supercritical Fluid Extraction of Emulsions (SFEE)

Objective: To produce aqueous nanosuspensions of poorly soluble drugs by extracting the internal phase of oil-in-water emulsions using scCOâ‚‚.

Materials:

• High-pressure vessel with stirring capability
• Carbon dioxide (high purity grade)
• Drug substance
• Organic solvent (dichloromethane, ethyl acetate)
• Aqueous phase with stabilizer (e.g., phospholipids, polymers)
• High-pressure homogenizer or ultrasonicator

Procedure:

• Organic Phase Preparation: Dissolve the drug in a suitable water-immiscible organic solvent (typical concentration: 10-100 mg/mL) [45].
• Aqueous Phase Preparation: Prepare an aqueous solution containing an appropriate stabilizer (e.g., 0.5-2% w/v phospholipid or surfactant) [45].
• Emulsion Formation: Create an oil-in-water emulsion by adding the organic phase to the aqueous phase under high-shear mixing (homogenization or ultrasonication) [45].
• High-Pressure Loading: Transfer the emulsion to the high-pressure extraction vessel.
• SC-COâ‚‚ Extraction: Pressurize the system with scCOâ‚‚ and maintain with agitation for 1-2 hours to extract the organic solvent from the emulsion droplets into the scCOâ‚‚ phase [45].
• Depressurization and Collection: Slowly depressurize the system and collect the aqueous nanosuspension.
• Characterization: Analyze particle size (DLS), residual solvent (GC), crystallinity (PXRD), and dissolution profile [45].

Critical Parameters:

• Emulsion droplet size directly determines final particle size
• Emulsion stability during extraction is crucial for process reliability
• Selection of organic solvent based on drug solubility and extractability by scCOâ‚‚ [45]

Table 2: SFEE Results for Model Compounds

Drug	Stabilizer System	Mean Particle Size (nm)	Residual Solvent	Dissolution Enhancement
Cholesterol Acetate	Phospholipids	100-1000	<100 ppm	Significant increase in dissolution rate [45]
Griseofulvin	Surfactant blend	200-800	<100 ppm	5-10 fold increase vs. micronized powder [45]
Megestrol Acetate	Polymer stabilizer	300-900	<100 ppm	5-10 fold increase vs. micronized powder [45]

Protocol 4: Ionic Liquid-ScCOâ‚‚ Integrated System

Objective: To utilize ionic liquids as reaction/dissolution media with subsequent extraction and particle formation using scCOâ‚‚.

Materials:

• High-pressure reaction vessel with stirring capability
• Carbon dioxide (high purity grade)
• Drug substance
• Appropriate ionic liquid (e.g., imidazolium-based)
• scCOâ‚‚ extraction system

Procedure:

• Drug Dissolution: Dissolve the poorly soluble drug in a selected ionic liquid (typical concentration: 1-10% w/w) at elevated temperature if necessary [42] [28].
• Reaction (Optional): Perform any desired chemical or enzymatic modification of the drug in the IL medium [42].
• System Loading: Transfer the drug-IL solution to the high-pressure vessel.
• scCOâ‚‚ Extraction: Pressurize the system with scCOâ‚‚ and maintain with agitation. scCOâ‚‚ will preferentially extract the drug from the IL phase without significant IL contamination [42] [28].
• Particle Formation: As the drug-saturated scCOâ‚‚ solution is expanded through a restriction device, particles form in the collection chamber.
• Separation: Separate the precipitated drug particles from the COâ‚‚ stream.
• IL Reuse: The IL remains in the vessel and can be reused for subsequent batches [42].

Critical Parameters:

• Selection of IL based on drug solubility and selectivity
• scCOâ‚‚ density adjustment for optimal extraction efficiency
• Pressure and temperature optimization for particle formation [42] [28]

Workflow Visualization

SCF-IL Drug Processing Workflow

Solubility Modeling and Data Analysis

Accurate solubility prediction is essential for efficient process design. Recent advances combine traditional thermodynamic models with machine learning approaches for improved accuracy.

Experimental Solubility Measurement Protocol

Objective: To determine drug solubility in scCOâ‚‚ under various temperature and pressure conditions.

Materials:

• Static equilibrium apparatus with sapphire window cell
• UV-Vis spectrophotometer
• High-pressure COâ‚‚ delivery system
• Temperature-controlled oven
• Collection vials with dimethyl sulfoxide (DMSO)

Procedure:

• System Preparation: Place the drug (approximately 1 g) in the equilibrium cell equipped with sintered steel filters at both ends [30].
• Equilibration: Place the cell in a temperature-controlled oven (± 0.1 K) and pressurize with COâ‚‚ to the target pressure (± 0.1 MPa). Maintain for 60 minutes to reach equilibrium [30].
• Sampling: After equilibrium, accumulate 600 μL of saturated scCOâ‚‚ in a sampling loop and release into a vial containing DMSO [30].
• Analysis: Measure drug concentration in DMSO using UV-Vis spectrophotometry at the predetermined λmax (e.g., 266 nm for 5-fluorouracil) [30].
• Calculation: Determine solubility using the formula: [ S{drug} = \frac{C{drug} \cdot V{collection}}{V{CO2}} ] where (C{drug}) is concentration in g/L, (V{collection}) is collection vial volume, and (V{CO_2}) is COâ‚‚ volume [30].

Modeling Approaches

Density-Based Models:

• Chrastil Model: (c2 = (\rho1)^\kappa \exp\left(A1 + \frac{A2}{T}\right))
• Méndez-Santiago-Teja (MT) Model: (T \ln(y2 P) = B1 + B2 \rho1 + B_3 T) [30]

Machine Learning Approaches: Recent studies have employed artificial intelligence models including:

• Adaptive Neuro-Fuzzy Inference System (ANFIS)
• Gene Expression Programming (GEP)
• Random Forest, Gradient Boosting, Decision Tree, and Kernel Ridge methods [44]

Table 3: Machine Learning Model Performance for Solubility Prediction

Model Type	Database Size	Input Parameters	R² (Training)	R² (Validation)	AARD%
ANFIS	1816 datasets	T, P, MW~SDs~, MP~SDs~	0.991	0.990	13.89-15.27% [44]
GEP	1816 datasets	T, P, MW~SDs~, MP~SDs~	Lower than ANFIS	Lower than ANFIS	Higher than ANFIS [44]
Sodeifian Model 2	7 density-based models	T, P, ρ	-	-	4.12% (for 5-FU) [30]
PR EoS (vdW2)	Experimental data	T, P, component properties	Varies by drug	Varies by drug	14-23% (for aspirin) [44]

The Researcher's Toolkit: Essential Materials

Table 4: Key Research Reagent Solutions for SCF and IL Technologies

Reagent/Material	Function/Application	Examples/Specifications
Supercritical CO₂	Primary processing fluid	High purity grade (>99.9%), critical parameters: T~c~=31.1°C, P~c~=73.8 bar [43] [30]
Imidazolium-based ILs	Versatile polar solvents for drug dissolution	1-butyl-3-methylimidazolium hexafluorophosphate ([BMIM][PF₆]), tunable properties [42]
Biocompatible Polymers	Particle engineering and stabilization	PLGA, PVP, Poloxamers, PEG [43] [41]
Stabilizers/Surfactants	Emulsion stabilization and particle coating	Phospholipids, Polysorbates, HPMC [45]
Co-solvents	Modifying solvent power of SC-COâ‚‚	Ethanol, methanol, DMSO (1-10% modifier) [30] [41]
Cyclodextrins	Complexation agents for solubility enhancement	β-cyclodextrin, hydroxypropyl-β-cyclodextrin [41]
2-(Allyloxy)aniline	2-(Allyloxy)aniline | High Purity | For Research Use	2-(Allyloxy)aniline: A versatile aniline derivative for organic synthesis & material science research. For Research Use Only. Not for human or veterinary use.
Biefm	Biefm | Research Compound | Supplier	High-purity Biefm for research applications. Explore its unique biochemical properties. For Research Use Only. Not for human or veterinary use.

Ionic liquids and supercritical fluids represent powerful complementary technologies for addressing the critical challenge of poor drug solubility. The protocols outlined in this application note provide researchers with practical methodologies for implementing these approaches, from basic solubility measurement to advanced particle engineering techniques. The integration of machine learning with traditional thermodynamic modeling further enhances our ability to predict and optimize processes, potentially reducing experimental overhead. As these technologies continue to evolve, their combination offers particularly promising avenues for developing efficient, sustainable pharmaceutical processing methods that can significantly improve drug bioavailability and therapeutic efficacy.

The development of advanced drug delivery systems is increasingly leveraging alternative solvents to overcome the limitations of conventional pharmaceutical manufacturing. Among the most promising are Ionic Liquids (ILs) and Supercritical Fluids (SCFs), both recognized as environmentally benign solvents with unique properties that enable enhanced drug delivery capabilities [28]. ILs are organic salts typically composed of asymmetric organic cations and organic or inorganic anions with melting points below 100°C, offering non-volatility, tunable physicochemical properties, and excellent solvation capabilities [46] [47]. SCFs, particularly supercritical carbon dioxide (SC-CO₂), exist at temperatures and pressures above their critical point, exhibiting hybrid properties of gases and liquids—including low viscosity, high diffusivity, and liquid-like density [48] [49]. Their complementary characteristics make them exceptionally valuable for pharmaceutical formulation, with ILs providing enhanced drug solubility and permeability, while SCFs enable precise particle engineering and solvent-free processing [28] [48]. This integration aligns with green chemistry principles, reducing reliance on volatile organic solvents and enabling more sustainable pharmaceutical development [50].

Ionic Liquids in Drug Formulations

Design and Properties of Pharmaceutical Ionic Liquids

Ionic liquids represent a versatile platform for drug formulation due to their highly tunable nature. By selecting appropriate cation-anion combinations, researchers can precisely engineer ILs with specific properties tailored to pharmaceutical applications. ILs are categorized into three generations based on their development timeline and properties: the first generation focused on unique physical properties but exhibited toxicity; the second generation offered tunable physical and chemical properties with stability in water and air; while the third generation emphasizes biocompatibility, reduced toxicity, and enhanced biodegradability using natural sources such as choline cations and amino acid or fatty acid anions [47] [34]. Their key physicochemical properties—including density, viscosity, melting point, and polarity—can be optimized through structural modifications of their constituent ions [34]. This tunability enables formulators to address multiple drug delivery challenges simultaneously, including poor solubility, low permeability, and chemical instability.

Table 1: Generations of Ionic Liquids in Pharmaceutical Applications

Generation	Key Characteristics	Common Components	Pharmaceutical Applications
First	High thermal stability, low melting points, but limited biodegradability and high aquatic toxicity	Dialkyl imidazolium, alkylpyridinium cations with metal halide anions	Limited due to toxicity concerns
Second	Customizable physical/chemical properties, stable in water and air	Dialkyl imidazolium, alkylpyridinium, ammonium, phosphonium cations with BF₄⁻, PF₆⁻ anions	Catalysis, separations, electrochemical processes
Third	Reduced toxicity, enhanced biodegradability, biocompatible	Choline, amino acid-based cations; amino acids, fatty acids as anions	Transdermal drug delivery, bioavailability enhancement, biomedicine

Mechanisms for Enhanced Drug Delivery

Ionic liquids improve drug delivery through multiple mechanisms that enhance drug permeation across biological barriers. In transdermal drug delivery, ILs facilitate transport through the skin's stratum corneum via several coordinated actions: lipid fluidization (increasing lipid matrix fluidity), lipid extraction (creating transient pores or pathways for drug diffusion), and disruption of keratin in the stratum corneum to reduce barrier function [46] [34]. These mechanisms enable improved delivery of both small molecules and macromolecular drugs, including peptides and proteins [46]. The specific mechanism predominating depends on the IL structure and the drug properties, with some ILs acting primarily through structural disruption of the skin's lipid matrix while others enhance drug partitioning or modify drug physicochemical characteristics [46].

Application Notes: Ionic Liquids for Transdermal Delivery

Protocol 1: Development of IL-Based Formulations for Enhanced Skin Permeation

Objective: To formulate an ionic liquid-based transdermal delivery system for improved skin permeation of poorly soluble active pharmaceutical ingredients (APIs).

Materials:

• Cation precursors: Choline chloride, amino acid derivatives (e.g., L-proline)
• Anion precursors: Fatty acids (e.g., geranic acid, octanoic acid), pharmaceutical acids (e.g., ibuprofen)
• Model drugs: Anti-inflammatory drugs (e.g., ketoprofen, ibuprofen), anticancer drugs (e.g., navitoclax)
• Equipment: Magnetic stirrer with heating, rotary evaporator, pH meter, Franz diffusion cells, analytical HPLC system

Procedure:

• Synthesis of ILs:
  • For stoichiometric synthesis, combine equimolar amounts of cation and anion precursors in deionized water.
  • Stir the reaction mixture at 40-60°C for 24-48 hours until a clear solution forms.
  • Remove water under reduced pressure using a rotary evaporator.
  • Dry the resulting IL under vacuum for 24 hours to remove residual moisture.
  • Confirm IL formation through NMR spectroscopy and FTIR analysis.

• Formulation Preparation:

  • For API-IL formation: Directly combine ionizable drugs with appropriate counter-ions using the above method.
  • For IL as permeation enhancer: Dissolve the API in the IL with gentle heating if necessary.
  • For emulsion systems: Incorporate IL-API complex into oil/water systems using biocompatible surfactants.

• Characterization and Evaluation:

  • Assess solubility enhancement through saturation shake-flask method.
  • Evaluate in vitro permeation using Franz diffusion cells with excised human or porcine skin.
  • Analyze skin retention by extracting drugs from different skin layers after permeation studies.
  • Determine cytotoxicity using MTT assay on human keratinocyte cell lines (HaCaT).

Key Applications:

• Choline geranate (CAGE) for dextran and peptide delivery: Induces lipid extraction, replacing skin lipids with ILs and water to facilitate faster diffusion [46].
• Proline ethylester-based ILs for ibuprofen delivery: Forms neutral species that facilitate transport across the hydrophobic stratum corneum [46].
• Choline octanoate (COA) for navitoclax delivery: Enhances skin penetration and prolongs drug retention in deeper skin layers [46].

Supercritical Fluid Technology in Drug Formulations

Principles and Processing Techniques

Supercritical fluid technology utilizes substances at temperatures and pressures above their critical point, where they exhibit unique properties intermediate between gases and liquids. Supercritical carbon dioxide (SC-CO₂) is the most widely used SCF in pharmaceutical applications due to its mild critical parameters (31.1°C, 74 bar), non-toxicity, non-flammability, and environmental acceptability [48] [49]. The physical properties of SCFs, including density, viscosity, and diffusivity, can be precisely controlled by adjusting temperature and pressure conditions, enabling fine-tuning of solvating power and processing characteristics [48]. This controllability makes SCFs particularly valuable for pharmaceutical processing of heat-sensitive compounds, as the technology operates at relatively low temperatures and eliminates organic solvent residues.

Table 2: Supercritical Fluid Processing Techniques for Drug Formulation

Technique	Principle	Advantages	Applications
RESS (Rapid Expansion of Supercritical Solutions)	Solute dissolved in SCF is rapidly depressurized through a nozzle, causing precipitation due to reduced solubility	Single-step process, no organic solvents, uniform particle size distribution	Micronization of pure APIs, particle size reduction
SAS/GAS (Supercritical/Gas Antisolvent)	SCF acts as antisolvent to solute dissolved in organic solvent, creating supersaturation and precipitation	Handles polar compounds, reduces solvent residues, controls crystal form	Nanoparticle formation, preparation of polymer-based composites
PGSS (Precipitation from Gas Saturated Solutions)	SCF dissolved in liquid solution is rapidly expanded, causing solvent vaporization and solute precipitation	Effective for polymers and heat-sensitive materials, low operating pressures	Co-precipitation of APIs with carriers, composite particle formation

Mechanisms for Enhanced Drug Delivery

Supercritical fluid technology enhances drug delivery primarily through particle engineering approaches that improve drug bioavailability and performance. The rapid expansion processes in SCF technology generate extremely high supersaturation ratios (typically 10⁵ to 10⁸), resulting in rapid nucleation rates that produce small particles with narrow size distributions [48]. This controlled particle formation enables enhanced dissolution rates for poorly water-soluble drugs by increasing surface area and creating optimized crystal morphologies [49]. Additionally, SCF processes can produce amorphous solid dispersions, further enhancing solubility, and can encapsulate drugs within polymeric carriers for controlled release applications [48] [49]. The technology also facilitates the formation of nanoparticles that leverage the enhanced permeability and retention (EPR) effect for targeted drug delivery to tumor tissues [49].

Application Notes: SCF Technology for Particle Engineering

Protocol 2: Supercritical Antisolvent (SAS) Processing for Drug Nanoparticle Formation

Objective: To produce drug nanoparticles with enhanced dissolution characteristics using supercritical COâ‚‚ as an antisolvent.

Materials:

• Supercritical fluid: Carbon dioxide (high purity grade)
• Drug compounds: Poorly water-soluble APIs (e.g., anticancer agents, antibiotics)
• Organic solvents: Methanol, ethanol, acetone, dimethyl sulfoxide (HPLC grade)
• Equipment: SAS apparatus comprising COâ‚‚ supply, syringe pump, precipitation vessel, co-solvent pump, temperature control system, back-pressure regulator

Procedure:

• Solution Preparation:
  • Dissolve the drug substance in an appropriate organic solvent (typically 1-5% w/v concentration).
  • Filter the solution through a 0.45 μm membrane to remove undissolved particles.

• SAS Apparatus Setup:

  • Pre-heat the precipitation vessel to the desired temperature (typically 35-60°C).
  • Pressurize the vessel with SC-COâ‚‚ to the target pressure (typically 80-150 bar) using the syringe pump.
  • Maintain constant temperature and pressure throughout the process.

• Precipitation Process:

  • Pump the drug solution through a nozzle into the precipitation vessel at a controlled flow rate (typically 0.5-2 mL/min).
  • Simultaneously pump SC-COâ‚‚ into the vessel at a constant flow rate.
  • Allow the antisolvent process to continue for 30-60 minutes to ensure complete precipitation and solvent removal.

• Particle Collection:

  • Slowly depressurize the vessel at a controlled rate (approximately 1-5 bar/min).
  • Collect the precipitated particles from the vessel filter.
  • Further dry the particles under vacuum to remove trace solvent residues.

• Characterization:

  • Analyze particle size and morphology by scanning electron microscopy (SEM).
  • Determine crystal form by X-ray diffraction (XRD).
  • Assess dissolution rate using USP apparatus in relevant dissolution media.

Key Applications:

• SHIFT (Superstable Homogeneous Intermix Formulating Technology): Enhances dispersion of hydrophilic molecules (e.g., indocyanine green) in hydrophobic oil phases for improved stability and performance in embolization therapy [49].
• Drug micronization: Production of nanoparticles with improved solubility and bioavailability for various active compounds, including chemotherapeutic agents and antibiotics [49].
• Polymer-based drug delivery systems: Fabrication of microparticles, nanoparticles, solid lipid nanoparticles, and liposomes for controlled release applications [48].

Integrated Experimental Protocols

Combined IL-SCF Approach for Reaction and Separation

Protocol 3: Integrated Reaction and Extraction System Using ILs and SC-COâ‚‚

Objective: To develop a continuous process where chemical reactions are carried out in ionic liquids with subsequent product extraction using supercritical COâ‚‚.

Materials:

• Ionic liquid reaction medium: Imidazolium or cholinium-based ILs appropriate for the specific catalytic reaction
• Supercritical fluid: Carbon dioxide (high purity grade)
• Reaction substrates and catalysts: Specific to the target chemical transformation
• Equipment: High-pressure reaction vessel, SC-COâ‚‚ supply, pumps, back-pressure regulator, collection vessel, temperature control system

Procedure:

• Reaction Setup:
  • Charge the ionic liquid and reaction substrates into the high-pressure reaction vessel.
  • Initiate the reaction under appropriate conditions (temperature, stirring, time).

• Integrated Extraction:

  • After reaction completion, pressurize the vessel with SC-COâ‚‚ to desired pressure (typically 100-200 bar).
  • Maintain temperature above the critical point of COâ‚‚ (≥31.1°C).
  • Allow SC-COâ‚‚ to circulate through the IL phase for a predetermined time to extract reaction products.

• Separation and Collection:

  • Pass the SC-COâ‚‚ stream containing dissolved products through a back-pressure regulator into a collection vessel.
  • Depressurize to separate products from COâ‚‚.
  • Recycle the ionic liquid for subsequent reaction cycles.

• Analysis:

  • Quantify extraction efficiency by analyzing residual products in the IL phase.
  • Assess IL integrity and potential for reuse through spectroscopic methods.
  • Determine product purity and compare with conventional separation methods.

Applications:

• Catalytic reactions in ILs with clean product separation [28]
• Extraction of organic solutes from IL media without IL contamination [28]
• Multifunctional use of SC-COâ‚‚ as extraction medium, transport medium, and miscibility controller [28]

Analytical and Characterization Methods

Protocol 4: Characterization of Formulations Using ILs and SCFs

Objective: To comprehensively characterize the physicochemical properties and performance of drug formulations developed using ionic liquids and supercritical fluid technology.

Materials:

• Test formulations: IL-based drug formulations or SCF-processed particles
• Reference standards: Pure drug substances, conventional formulations
• Equipment: HPLC system, Franz diffusion cells, scanning electron microscope, X-ray diffractometer, differential scanning calorimeter, FTIR spectrometer

Procedure:

• Particle Characterization (for SCF-processed materials):
  • Size and morphology: Analyze by SEM with image analysis software.
  • Crystal form: Determine by XRD and DSC.
  • Surface area: Measure by BET nitrogen adsorption.

• Solubility and Dissolution Assessment:

  • Equilibrium solubility: Determine using shake-flask method in relevant media.
  • Dissolution rate: Perform using USP apparatus with sink or non-sink conditions.

• Permeation Studies (for IL formulations):

  • Use Franz diffusion cells with excised skin or synthetic membranes.
  • Analyze permeation samples by HPLC at predetermined time points.
  • Calculate flux, permeability coefficients, and enhancement ratios.

• Stability Evaluation:

  • Conduct accelerated stability studies under ICH guidelines.
  • Monitor physical and chemical stability over time.

The Scientist's Toolkit: Essential Research Reagents and Materials

Table 3: Key Research Reagent Solutions for IL and SCF Formulation Development

Reagent/Material	Function/Application	Examples/Specific Types
Ionic Liquid Components
Choline derivatives	Biocompatible cations for third-generation ILs	Choline chloride, choline bicarbonate
Amino acid-based ions	Biocompatible anions/cations for pharmaceutical ILs	L-proline, glycine, alanine derivatives
Fatty acid anions	Hydrophobic components for permeability enhancement	Geranic acid, octanoic acid, oleic acid
Supercritical Fluids
Carbon dioxide (SC-COâ‚‚)	Primary supercritical solvent for particle engineering	High-purity grade COâ‚‚ (99.99%)
Co-solvents	Modifiers for enhanced solubility in SCF processes	Ethanol, methanol (HPLC grade)
Pharmaceutical Carriers
Biodegradable polymers	Matrix materials for controlled release systems	PLGA, PLA, PCL
Lipid carriers	Vehicles for enhanced drug encapsulation	Glyceryl tripalmitate, Compritol 888 ATO
Analytical Tools
HPLC/UPLC systems	Quantitative analysis of drugs and permeation studies	Reverse-phase C18 columns
Franz diffusion cells	In vitro permeation assessment	Standard 9mm orifice, with temperature control
1-Methyl-1H-indole-3,5,6-triol	1-Methyl-1H-indole-3,5,6-triol|Adrenolutin|CAS 642-75-1	1-Methyl-1H-indole-3,5,6-triol (Adrenolutin), CAS 642-75-1. A high-purity hydroxylated indole for research use only (RUO). Not for human or veterinary use.
1-Methylphysostigmine	1-Methylphysostigmine | Acetylcholinesterase Inhibitor	1-Methylphysostigmine is a cholinesterase inhibitor for neurological research. For Research Use Only. Not for human or veterinary use.

Workflow and Pathway Visualization

Technology Selection Workflow for Advanced Formulations

This workflow illustrates the strategic decision-making process for implementing IL and SCF technologies in advanced drug formulation development. Researchers can select the appropriate technology platform based on specific formulation challenges, with potential for integration of both approaches for synergistic effects. The IL pathway focuses on molecular-level solutions to permeability barriers, while the SCF pathway addresses particle-level challenges for solubility enhancement, with combined approaches offering comprehensive solutions for complex delivery challenges.

Mechanisms of IL and SCF Technologies in Drug Delivery

This diagram illustrates the complementary mechanisms through which ionic liquids and supercritical fluids enhance drug delivery. ILs primarily target biological barriers through molecular interactions with membrane components, while SCFs focus on physical particle properties to improve solubility and dissolution. Understanding these distinct yet complementary mechanisms enables researchers to select appropriate technologies based on specific drug delivery challenges.

Combined IL/SCF Systems for Integrated Reaction and Separation Processes

Combined Ionic Liquid (IL) and Supercritical Fluid (SCF) systems represent a groundbreaking approach in green chemical processing, offering unique advantages for integrated reaction and separation. These systems leverage the non-volatility and tunability of ionic liquids with the high diffusivity and low environmental impact of supercritical COâ‚‚ (scCOâ‚‚) to create multifunctional processes. This is particularly transformative for equilibrium-limited reactions and pharmaceutical synthesis, where they can significantly increase yields, reduce energy consumption, and minimize the use of hazardous organic solvents [51] [42]. This document provides a detailed overview of the underlying principles, key applications, and specific experimental protocols for utilizing these systems, with a focus on pharmaceutical and chemical production.

Fundamental Principles of IL/SCF Systems

Ionic Liquids (ILs): Tunable Green Solvents

Ionic liquids are salts that exist in a liquid state at or near room temperature. They are composed entirely of ions and possess a unique set of properties making them ideal for combined processes.

• Structure and Tunability: The physical and chemical properties of ILs (e.g., polarity, hydrophobicity, melting point) are determined by the mutual fit of the cation and anion. Common cations include imidazolium, pyridinium, phosphonium, and ammonium. By varying the anion-cation combination, ILs can be designed for specific tasks, creating "task-specific ionic liquids" [51] [42].
• Key Properties: ILs exhibit negligible vapor pressure, non-flammability, high thermal stability, and excellent solubility for a wide range of materials, including polar and non-polar compounds, gases, and catalysts [42].
• Green Credentials: As non-volatile solvents, ILs can drastically reduce the emission of volatile organic compounds (VOCs) compared to traditional organic solvents, aligning with the principles of green chemistry [51].

Supercritical COâ‚‚ (scCOâ‚‚): An Efficient Processing Medium

Supercritical CO₂ is CO₂ held above its critical temperature (31.1 °C) and critical pressure (73.8 bar), where it exhibits properties between a gas and a liquid.

• Solvation and Transport Properties: scCOâ‚‚ has gas-like high diffusivity and low viscosity, coupled with liquid-like density and solvating power. This allows for rapid mass transfer and efficient penetration into porous materials and viscous media [52].
• Environmental and Safety Benefits: scCOâ‚‚ is non-toxic, non-flammable, relatively inexpensive, and readily available. It is considered a green alternative to harmful organic solvents [51] [52].
• Tunable Solvency: The solvating power of scCOâ‚‚ is highly dependent on pressure and temperature, allowing for precise control over dissolution and precipitation processes [52].

Synergistic Coupling of ILs and scCOâ‚‚

The combination of ILs and scCOâ‚‚ creates a highly versatile and efficient biphasic system with distinct phases that are easily separable.

• Complementary Phases: The system forms an IL-rich phase and a scCOâ‚‚-rich phase. A key characteristic is that COâ‚‚ is highly soluble in most ILs, while ILs have negligible solubility in the scCOâ‚‚ phase [51] [42]. This prevents cross-contamination.
• The "Magic" of the Combination:
  • Reaction Medium: The IL phase can act as a solvent for catalysts, reagents, and reactants, facilitating the reaction.
  • Separation and Product Recovery: scCOâ‚‚ can be used to extract reaction products from the IL phase with high purity, leaving the IL and catalyst behind for reuse [42].
  • Process Intensification: This integration allows reaction and separation to occur in a single, intensified unit operation, simplifying process flow and reducing capital costs [53] [54].

Key Applications and Experimental Protocols

Application Note 1: Metal Ion Extraction

This protocol outlines the use of IL/scCOâ‚‚ systems for the extraction of metal ions, a process relevant to environmental remediation and resource recovery.

Detailed Protocol:

• Synthesis of Task-Specific IL (TSIL): Functionalize an imidazolium cation (e.g., 1-butyl-3-methylimidazolium, [BMIM]) with a chelating group (e.g., thiourea, thioether) to create a TSIL that selectively binds to target metal ions. Purify the TSIL via repeated washing and drying under vacuum [42].
• Saturation with Analyte: Dissolve the target metal salt (e.g., HgClâ‚‚, CdClâ‚‚) in an aqueous solution. Mix the aqueous solution with the synthesized TSIL in a ratio of 1:10 (v/v) and stir vigorously for 2 hours at room temperature to allow for complexation. Allow the mixture to settle and separate the IL phase, now loaded with the metal complex.
• scCOâ‚‚ Extraction Setup:
  • Vessel: Use a high-pressure vessel with a visible window (e.g., 50 mL capacity).
  • Procedure: Place the metal-loaded TSIL into the vessel. Pressurize the system with COâ‚‚ to the desired pressure (e.g., 150 bar) and heat to the target temperature (e.g., 40 °C) using a circulating water bath.
  • Dynamic Extraction: Maintain the system at constant temperature and pressure while allowing scCOâ‚‚ to flow through the vessel continuously for a set period (e.g., 60 minutes) at a flow rate of 1-2 mL/min (liquid COâ‚‚).
• Analyte Collection and Analysis:
  • Collection: The scCOâ‚‚ stream, containing the extracted analyte, is passed through a restrictor valve into a collection vial containing a suitable solvent (e.g., methanol). The pressure drop causes the COâ‚‚ to gasify, depositing the extracted material.
  • Analysis: Analyze the collected solute using inductively coupled plasma mass spectrometry (ICP-MS) or atomic absorption spectroscopy (AAS) to determine extraction efficiency. The remaining IL can be analyzed to confirm metal removal.

Key Parameters Table: Table 1: Key parameters and their effects on metal ion extraction efficiency.

Parameter	Typical Range	Effect on Process
Pressure	100 - 250 bar	Higher pressure increases COâ‚‚ density and solvating power, enhancing extraction.
Temperature	40 - 60 °C	Complex effect; can increase solute vapor pressure but decrease CO₂ density.
TSIL Structure	Varies with cation/anion	Determines selectivity and binding strength for specific metal ions.
Extraction Time	30 - 120 min	Longer times generally increase yield until equilibrium is reached.
COâ‚‚ Flow Rate	1 - 3 mL/min	Affects the kinetics of extraction and process efficiency.

Application Note 2: Catalytic Hydrogenation in IL/scCOâ‚‚

This protocol describes a homogeneous catalytic reaction where the catalyst is immobilized in the IL phase, and scCOâ‚‚ is used for both reagent delivery and product isolation.

Detailed Protocol:

• Reaction Mixture Preparation: Charge a high-pressure autoclave reactor (e.g., 100 mL) with the substrate (e.g., an alkene) and a catalyst soluble in the chosen IL (e.g., a Rhodium-based complex like [Rh(nbd)(PPh₃)â‚‚]⁺ in [BMIM][PF₆]). Use a substrate-to-catalyst molar ratio of 1000:1 [42].
• Reaction with Hâ‚‚/scCOâ‚‚:
  • Pressurization: Pressurize the reactor first with Hâ‚‚ to the reaction pressure (e.g., 10 bar), then with COâ‚‚ to the total desired pressure (e.g., 100 bar).
  • Initiation: Heat the reactor to the reaction temperature (e.g., 40 °C) and stir vigorously to ensure efficient mixing of the gas, IL, and substrate phases.
  • Monitoring: Let the reaction proceed for a predetermined time (e.g., 4-6 hours), monitoring pressure drop or by sampling for GC analysis to track conversion.
• Product Separation:
  • Phase Separation: After the reaction, slowly vent the Hâ‚‚ and COâ‚‚. The reaction mixture will separate into distinct phases.
  • scCOâ‚‚ Extraction: The product (e.g., the hydrogenated alkane) can be extracted from the IL phase using pure scCOâ‚‚ in a separate extraction vessel, as described in Application Note 1. The scCOâ‚‚ dissolves the product but not the catalyst or the IL.
• Catalyst and IL Reuse: The remaining IL phase, containing the active catalyst, can be directly reused for subsequent reaction cycles by adding fresh substrate and repressurizing with Hâ‚‚ and COâ‚‚.

Application Note 3: Enhancing Drug Solubility and Bioavailability

IL/scCOâ‚‚ systems, particularly with scCOâ‚‚, are highly effective in the pharmaceutical industry for producing drug nanoparticles with enhanced solubility and bioavailability.

Detailed Protocol:

• Drug and Excipient Preparation: Weigh the poorly water-soluble API (e.g., Ibuprofen) and a stabilizer polymer (e.g., PVP K30) in a 1:1 mass ratio.
• Supercritical Antisolvent (SAS) Process:
  • Vessel Setup: Use a particle formation vessel with a frit at the bottom.
  • Dissolution: Dissolve the API and polymer in a suitable organic solvent (e.g., acetone).
  • Precipitation: Pump the solution through a nozzle into the particle formation vessel simultaneously with scCOâ‚‚, which acts as an antisolvent. The scCOâ‚‚ rapidly extracts the organic solvent, causing supersaturation and the precipitation of fine API particles coated with the polymer.
  • Washing: Continue flowing pure scCOâ‚‚ through the vessel to remove residual solvent.
• Collection and Analysis:
  • Depressurization: Slowly depressurize the vessel to collect the dried, nanonized powder.
  • Characterization: Analyze the resulting particles for size distribution (via Dynamic Light Scattering), morphology (via Scanning Electron Microscopy), crystallinity (via X-Ray Diffraction), and dissolution rate [52].

The Scientist's Toolkit: Essential Research Reagents & Materials

Table 2: Key reagents and materials for working with IL/SCF systems.

Item	Function / Relevance	Example(s)
Ionic Liquids	Serve as the non-volatile, tunable reaction or separation medium.	[BMIM][PF₆], [BMIM][BF₄], [OMIM][Tf₂N], Task-Specific ILs.
High-Purity CO₂	Source for creating the supercritical phase.	≥ 99.99% purity to prevent contamination or side reactions.
High-Pressure Reactor	Vessel to contain the IL/SCF system under high pressure and temperature.	Autoclave with mechanical stirrer, sapphire view windows, and temperature/pressure control.
Catalysts	To facilitate reactions within the IL phase.	Homogeneous (e.g., Rhodium complexes) or heterogeneous (e.g., immobilized on silica) catalysts.
Stabilizers/Polymers	For pharmaceutical applications to control nanoparticle growth and stability.	PVP, Poloxamers, HPMC.
scCOâ‚‚ Pump	To deliver and maintain COâ‚‚ at supercritical pressures.	High-pressure syringe pump or compressor.
Back-Pressure Regulator	To precisely control the system pressure.	Electronically heated or manually controlled regulator.
Ethyl 2,4-dioxopentanoate	Ethyl 2,4-dioxopentanoate | Research Chemical	Ethyl 2,4-dioxopentanoate: A versatile β-keto ester for organic synthesis and heterocyclic compound research. For Research Use Only. Not for human or veterinary use.

Workflow Visualization

The following diagram illustrates the logical workflow and decision process for designing a combined IL/SCF system for a specific application.

Challenges and Future Outlook

Despite their promise, the widespread industrial adoption of IL/scCOâ‚‚ systems faces hurdles.

• Cost: Ionic liquids are currently more expensive than conventional solvents, though this is offset in closed-loop systems where they are recycled [51] [42].
• Toxicity and Biodegradability Data: Comprehensive data on the environmental impact and toxicity of many ILs is still limited, driving research into biodegradable IL derivatives [51] [42].
• System Complexity: The high-pressure nature of scCOâ‚‚ processes requires specialized equipment and engineering expertise.

The future of this field is bright, with research focusing on the development of cheaper, greener ILs and the integration of advanced modeling techniques. Machine Learning (ML) and artificial intelligence (AI) are now being employed to predict key parameters like solubility, bioavailability, and optimal process conditions, reducing the need for extensive and costly experimental trials [52]. This data-driven approach will accelerate the design and optimization of next-generation IL/SCF systems for sustainable chemical manufacturing and pharmaceutical development.

Navigating Challenges and Optimizing Processes for Industrial Viability

Addressing the High Initial Investment and Operational Costs

The transition to more sustainable industrial processes often hinges on the adoption of alternative solvents like ionic liquids (ILs) and supercritical fluids (SCFs). While their environmental and performance benefits are well-documented, their commercial deployment is frequently hampered by significant economic hurdles. A primary challenge identified in recent literature is the lack of detailed studies and frameworks addressing the economic feasibility, supply chain logistics, and scalability of green solvent production and utilization across various industries [50]. Furthermore, these solvents, particularly some advanced ILs, often involve high initial production costs [50]. This application note provides a structured analysis of these cost components and offers detailed, actionable protocols for researchers to quantify, justify, and mitigate these expenses within a drug development and research context. The focus is on the synergistic use of ILs and SCFs, particularly supercritical COâ‚‚ (scCOâ‚‚), a combination that can unlock unique process efficiencies to offset initial investments [28] [55].

Cost Analysis and Strategic Justification

A clear understanding of where costs originate is the first step toward managing them. The table below breaks down the major cost components and proposes strategic justifications for their inclusion in research proposals and project planning.

Table 1: Analysis of Major Cost Components and Strategic Justifications

Cost Component	Specific Challenges	Strategic Justification & Mitigation Pathways
Capital Investment	High-pressure reactors, pumps, and pressure-rated vessels for SCF processes; specialized equipment for handling viscous ILs.	scCOâ‚‚ equipment offers multi-functional use (extraction, reaction, separation), consolidating process steps and reducing overall facility footprint [28] [56].
Solvent Production & Sourcing	High cost of synthesizing and purifying many ILs; sourcing high-purity COâ‚‚ for scCOâ‚‚ processes.	Leverage scCOâ‚‚ for IL purification [55]; utilize bio-based precursors for ILs [50]; implement solvent recycling loops to minimize consumption [50] [57].
Process Optimization & Scalability	Lack of established scale-up protocols and comprehensive Life-Cycle Assessments (LCAs) for integrated IL/scCOâ‚‚ processes [50].	Invest in early-stage R&D to optimize performance under diverse industrial conditions (e.g., temperatures, pressures) [50]. Use tunability to reduce energy-intensive steps.
Operational Efficiency	Energy costs associated with maintaining supercritical conditions; potential need to lower IL viscosity for processing.	Demonstrated process enhancements include higher reaction rates, selectivity, and yield [50] [56]. scCOâ‚‚ can reduce IL viscosity, improving transport and lowering energy needs for mixing [55].

A critical tool for justifying these investments is a thorough Life-Cycle Assessment (LCA). While current LCAs are limited, conducting one for a specific process can highlight significant environmental and long-term economic benefits, such as reduced volatile organic compound (VOC) emissions, lower toxicity, and improved worker safety, which translate into reduced regulatory and disposal costs [50]. The inherent customizability of ILs and the tunable solvent power of scCOâ‚‚ allow for the design of highly efficient, integrated processes that can reduce waste and energy consumption over the entire product lifecycle [50] [5].

Detailed Experimental Protocols for Cost-Effective Research

Protocol 1: ScCOâ‚‚-Assisted Product Extraction from an Ionic Liquid Reaction Medium

This protocol exemplifies a key economic advantage: using scCOâ‚‚ to separate products from ILs without cross-contamination, enabling IL reuse and simplifying downstream processing [28].

1. Principle: The high solubility of scCOâ‚‚ in ILs, coupled with the negligible solubility of ILs in scCOâ‚‚, allows for the selective extraction of organic products from the IL phase. The dissolved COâ‚‚ also reduces the viscosity of the IL, enhancing mass transfer during extraction [28] [55].

2. Materials:

• Reaction Mixture: Product of interest synthesized in an IL (e.g., 1-butyl-3-methylimidazolium hexafluorophosphate, [bmim][PF₆]).
• Extraction Solvent: High-purity carbon dioxide (COâ‚‚) gas.
• Equipment: High-pressure reaction vessel, scCOâ‚‚ extraction system (including pump, co-solvent pump, pressure and temperature controls, and a separation vessel).

3. Step-by-Step Procedure: 1. Reaction: Conduct the catalytic or synthetic reaction in the selected IL within the high-pressure reactor. 2. Loading: Transfer the post-reaction mixture (IL + products) to the extraction vessel. 3. Pressurization & Heating: Pressurize the system with CO₂ above its critical pressure (73.8 bar) and heat it above its critical temperature (31.1°C) to achieve supercritical conditions [5]. A typical starting point is 40°C and 100 bar [55]. 4. Dynamic Extraction: Allow the scCO₂ to flow continuously through the IL phase for a predetermined time (e.g., 30-120 minutes). The scCO₂ will dissolve and carry the product out of the vessel. 5. Separation & Recovery: De-pressurize the scCO₂ stream into a separation vessel, causing the product to precipitate out due to the loss of solvent power. The scCO₂ can be re-liquefied and recycled. 6. IL Reuse: The "clean" IL remaining in the extraction vessel can be directly reused in subsequent reaction cycles after confirming its activity.

4. Economic Considerations:

• Key Cost Factors: Energy for compression, cost of COâ‚‚, and extraction time.
• Cost-Saving Measures: Optimize pressure/temperature to maximize yield while minimizing energy input; implement COâ‚‚ recycling; maximize the number of IL reuse cycles.

Protocol 2: In Situ FT-IR Monitoring of ScCOâ‚‚ Drying and Purification of Ionic Liquids

This protocol addresses the cost and performance issues related to hygroscopic ILs, which often require energy-intensive vacuum drying [55].

1. Principle: The high diffusivity and low surface tension of scCOâ‚‚ allow it to penetrate and remove trace water and volatile organic impurities from ILs. In situ Fourier-Transform Infrared (FT-IR) spectroscopy monitors the process in real-time, eliminating guesswork and optimizing time and energy use [55].

2. Materials:

• Ionic Liquid: Hydrated or impure IL sample (e.g., 1-butyl-3-methylimidazolium tetrafluoroborate, [bmim][BFâ‚„]).
• Drying Agent: High-purity COâ‚‚ gas.
• Equipment: High-pressure cell with ATR-IR (Attenuated Total Reflection) and/or transmission IR capabilities, IR spectrometer, scCOâ‚‚ delivery system.

3. Step-by-Step Procedure: 1. Loading: Place the wet IL sample in the high-pressure cell in contact with the ATR crystal. 2. Baseline Measurement: Collect a background IR spectrum of the wet IL. 3. ScCO₂ Exposure: Pressurize the cell with scCO₂ (e.g., 100 bar, 40°C) [55]. 4. In Situ Monitoring: * ATR-IR Mode (IL phase): Monitor the O-H stretching bands of water (around 3500 cm⁻¹) and the CO₂ asymmetric stretch (~2340 cm⁻¹) in the IL phase. The decrease in water signal indicates drying progress [55]. * Transmission-IR Mode (SCF phase): Monitor the supercritical phase for traces of water or organic impurities being carried out of the IL. 5. Process Endpoint: The process is stopped when the water signals in the IL phase plateau, indicating that drying is complete. This is significantly faster than traditional vacuum drying [55]. 6. Depressurization: Slowly release the CO₂, leaving a dry, purified IL.

5. Economic Considerations:

• Key Cost Factors: Capital cost of in situ IR equipment, cost of COâ‚‚.
• Cost-Saving Measures: Replaces days of vacuum drying with a process that can take minutes to hours, saving energy and time. Prevents product degradation during long drying and ensures consistent IL quality for reproducible results.

Workflow and Logical Pathway for Cost Management

The following diagram synthesizes the strategic and experimental approaches into a coherent decision-making pathway for researchers facing high costs.

The Scientist's Toolkit: Key Research Reagent Solutions

The successful and cost-effective implementation of the aforementioned protocols relies on a core set of materials and reagents. The table below details these essential components.

Table 2: Essential Materials for IL/scCOâ‚‚ Research

Research Reagent / Material	Function & Rationale	Key Economic & Performance Considerations
Supercritical COâ‚‚ (scCOâ‚‚)	Primary extraction and purification solvent; viscosity modifier for ILs.	Inexpensive, non-toxic, non-flammable, and easily removable by depressurization. Its recyclability drastically reduces operational costs and environmental impact [28] [5].
Imidazolium-Based ILs (e.g., [bmim][BF₄], [bmim][PF₆])	Versatile, water-stable reaction media with tunable properties.	Well-studied and commercially available, though cost can be high. Reusability after scCO₂ extraction is a key economic driver, amortizing initial cost over multiple cycles [28] [58].
High-Pressure Vessels & Reactors	Contain IL/scCOâ‚‚ mixtures at operational pressures and temperatures.	Major capital cost. Justified by enabling multi-functional processes (reaction, extraction, drying) in a single unit, replacing multiple traditional pieces of equipment [28] [56].
In Situ Analytical Probes (e.g., ATR-FTIR)	Enable real-time monitoring of reactions and purification processes.	Reduces time and material waste by providing precise process endpoints (e.g., confirming drying or extraction completion), optimizing resource use [55].
Co-solvents (e.g., ethanol, methanol)	Added in small quantities to scCOâ‚‚ to modify polarity and enhance solubility of polar compounds.	Increases the scope of extractable products but adds complexity and cost to solvent recovery. Use should be optimized and minimized [56].

The high initial investment and operational costs associated with ionic liquids and supercritical fluids are not insurmountable barriers but rather strategic challenges. By adopting an integrated approach that leverages the unique synergies between ILs and scCOâ‚‚, researchers can design processes where the economic value is realized through solvent recycling, process intensification, and superior performance metrics. The protocols and strategies outlined here provide a concrete foundation for developing cost-effective, sustainable, and efficient processes that can advance drug development and align with the principles of green chemistry.

Overcoming Mass Transfer Limitations and Process Kinetics

The adoption of ionic liquids (ILs) and supercritical fluids, particularly supercritical carbon dioxide (scCOâ‚‚), as alternative solvents in chemical processing represents a significant advancement in green chemistry. However, their unique physical properties introduce distinct mass transfer limitations that can dictate the overall efficiency and kinetics of a process. ILs, characterized by their high viscosity and low vapor pressure, often suffer from slow diffusion rates, which can limit substrate access to catalytic sites or impede product removal [57]. Conversely, scCOâ‚‚, while benefiting from gas-like diffusivity and low viscosity, faces challenges related to substrate solubility and the pressure-dependent density that controls its solvent power [4]. Overcoming these limitations is not merely an engineering challenge; it is fundamental to unlocking the potential of these solvents for industrial applications in pharmaceuticals, materials science, and energy storage. This document outlines the core principles, quantitative parameters, and practical protocols for researchers to understand, model, and overcome these kinetic barriers, thereby enabling the design of more efficient and sustainable chemical processes.

Fundamental Principles and Key Parameters

The design of efficient processes using ILs and scCOâ‚‚ requires a deep understanding of the physical properties that govern mass transfer and kinetics. Table 1 provides a comparative overview of these key properties, highlighting the complementary nature of these two classes of solvents.

Table 1: Key Properties Governing Mass Transfer and Kinetics in Ionic Liquids and Supercritical COâ‚‚

Property	Ionic Liquids	Supercritical COâ‚‚	Impact on Mass Transfer & Kinetics
Viscosity	High (e.g., 50-1000 mPa·s) [57]	Low (e.g., 0.05-0.1 mPa·s) [4]	High viscosity in ILs reduces diffusion rates; low viscosity in scCO₂ enhances penetration.
Diffusivity	Low (~0.01 mm²/s)	Intermediate (~0.1 mm²/s) [4]	Lower diffusivity in ILs can lead to transport-limited reactions.
Density	High (~1-1.5 g/cm³) [57]	Tunable with pressure (0.1-1 g/cm³) [4]	Density of scCO₂ directly controls its solvating power, affecting solubility and reaction rates.
Surface Tension	Present	Absent [4]	Absence of surface tension in scCOâ‚‚ improves wetting and access to porous matrices.
Vapor Pressure	Negligible [57]	High (tunable with T and P)	Near-zero vapor pressure of ILs prevents solvent loss but complicates product separation.

A particularly powerful strategy involves the combination of ILs and scCOâ‚‚ to create integrated reaction-separation systems. This synergy leverages the high solubility of scCOâ‚‚ in ILs and the negligible solubility of ILs in scCOâ‚‚. The dissolved COâ‚‚ acts as a miscibility controller and viscosity reducer for the IL phase, thereby enhancing diffusion rates within the ionic liquid. Following reaction, scCOâ‚‚ can be used to extract organic products from the IL without cross-contamination, facilitating catalyst recycling and product purification [28] [59]. This combination directly addresses the mass transfer limitations of ILs while utilizing scCOâ‚‚ as a green processing medium.

Quantitative Data and Modeling

Predicting and optimizing process kinetics requires robust mathematical models and reliable physicochemical data. The Broken and Intact Cell (BIC) model is a widely accepted framework for describing supercritical fluid extraction kinetics from botanical matrices [60]. This model conceptualizes the plant particle as consisting of both broken cells (on the surface) and intact cells (in the interior). The extraction curve is divided into three periods: i) the constant extraction rate period (CER), where easily accessible solute on the particle surface is extracted; ii) the falling extraction rate period (FER), where diffusion from intact cells within the particle becomes rate-limiting; and iii) the diffusion-controlled period (DC), where only solute strongly bound to the matrix remains [60].

The evolution of the extraction yield is often modeled using equations that account for these resistances. For instance, the extraction yield ( Y ) at time ( t ) can be related to the initial solute concentration and mass transfer coefficients for the fluid and solid phases [60].

Table 2: Key Parameters for scCOâ‚‚ Extraction Mass Transfer Models

Parameter	Description	Typical Determination Method
Initial Solute Concentration ((c_0))	The initial amount of extractable solute per mass of solid matrix.	Exhaustive Soxhlet extraction or theoretical yield.
Fluid Phase Mass Transfer Coefficient ((k_f))	Describes resistance to mass transfer in the fluid film surrounding the particle.	Correlations involving Reynolds and Schmidt numbers.
Solid Phase Mass Transfer Coefficient ((k_s))	Describes resistance to diffusion of solute within the solid particle matrix.	Fitting of experimental kinetic data to the model.
Axial Dispersion Coefficient ((D_{ax}))	Measures the degree of back-mixing or deviation from ideal plug flow in a packed bed.	Residence time distribution experiments.
Solubility of Solute in scCOâ‚‚ ((y_s))	The equilibrium concentration of the solute in the scCOâ‚‚ at a given T and P.	Gravimetric or chromatographic analysis of equilibrium cells.

For reactions in IL/scCOâ‚‚ systems, kinetics are also highly dependent on phase behavior. The presence of scCOâ‚‚ can create a single phase with reactants or a multiphase system, significantly altering the observed reaction rate. For example, in the synthesis of the ionic liquid [HMIm][Br], higher COâ‚‚ pressure was found to moderately decrease the kinetic rate constant, but the overall efficiency was enhanced by improved phase behavior and separation capabilities [61].

Experimental Protocols

Protocol: Kinetic Study of a Model Reaction in an IL/scCOâ‚‚ Biphasic System

This protocol details the investigation of reaction kinetics and mass transfer for a catalytic reaction occurring in an ionic liquid with scCOâ‚‚ as a mobile phase, suitable for systems like hydrogenation or hydroformylation.

Research Reagent Solutions Table 3: Essential Materials for IL/scCOâ‚‚ Kinetic Studies

Item	Function/Benefit
Imidazolium-based IL (e.g., [C₄mim][PF₆])	Non-volatile, structured solvent and catalyst reservoir.
Homogeneous Catalyst (e.g., [Rh(COD)(DIPAMP)]BFâ‚„)	Molecular catalyst for selective reactions.
Supercritical COâ‚‚ (High Purity Grade)	Transport fluid, extraction medium, and viscosity modifier.
High-Pressure View Cell or Autoclave	Allows visual monitoring of phase behavior under pressure.
In-situ ATR-IR Probe (e.g., ReactIR)	Provides real-time concentration data for kinetic analysis.

Procedure:

• Reactor Preparation: Charge a high-pressure stirred autoclave (e.g., a 50 mL Parr reactor) with a known mass of the ionic liquid (e.g., 5 g) and the homogeneous catalyst. Seal the system.
• Initial Scoping - Phase Behavior: Pressurize the reactor with COâ‚‚ to a desired pressure and temperature. Use a view cell in a parallel experiment to determine the pressure at which a single homogeneous phase is formed versus when a biphasic system (IL + scCOâ‚‚) exists. This information is critical for interpreting kinetic data.
• Reaction Cycle: a. Purge the reactor with an inert gas to remove air. b. Pressurize with scCOâ‚‚ to a pre-determined sub-single-phase pressure to ensure the system is biphasic. c. Introduce the substrate(s) via a high-pressure syringe pump, either dissolved in a minor co-solvent or directly into the COâ‚‚ stream. This marks time ( t = 0 ). d. If using an in-situ IR probe, begin monitoring the appearance of products or disappearance of reactants immediately. e. If sampling is required, release small aliquots of the COâ‚‚-phase effluent at regular intervals into a trap containing a cold solvent, and analyze the collected fractions by GC or HPLC.
• Product Separation & Catalyst Recycling: After the reaction is complete, slowly vent the COâ‚‚ through a separator to collect the products. The catalyst remains in the IL phase. The IL-catalyst mixture can then be reused for subsequent runs by repeating step 3 to assess catalyst stability and leaching.

Protocol: Measuring Supercritical Fluid Extraction Kinetics

This protocol outlines a standard procedure for obtaining kinetic data for the extraction of a bioactive compound (e.g., a lipid or antioxidant) from a solid plant matrix using scCOâ‚‚, which can be modeled using the BIC model.

Procedure:

• Sample Preparation: The solid biomass (e.g., rosemary leaves) is dried and milled to a defined particle size range (e.g., 0.3-0.5 mm). The moisture content is precisely measured. A known mass of the solid is then loosely packed into a high-pressure extraction vessel.
• System Pre-equilibration: The extraction vessel is placed in a temperature-controlled chamber. The system is heated to the desired temperature and then pressurized with COâ‚‚ to the target pressure using a compressor. The COâ‚‚ flow rate is set using a mass flow controller.
• Dynamic Extraction: The scCOâ‚‚ is passed continuously through the fixed bed of solid material. The outlet valve is adjusted to maintain constant pressure.
• Fraction Collection & Quantification: The effluent stream, laden with solute, is depressurized through a restrictor valve into a collection vial. The solute precipitates out and is dissolved in a known volume of a trapping solvent. a. Fractions are collected at precise time intervals (e.g., every 5-10 minutes for the first hour, then less frequently). b. The mass of each fraction is determined gravimetrically after evaporating the trapping solvent. c. Alternatively, the composition of each fraction can be analyzed by GC-MS or HPLC to track the yield of specific compounds over time.
• Data Compilation: The total cumulative yield is calculated by summing the masses of all fractions up to a given time. A plot of cumulative yield versus time is constructed, which typically shows the characteristic CER, FER, and DC periods.

Advanced Applications and Integrated Strategies

Overcoming mass transfer limitations is not just a matter of optimization; it enables entirely new process configurations. A prime example is the use of Supported Ionic Liquid Phase (SILP) catalysts combined with scCOâ‚‚ in continuous-flow reactors [62]. In this configuration, a thin film of an IL containing a homogeneous catalyst is supported on the high-surface-area pores of an inert solid, such as silica. scCOâ‚‚ is then used as the mobile phase, transporting reactants to the catalyst and products away from it.

This integrated strategy directly tackles key limitations:

• Reduces Internal Diffusion Resistance: The thin IL film (SILP) drastically shortens the diffusion path compared to a bulk IL phase, enhancing the solid-phase mass transfer coefficient.
• Enables Continuous Processing: The solid support allows for a fixed-bed reactor design, while the scCOâ‚‚ ensures efficient product-catalyst separation and prevents IL leaching.
• Improves Catalyst Productivity: The system combines the high selectivity and activity of homogeneous catalysts with the easy handling of heterogeneous systems, leading to intensified processes with high space-time-yields [62].

This approach has been successfully demonstrated for reactions such as continuous-flow hydroformylation, achieving stable catalyst activity and very low leaching rates over extended periods, showcasing a viable path for the industrial application of these advanced solvent systems.

Optimizing Temperature, Pressure, and Co-solvent Selection

In the pursuit of sustainable chemical processes, ionic liquids (ILs) and supercritical fluids (SCFs) have emerged as cornerstone technologies. Their combination is particularly powerful for applications ranging from biomass processing and natural product extraction to catalytic reactions and materials synthesis [28] [63]. The efficiency of these applications is highly dependent on the precise optimization of critical operational parameters, primarily temperature, pressure, and co-solvent selection. This document provides detailed application notes and experimental protocols to guide researchers in systematically optimizing these parameters, framed within a thesis investigating ionic liquids and supercritical fluids as alternative solvents.

The physical properties of SCFs, such as density and solvent strength, are highly tunable with temperature and pressure. This tunability is key to optimizing processes like Supercritical Fluid Extraction (SFE). The table below summarizes the critical properties of common supercritical fluids [4] [6].

Table 1: Critical Properties of Common Supercritical Fluids

Solvent	Molecular Mass (g/mol)	Critical Temperature (°C)	Critical Pressure (MPa)	Critical Density (g/cm³)
Carbon Dioxide (COâ‚‚)	44.01	31.1	7.38	0.469
Water (Hâ‚‚O)	18.015	374.0	22.06	0.322
Methane (CHâ‚„)	16.04	-82.6	4.60	0.162
Ethane (C₂H₆)	30.07	32.2	4.87	0.203
Nitrous Oxide (Nâ‚‚O)	44.01	36.4	7.35	0.452

The properties of a supercritical fluid exist on a spectrum between gases and liquids, as shown in the following comparative table [4] [63].

Table 2: Comparative Physical Properties of Gases, SCFs, and Liquids

Phase	Density (kg/m³)	Viscosity (μPa·s)	Diffusivity (mm²/s)
Gases	1	10	1–10
Supercritical Fluids	100–1000	50–100	0.01–0.1
Liquids	1000	500–1000	0.001

Experimental Protocols

Protocol 1: ScCOâ‚‚ Extraction from an Ionic Liquid Matrix

Application Note: This protocol is designed for the extraction of organic solutes from an ionic liquid using supercritical carbon dioxide (scCOâ‚‚). This process leverages the unique finding that scCOâ‚‚ has high solubility in many ILs, while ILs have negligible solubility in scCOâ‚‚, preventing cross-contamination [28]. The key parameters to optimize are pressure and temperature, which control the density and solvating power of the scCOâ‚‚.

Materials:

• High-pressure extraction vessel (e.g., 50-100 mL)
• Syringe or HPLC pump for COâ‚‚ delivery
• Co-solvent pump (if required)
• Back-pressure regulator
• Temperature-controlled oven or heating jacket
• Collection vial

Methodology:

• Preparation: Charge the extraction vessel with the ionic liquid containing the target solute(s). Ensure the vessel is sealed and placed in the temperature-controlled environment.
• System Stabilization: Set the back-pressure regulator to the desired initial pressure. Allow the system temperature to equilibrate.
• Pressurization: Pump COâ‚‚ into the vessel until the target pressure is achieved. The most common operating range for scCOâ‚‚ is 40–80 MPa and 40–80°C [63].
• Static Extraction: Maintain the pressure and temperature for a static period (e.g., 15-60 minutes) to allow for solute diffusion and partitioning.
• Dynamic Extraction: Open the outlet valve to allow a continuous flow of scCOâ‚‚ through the vessel and into the collection vial. The depressurization of COâ‚‚ in the collection vial causes it to revert to a gas, leaving the extracted solute behind.
• Co-solvent Addition (If Applicable): For polar solutes, a co-solvent (e.g., 1-10% methanol or ethanol) can be introduced via a co-solvent pump to enhance solubility in the scCOâ‚‚.
• Analysis: Analyze the collected solute and the remaining ionic liquid to determine extraction efficiency and confirm the absence of IL in the extract.

Optimization Notes:

• Pressure: Higher pressures increase scCOâ‚‚ density, generally increasing solvating power for non-polar compounds [4] [6].
• Temperature: Near the critical point, increasing temperature can decrease density and thus solubility. At higher pressures, increasing temperature can increase the vapor pressure of solutes, enhancing solubility [4].
• Co-solvent: Polar co-solvents can modify the scCOâ‚‚ polarity and interact specifically with target solutes, significantly improving the extraction of polar molecules like alkaloids or phenolic compounds [63].

Protocol 2: Optimization of a Reactive Extraction System

Application Note: This protocol outlines a process where a chemical reaction (e.g., a catalytic transformation) is carried out in an ionic liquid, followed by product extraction using scCOâ‚‚. This combines the excellent catalytic properties of ILs with the clean separation power of scCOâ‚‚ [28]. Multifunctional use of scCOâ‚‚ can act as an extraction medium, transport medium, and miscibility controller.

Materials:

• High-pressure reactor vessel (compatible with reaction conditions)
• scCOâ‚‚ pumping and pressure control system
• In-line sampling or analysis capability (e.g., view cells, FTIR)
• Product collection system

Methodology:

• Reaction Phase: Conduct the catalytic reaction in the ionic liquid within the reactor vessel. Monitor reaction completion using standard analytical techniques.
• Extraction Phase Transition: After the reaction, adjust the system temperature and pressure to bring the scCOâ‚‚ into its supercritical state. The pressure may be used to control the miscibility of reagents and products between the IL and scCOâ‚‚ phases.
• Product Extraction: Initiate a flow of scCOâ‚‚ through the reactor. The product will partition into the scCOâ‚‚ phase and be transported to the collection vessel.
• Parameter Tuning: Systematically vary the pressure (e.g., 10-30 MPa) and temperature (e.g., 40-100°C) to find the optimum for maximum product extraction yield and rate. Higher pressures often lead to higher dissolution capacities but may also co-extract unwanted species.
• Ionic Liquid Reuse: The IL, now free of the reaction product, can often be recycled directly for subsequent reaction cycles.

Optimization Notes:

• The "cross-over region" near the critical point is where small changes in pressure and temperature cause large changes in solvent density and properties. Careful mapping of this region is crucial for process optimization [63].
• The choice of IL anion can dramatically affect scCOâ‚‚ solubility. For instance, ILs with fluorinated anions like [Tfâ‚‚N]⁻ or [PF₆]⁻ typically exhibit higher scCOâ‚‚ capacities [28] [64].

Process Workflow and Optimization Pathways

The following diagram illustrates the logical workflow for developing and optimizing a process involving ionic liquids and supercritical fluids.

Diagram 1: Process development workflow for IL-SCF systems.

The Scientist's Toolkit: Essential Research Reagents

The following table details key reagents and materials used in research involving ionic liquids and supercritical fluids.

Table 3: Key Research Reagent Solutions

Reagent/Material	Function/Application	Critical Properties / Notes
Supercritical CO₂	Primary SCF solvent for extraction, reaction, and cleaning.	Tc = 31.1°C, Pc = 7.38 MPa [6]. Non-toxic, non-flammable, tunable solvent power.
Ionic Liquids (e.g., [bmim][PF₆])	Non-volatile, tunable reaction or separation medium.	High polarity, excellent solvents for catalysis [28] [64].
Methanol, Ethanol	Polar co-solvents to modify scCOâ‚‚ polarity.	Typically used at 1-10% (v/v) to enhance solubility of polar molecules [63].
Ethyl Lactate	Bio-based solvent and potential co-solvent.	Derived from renewable resources; biodegradable; used in cleaning and coatings [50].
Deep Eutectic Solvents (DES)	Low-cost, tunable solvents often derived from natural products.	Biodegradable, can be used in combination with SCFs for fractionation [50].
Polymer Matrix (e.g., PVDF)	Component for creating ionogels.	Confines ILs, enhancing ion diffusion for electrochemical applications [12].

Ensuring Biocompatibility and Managing Toxicity Profiles of Ionic Liquids

Ionic liquids (ILs), salts with melting points below 100°C, have emerged as promising alternative solvents in pharmaceutical research and drug development due to their unique properties, including negligible vapor pressure and excellent solvation power [65] [29]. However, their potential for environmental release through aqueous waste streams and their interactions with biological systems necessitate rigorous biocompatibility assessment and toxicity profiling [65]. A fundamental understanding of the molecular mechanisms responsible for IL toxicity is crucial for designing inherently safer ILs and leveraging their potential in biological applications such as antimicrobial, antifungal, and therapeutic agents [65]. This application note provides a structured framework for evaluating IL biocompatibility, integrating experimental and computational approaches to manage toxicity profiles effectively within a research context.

Biocompatibility Testing and Regulatory Framework

Biocompatibility is the ability of a medical device or material to perform its intended function without causing adverse biological responses when in contact with living tissue [66]. For ILs, this translates to a requirement for comprehensive documentation and testing to prove they will not cause harmful reactions when used in or on the human body [66]. The global market for biocompatibility testing solutions, projected to reach USD 8.5 billion by 2033, reflects the growing emphasis on these safety assessments, driven by stringent regulatory requirements and the rising demand for safe medical products [67].

Regulatory frameworks from the FDA, CE, and ISO 10993 require a risk-based evaluation approach, moving away from a one-size-fits-all testing paradigm [68] [66]. The FDA's guidance, for instance, emphasizes a least-burdensome approach, particularly for devices contacting intact skin, and encourages the use of existing data and material controls within Quality Management Systems to justify the omission of full biocompatibility testing where sufficient historical evidence exists [68]. This framework is highly relevant for IL research, suggesting that established safety data on certain IL structures may eventually support similar streamlined evaluations.

Table 1: Standard Biocompatibility Tests Based on ISO 10993 for Different Contact Types

Test Category	Contact Type	Commonly Used Assays	Key Endpoints Measured
Cytotoxicity	All contact types	Agar diffusion test, MEM elution test, MTT/XTT assays	Cell death, inhibition of cell growth, colony formation
Sensitization	Skin/mucosal contact	Guinea Pig Maximization Test, Local Lymph Node Assay	Allergic contact dermatitis potential
Irritation	Skin/mucosal contact	Skin irritation tests, Intracutaneous reactivity test	Reversible inflammatory response in tissues
Systemic Toxicity	All contact types	Acute systemic toxicity tests	Generalized adverse effects in multiple organ systems
Genotoxicity	All contact types in vivo	Bacterial reverse mutation assay (Ames test), In vitro mammalian cell assays	DNA damage, gene mutations, chromosomal aberrations

The biological evaluation of ILs should follow a phased approach, beginning with material characterization to identify and quantify potential leachables, followed by in silico and in vitro assessments before considering any in vivo studies [66]. This structured approach aligns with the 3Rs principle (Replacement, Reduction, and Refinement) for animal testing and is increasingly supported by regulatory agencies [68] [69].

Experimental Protocol for Assessing IL Toxicity

This section provides a detailed methodology for evaluating the cytotoxicity of ionic liquids and investigating their mechanism of action, with a focus on membrane interactions.

Cytotoxicity Assay and ECâ‚…â‚€ Determination

Objective: To determine the half-maximal effective concentration (ECâ‚…â‚€) of an ionic liquid on a chosen cell line, providing a quantitative measure of its cytotoxicity.

Materials:

• Test System: Suitable cell line (e.g., IPC-81 mammalian cells, Chlamydomonas reinhardtii for environmental toxicity) [65].
• Ionic Liquids: Series of 1-n-alkyl-3-methylimidazolium chloride ([Câ‚™mim]Cl, n = 4 to 12) [65].
• Equipment: Cell culture hood, COâ‚‚ incubator, multi-well plate reader, hemocytometer or automated cell counter.

Procedure:

• Cell Seeding: Harvest exponentially growing cells and seed them at a predetermined density (e.g., 1x10⁴ cells/well) into a 96-well plate. Incubate for 24 hours under standard conditions (37°C, 5% COâ‚‚) to allow cell attachment.
• IL Preparation and Dilution: Prepare a concentrated stock solution of the IL in the appropriate culture medium or solvent. Create a series of two-fold dilutions to generate a concentration gradient covering a range expected to cause 0-100% cell death.
• Treatment: After the 24-hour attachment period, carefully remove the medium from the wells and replace it with the medium containing the different concentrations of IL. Include control wells with medium only and solvent-only if applicable. Perform each concentration in at least triplicate.
• Incubation: Incub the plate for the desired exposure period (e.g., 24, 48, or 72 hours).
• Viability Assessment: At the endpoint, assess cell viability using a colorimetric assay like MTT. Briefly, add MTT reagent to each well and incubate for 2-4 hours. During this time, metabolically active cells convert MTT to purple formazan crystals. Solubilize the crystals with a detergent (e.g., SDS in DMSO) and measure the absorbance at 570 nm using a plate reader.
• Data Analysis: Calculate the percentage of cell viability for each IL concentration relative to the untreated control. Plot the percentage viability against the logarithm of the IL concentration. Fit a sigmoidal dose-response curve to the data to calculate the ECâ‚…â‚€ value.

Cytotoxicity Assay Workflow

Investigating the Molecular Mechanism of Membrane Disruption

Objective: To elucidate the interaction of ILs with lipid bilayers as a proposed mechanism of cytotoxicity using confocal laser scanning microscopy (CLSM) and molecular dynamics (MD) simulations [65].

Materials:

• Lipid Bilayer Model: L-α-phosphatidylcholine (α-PC) bilayer containing 1 mol% fluorescently labeled lipids [65].
• Probe: Octadecyl rhodamine B chloride (R18) membrane fusion probe [65].
• Ionic Liquids: [Câ‚™mim]Cl (e.g., n=4, 10, 12).
• Equipment: Confocal Laser Scanning Microscope.

Procedure (CLSM):

• Bilayer Preparation: Prepare a supported α-PC lipid bilayer on a clean glass surface according to established protocols.
• Baseline Imaging: Place the bilayer in the CLSM chamber and image it in an aqueous buffer to establish a baseline of a homogeneous, featureless membrane [65].
• IL Introduction: Introduce an aqueous solution of the IL at a concentration near its ECâ‚…â‚€ directly into the chamber while continuously imaging.
• Morphological Analysis: Observe and record the appearance of morphological defects in the bilayer over time, such as disks, multilayers, fibers, and vesicles, which indicate membrane reorganization [65].
• Quantification with R18 Probe: To confirm IL insertion, incorporate the self-quenching R18 probe into the α-PC bilayer. Upon addition of the IL, monitor the fluorescence intensity over time. An increase in intensity signifies probe dilution due to IL insertion and subsequent membrane reorganization [65].

Computational Support (MD Simulations):

• System Setup: Construct a simulation system containing a hydrated lipid bilayer (e.g., POPC) and IL cations.
• Simulation Run: Perform atomistic and coarse-grained MD simulations to observe the spontaneous insertion of IL cations into the bilayer.
• Analysis: Analyze the simulation trajectories to determine the depth of cation penetration, orientation within the bilayer, and the resulting changes to membrane properties like bending modulus. These simulations can reveal that longer alkyl chains embed more deeply, causing greater membrane disruption and correlating with higher cytotoxicity [65].

IL-Membrane Interaction Mechanism

In Silico Profiling and AI-Based Toxicity Prediction

The advent of computational approaches has revolutionized toxicity assessment, enabling rapid, cost-effective early-stage screening of compounds. Artificial intelligence (AI) and machine learning models are now capable of predicting a wide range of toxicity endpoints, such as hepatotoxicity, cardiotoxicity, and genotoxicity, based on diverse molecular representations [69].

Workflow for AI-Based Toxicity Prediction:

• Data Collection: Gather drug toxicity data from large-scale public databases such as:
  • Tox21: Qualitative toxicity measurements for 8,249 compounds across 12 targets [69].
  • ToxCast: High-throughput screening data for ~4,746 chemicals across hundreds of endpoints [69].
  • ChEMBL, DrugBank, hERG Central: Provide bioactivity and specific toxicity data [69].
• Data Preprocessing: Handle missing values, standardize molecular representations (e.g., SMILES strings, molecular graphs), and calculate molecular descriptors (e.g., molecular weight, clogP) [69].
• Model Development: Select and train appropriate algorithms. Commonly used models include:
  • Graph Neural Networks (GNNs): Excel at learning from the inherent graph structure of molecules, identifying toxicity-associated substructures [69].
  • Random Forest & XGBoost: Powerful for classification and regression tasks using engineered molecular features [69].
  • Transformer-based Models: Originally for natural language processing, now applied to chemical sequences (SMILES) [69].
• Model Evaluation & Interpretation: Evaluate performance using metrics like Area Under the ROC Curve (AUROC), accuracy, and precision. Use interpretability techniques like SHAP to identify structural features or "hot spots" responsible for predicted toxicity, which guides the rational design of safer ILs [69] [70].

In silico profiling platforms consolidate predictions across individual mechanisms and effects, creating a comprehensive toxicity profile for a compound. This supports lead optimization by enabling researchers to refine chemical structures to minimize toxicity while maintaining efficacy [70]. These tools are also integral to read-across methodologies, where the known toxicity profile of a well-studied "source" IL is used to predict the toxicity of a similar "target" IL, justifying the similarity based on chemical structure and properties [70].

Table 2: Key In Silico Tools and Databases for IL Toxicity Profiling

Tool/Database Name	Type	Primary Application	Relevance to IL Research
Tox21	Database	Benchmarking for nuclear receptor & stress response pathways	Screening ILs for specific biological activity [69].
hERG Central	Database	Cardiotoxicity prediction (hERG channel blockade)	Assessing a critical safety endpoint for ILs with pharmaceutical potential [69].
Leadscope Model Applier	Software Suite	Endpoint-specific QSAR models and toxicity profiling	Generating comprehensive in silico toxicity profiles for new ILs [70].
Graph Neural Networks (GNNs)	AI Model	Predicting various toxicity endpoints from molecular structure	Identifying toxicophores (structural alerts) within IL cations/anions [69].

The Scientist's Toolkit: Essential Research Reagents and Materials

Table 3: Key Reagent Solutions for IL Biocompatibility Testing

Research Reagent / Material	Function and Application	Experimental Context
1-n-alkyl-3-methylimidazolium chloride series	Model ILs for establishing structure-activity relationships (SAR), specifically investigating the effect of alkyl chain length on toxicity [65].	Cytotoxicity assays, Membrane interaction studies.
L-α-phosphatidylcholine (α-PC)	Major component of cell membranes; used to create supported lipid bilayers as a model system for studying IL-membrane interactions [65].	Confocal Laser Scanning Microscopy (CLSM).
Octadecyl rhodamine B chloride (R18)	A fluorescent membrane probe that exhibits self-quenching at high concentrations. An increase in fluorescence indicates its dilution due to membrane fusion or disruption [65].	Quantifying IL-induced membrane disruption in CLSM.
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)	A yellow tetrazole that is reduced to purple formazan by metabolically active cells. The amount of formazan produced is proportional to cell viability [65].	Colorimetric cell viability and cytotoxicity assays.
Drosophila melanogaster	An invertebrate model organism with a well-defined genome and short generation time, useful for assessing whole-organism toxicity, transgenerational effects, and behavioral impacts of IL exposure [71].	In vivo toxicity testing across multiple generations.

The safe and effective application of ionic liquids in the life sciences hinges on a thorough and strategic approach to evaluating their biocompatibility and toxicity. This integrated framework, which combines computational predictions, targeted in vitro assays, and mechanistic biophysical studies, allows researchers to efficiently identify and mitigate potential risks early in the development process. The molecular understanding of toxicity mechanisms, such as alkyl chain length-dependent membrane disruption, provides a powerful foundation for the rational design of greener, safer ILs. By adhering to evolving regulatory guidelines and leveraging advanced in silico and in vitro tools, scientists can accelerate the translation of ionic liquids from promising research solvents to viable components in pharmaceutical and biomedical applications.

The integration of ionic liquids (ILs) and supercritical fluids (SCFs), particularly supercritical carbon dioxide (scCOâ‚‚), represents a promising pathway for developing sustainable industrial processes, especially in pharmaceuticals. Scaling these advanced solvent systems from the laboratory to industrial production requires careful consideration of unique physicochemical properties, process intensification strategies, and compliance with stringent regulatory standards. This application note outlines key considerations, protocols, and practical guidance for successful scale-up, framed within ongoing research on ionic liquids and supercritical fluids as alternative solvents.

Fundamental Properties and Scale-Up Implications

Key Properties of Ionic Liquids and Supercritical Fluids

Table 1: Critical Properties of Common Supercritical Fluids [4]

Solvent	Molecular Mass (g/mol)	Critical Temperature (K)	Critical Pressure (MPa)	Critical Density (g/cm³)
Carbon dioxide	44.01	304.1	7.38	0.469
Water	18.015	647.096	22.064	0.322
Methane	16.04	190.4	4.60	0.162
Ethane	30.07	305.3	4.87	0.203
Propane	44.09	369.8	4.25	0.217
Ethylene	28.05	282.4	5.04	0.215
Methanol	32.04	512.6	8.09	0.272
Ethanol	46.07	513.9	6.14	0.276
Acetone	58.08	508.1	4.70	0.278
Nitrous oxide	44.013	306.57	7.35	0.452

Table 2: Comparison of Transport Properties [4]

Fluid Type	Density (kg/m³)	Viscosity (μPa·s)	Diffusivity (mm²/s)
Gases	1	10	1-10
Supercritical Fluids	100-1000	50-100	0.01-0.1
Liquids	1000	500-1000	0.001
Ionic Liquids	1000-1400	100-500	0.0001-0.001

Synergistic Benefits of IL-SCF Systems

The combination of ionic liquids and supercritical fluids creates advanced solvent systems with complementary properties. Ionic liquids provide negligible vapor pressure, high functionality, and excellent thermal stability, while scCOâ‚‚ reduces IL viscosity and surface tension, enhancing mass transfer rates [72]. This synergy enables novel process designs, such as the Levodopa production process that reduces energy consumption by 24% and minimizes waste production by 99% compared to conventional methods [73].

Scale-Up Challenges and Solutions

Technical Challenges in Industrial Implementation

Table 3: Scale-Up Challenges and Mitigation Strategies

Challenge Area	Specific Issues	Mitigation Strategies
Particle Generation	Atomization efficiency, nucleation control, post-nucleation growth	Nozzle design optimization, pressure and temperature control, additive incorporation
Particle Collection	Losses, agglomeration, contamination	Cyclone separators, electrostatic precipitation, membrane filtration
Fluid Purification/Recycle	Residual solvent removal, COâ‚‚ purity maintenance, contamination prevention	Activated carbon adsorption, distillation, membrane processes
Equipment Design	High-pressure compatibility, corrosion resistance, sealing mechanisms	Specialized alloys, polymer coatings, magnetic drive agitators
Process Control	Maintaining supercritical conditions, reproducibility, quality consistency	Advanced process analytics, real-time monitoring, automation systems

Economic and Regulatory Considerations

The scale-up of IL-SCF processes faces significant economic hurdles, including high initial investment costs for high-pressure equipment and complex intellectual property situations [74]. However, these are often offset by significantly lower variable costs, reduced from 6.49 D/kg to 0.68 D/kg in the Levodopa process [73]. Regulatory compliance with Good Manufacturing Practices (GMP), traceability requirements, and sterility assurance must be integrated throughout scale-up planning, though the inherent sterility of SCF processes provides a distinct advantage for pharmaceutical applications [74].

Experimental Protocols for Process Development

Protocol 1: Phase Behavior Measurement for IL-SCF Systems

Objective: Determine the solubility of scCOâ‚‚ in ionic liquids and characterize phase behavior for reactor design.

Materials:

• High-pressure view cell with sapphire windows
• Precision syringe pump for COâ‚‚ delivery
• Magnetic stirring system with temperature control
• Selected ionic liquid (e.g., [bmim][PF₆] or [bmim][BFâ‚„])
• High-purity carbon dioxide (99.995%)

Procedure:

• Load the ionic liquid (approximately 1/3 of cell volume) into the view cell
• Seal and purge the system with low-pressure COâ‚‚ to remove air
• Heat the system to desired temperature (typically 313-333 K) using circulating bath
• Gradually introduce COâ‚‚ using syringe pump while monitoring pressure
• Record bubble point and dew point pressures at constant temperature
• Observe phase transitions visually through sapphire windows
• Repeat measurements at 5-10 K intervals across relevant temperature range
• Correlate data using Peng-Robinson or Sanchez-Lacombe equations of state [72]

Critical Parameters:

• Temperature control: ±0.1 K
• Pressure measurement accuracy: ±0.01 MPa
• Equilibrium time: 30-60 minutes per data point
• Ionic liquid water content: <100 ppm

Protocol 2: Particle Formation via Supercritical Antisolvent (SAS) Process

Objective: Produce micronized drug particles with controlled size and morphology using scCOâ‚‚ as antisolvent.

Materials:

• SAS apparatus with coaxial nozzle
• Solution vessel with temperature control
• Precipitation vessel with sight glasses
• COâ‚‚ pump and back-pressure regulator
• Organic solvent (e.g., dimethyl sulfoxide, methanol)
• Active pharmaceutical ingredient (API)

Procedure:

• Prepare API solution in appropriate organic solvent at saturation concentration
• Pre-heat/pre-pressurize precipitation vessel to desired operating conditions
• Pump COâ‚‚ through precipitation vessel until steady state is achieved
• Simultaneously pump API solution through coaxial nozzle into vessel
• Maintain constant pressure and temperature during operation (typically 8-15 MPa, 308-328 K)
• Continue COâ‚‚ flow to wash out residual solvent from precipitated particles
• Depressurize vessel gradually to collect product
• Characterize particles for size, morphology, and crystallinity

Critical Parameters:

• Nozzle diameter and design: 100-200 μm
• Solution flow rate: 1-5 mL/min
• COâ‚‚ flow rate: 20-50 g/min
• Solution concentration: 1-5% w/w
• Pressure control: ±0.1 MPa

Process Design and Equipment Considerations

The Scientist's Toolkit: Essential Research Reagents and Materials

Table 4: Key Research Reagents and Materials for IL-SCF Processes

Category	Specific Examples	Function and Application Notes
Ionic Liquids	[bmim][PF₆], [bmim][BF₄], [bmim][OcSO₄]	Green solvent media for reactions, extractions, and separations; catalyst stabilization
Supercritical Fluids	Carbon dioxide, water, ethanol	Tunable solvents for extraction, reaction, and particle formation; scCOâ‚‚ most common
Catalysts	Metal complexes, enzymes, acid/base catalysts	Reaction acceleration; enhanced stability in IL environments
Co-solvents	Methanol, acetone, dimethyl ether	Modifying solubility parameters and phase behavior in SCF systems
Stabilizers	Polymers, surfactants, cyclodextrins	Controlling particle growth and morphology during precipitation processes
Analytical Standards	Pure compounds for calibration	Quantifying process efficiency and product purity during development

Equipment Specification Guidelines

High-pressure equipment represents a significant investment and must be carefully specified for IL-SCF processes. Key considerations include:

• Pressure rating: Typically 30-50 MPa for most SCF processes
• Materials of construction: 316 stainless steel, Hastelloy, or titanium for corrosion resistance
• Heating/cooling systems: Jacketed vessels with accurate temperature control (±1 K)
• Mixing technology: Magnetic drives for high-pressure applications with limited leakage risk
• Instrumentation: Coriolis flow meters, precision pressure transducers, and in-situ particle analyzers
• Safety systems: Rupture discs, pressure relief valves, and automated shutdown protocols

Process Visualization and Workflow

IL-SCF Process Development Workflow

IL-SCF System Integration for Pharmaceutical Production

Successful scale-up of ionic liquids and supercritical fluid processes from laboratory to industrial production requires meticulous attention to phase behavior, transport phenomena, equipment design, and economic viability. The integrated approach outlined in this application note—combining fundamental property measurement, systematic process development, and appropriate equipment specification—provides a framework for implementing these innovative solvent systems at commercial scale. As demonstrated in the Levodopa production case study, properly scaled IL-SCF processes can deliver substantial benefits in energy efficiency, waste reduction, and product quality compared to conventional approaches. Future developments will likely focus on standardizing scale-up methodologies, reducing capital costs through equipment innovation, and expanding applications in pharmaceutical manufacturing and beyond.

Benchmarking Performance: Efficacy, Sustainability, and Economic Analysis

Head-to-Head: ILs and SCFs vs. Volatile Organic Solvents (VOCs)

The pursuit of sustainable industrial processes has catalyzed a fundamental shift in solvent selection, moving from traditional volatile organic compounds (VOCs) toward advanced alternatives like ionic liquids (ILs) and supercritical fluids (SCFs), particularly supercritical carbon dioxide (scCO₂). This transition is driven by the need to address the significant environmental and health concerns associated with VOCs, which exhibit high vapor pressure at room temperature and contribute to indoor air pollution and potential chronic health effects [75] [76]. In contrast, ILs—salts liquid at or below 100 °C—possess negligible vapor pressure, high thermal stability, and widely tunable physicochemical properties [1] [20]. Concurrently, scCO₂—CO₂ utilized above its critical point (31.1 °C and 7.3 MPa)—serves as a non-toxic, non-flammable solvent with zero surface tension and tunable solvating power, finding established roles in decaffeination and extraction [77]. This application note provides a comparative analysis and detailed protocols to facilitate the adoption of these alternative solvents in research and development, with a focus on pharmaceutical applications.

Solvent Properties: A Comparative Analysis

The choice of solvent dictates the efficiency, safety, and environmental footprint of a process. The table below summarizes the core characteristics of VOCs, ILs, and scCOâ‚‚.

Table 1: Key Properties of VOCs, Ionic Liquids, and Supercritical COâ‚‚

Property	Volatile Organic Compounds (VOCs)	Ionic Liquids (ILs)	Supercritical COâ‚‚ (scCOâ‚‚)
Vapor Pressure	High at room temperature [75]	Negligible (as low as 10⁻¹⁰ Pa) [1] [20]	Dense fluid, no distinct vapor phase under supercritical conditions [77]
Volatility	High; primary pathway for environmental release and human exposure [75] [76]	Extremely low; considered non-volatile [1]	-
Tunability	Limited; properties defined by molecular structure	Highly tunable; properties can be tailored by selecting cation/anion combinations [77] [1]	Tunable solvation power with pressure and temperature [77]
Thermal Stability	Varies; typically low to moderate	High; many are stable over a wide temperature range [1]	Stable in supercritical state
Toxicity & Environmental Impact	Varies widely; many are hazardous, contribute to smog, and are common indoor air pollutants [75] [76]	Varies; can be designed to be biodegradable and less toxic [77]	Generally recognized as safe (GRAS); non-flammable [77]
Representative Examples	Acetone, ethanol, ethyl acetate, toluene	1-Ethyl-3-methylimidazolium acetate ([EMIM]Ac), 1-Butyl-3-methylimidazolium tetrafluoroborate ([BMIM]BFâ‚„) [1]	-

Application Note 1: Biopolymer Processing with Ionic Liquids

Background and Principle

The dissolution and processing of biopolymers like cellulose is a significant industrial challenge due to their extensive hydrogen-bonding network. While VOCs often lack the ability to disrupt these strong interactions, certain ILs, such as 1-ethyl-3-methylimidazolium acetate ([EMIM]Ac), are highly effective solvents [78] [1]. The acetate anion acts as a powerful hydrogen-bond acceptor, breaking the inter- and intra-molecular hydrogen bonds in cellulose and leading to its dissolution.

Experimental Protocol: Dissolution of Microcrystalline Cellulose in [EMIM]Ac

The Scientist's Toolkit Table 2: Key Reagents and Materials for IL Biopolymer Processing

Item	Function/Description
Ionic Liquid	e.g., [EMIM]Ac; acts as the primary solvent. Must be dried prior to use (e.g., under vacuum at 60-80°C).
Biopolymer	e.g., Microcrystalline Cellulose; the solute to be dissolved.
Vacuum Oven	For removal of residual water from the IL, which is crucial for high dissolution efficiency.
Oil Bath with Stirrer	Provides controlled, uniform heating and agitation during dissolution.

Step-by-Step Procedure:

• IL Pre-treatment: Dry approximately 10 g of [EMIM]Ac in a vacuum oven (≤ 0.1 bar) at 70 °C for 12-24 hours to minimize water content.
• Setup: Charge the dried IL into a round-bottom flask equipped with a magnetic stir bar.
• Heating and Agitation: Place the flask in an oil bath pre-heated to 80 °C and begin stirring at a moderate speed (e.g., 300 rpm).
• Biopolymer Addition: Gradually add microcrystalline cellulose (2-5 wt% of the IL mass) to the stirred IL over 15-30 minutes to prevent clumping.
• Dissolution: Continue stirring at 80 °C for 1-4 hours. The mixture will transform from a opaque suspension to a clear, viscous solution.
• Regeneration (Optional): To regenerate the cellulose, slowly pour the dissolved biopolymer solution into a large excess of a anti-solvent (e.g., deionized water or ethanol) under vigorous stirring. Filter the precipitated cellulose and wash thoroughly with the anti-solvent.

Workflow Visualization

Application Note 2: Extraction and Catalysis using scCOâ‚‚ Microemulsions

Background and Principle

A key limitation of pure scCOâ‚‚ is its poor solvating power for polar molecules. This can be overcome by forming water-in-scCOâ‚‚ (W/C) microemulsions [77]. These systems consist of nanoscale water droplets stabilized by surfactants within the continuous scCOâ‚‚ phase, creating polar microenvironments ("microreactors") capable of dissolving ions, metal complexes, and biological molecules. This enables applications like extraction of polar compounds and conducting catalytic reactions in a green scCOâ‚‚ medium.

Experimental Protocol: Formation of a Water-in-scCOâ‚‚ Microemulsion

The Scientist's Toolkit Table 3: Key Reagents and Materials for scCOâ‚‚ Microemulsion

Item	Function/Description
COâ‚‚ Supply	Source of high-purity carbon dioxide gas.
Surfactant	e.g., Perfluoropolyether ammonium carboxylate (PEPE); stabilizes the water core in scCOâ‚‚.
Co-surfactant	e.g., 1-Pentanol; can enhance surfactant performance and microemulsion stability.
High-Pressure Cell	A viewable cell with sapphire windows is ideal for observing phase behavior.
Syringe Pump	For precise delivery of water and other liquid components into the high-pressure system.

Step-by-Step Procedure:

• System Assembly: Clean and dry a high-pressure view cell. Ensure all seals are intact and the system is leak-free.
• Surfactant Loading: Weigh and load a suitable surfactant (e.g., 50-100 mg of PEPE) into the cell.
• System Pressurization: Pressurize the cell with COâ‚‚ to a moderate pressure (e.g., 10-15 MPa) using a high-pressure pump and set the temperature to 40 °C using a thermostat.
• Water Addition: Using a high-pressure syringe pump, slowly introduce an aqueous solution (e.g., 50-200 µL of water or a buffered solution) into the cell while continuously stirring.
• Equilibration and Monitoring: Allow the system to equilibrate with continuous stirring. The formation of a transparent, single-phase microemulsion can be visually confirmed in a view cell, indicating successful dispersion of water nano-droplets. Cloudiness suggests phase separation.
• Application: Once the microemulsion is stable, it can be used for its intended application, such as the extraction of a polar metal ion from a solid matrix or as a medium for a catalytic reaction.

Workflow Visualization

Advanced Hybrid System: IL-scCOâ‚‚ Biphasic Catalysis

A powerful approach that combines the benefits of ILs and scCOâ‚‚ is biphasic catalysis. This protocol leverages the ability of scCOâ‚‚ to extract organic compounds from ILs, facilitating product separation and catalyst recycling [77] [20].

Concept: A reaction (e.g., hydrogenation) is conducted in an IL phase containing a catalyst that is insoluble in scCOâ‚‚. The substrate is delivered via the scCOâ‚‚ stream. After the reaction, the products are extracted from the IL phase into the flowing scCOâ‚‚, leaving the catalyst behind in the IL for reuse.

Brief Protocol:

• Reactor Charging: The catalyst is dissolved or suspended in the IL (e.g., [BMIM]PF₆) within a high-pressure reactor.
• Reaction: The reactor is pressurized with scCOâ‚‚ and the substrate (e.g., an alkene). Hâ‚‚ gas is introduced to a desired pressure. The mixture is stirred for the duration of the reaction.
• Product Separation: The stirring is stopped, allowing the IL and scCOâ‚‚ to form distinct phases. The scCOâ‚‚ phase, now containing the product (e.g., alkane), is vented from the reactor through a separator where the pressure is reduced, causing the COâ‚‚ to vaporize and deposit the product.
• Catalyst Recycling: The IL phase containing the catalyst remains in the reactor and can be reused for subsequent reaction cycles.

The transition from VOCs to ILs and scCOâ‚‚ represents a cornerstone of green chemistry in research and industry. While VOCs are characterized by high volatility and associated health risks, ILs offer unparalleled tunability and negligible vapor pressure, and scCOâ‚‚ provides a safe, adjustable alternative for extraction and reaction engineering. The hybrid IL-scCOâ‚‚ system further underscores the potential of these solvents to enable efficient, sustainable processes with integrated catalyst recycling. The protocols detailed herein provide a foundational toolkit for researchers to confidently integrate these advanced solvents into their work, contributing to the development of safer and more sustainable pharmaceutical and chemical technologies.

The transition toward sustainable industrial processes has intensified the search for alternative solvents, with ionic liquids (ILs) and supercritical fluids (SCFs) representing two of the most promising candidates. Frequently described as "green solvents," they offer properties such as low volatility, tunable solvation power, and reduced environmental persistence compared to conventional volatile organic compounds (VOCs) [50] [79]. However, legitimate claims of environmental superiority require rigorous assessment beyond simple chemical properties. This application note establishes detailed protocols for evaluating the environmental impact of ILs and SCFs using green chemistry metrics and life cycle assessment (LCA) methodologies, providing researchers and drug development professionals with a structured framework for sustainable solvent selection and process design.

Green Chemistry and LCA Methodological Framework

Principles of Green Chemistry and Green Analytical Chemistry

Green Chemistry, founded on twelve principles, aims to design chemical products and processes that reduce or eliminate the use and generation of hazardous substances [57]. In the context of solvents, this involves selecting alternatives that minimize toxicity, improve energy efficiency, and derive from renewable resources. Green Analytical Chemistry extends these principles to analytical activities, focusing on greening sample pretreatment and analysis techniques [80]. For ILs and SCFs, this translates to evaluating their entire role in a process, from synthesis and use to disposal and potential recycling.

Life Cycle Assessment (LCA) Fundamentals

LCA is a standardized methodology for evaluating the environmental impacts associated with all stages of a product's life, from raw material extraction ("cradle") to disposal ("grave") [81]. The LCA structure consists of four iterative stages:

• Goal and Scope Definition: Defines the study's purpose, audience, and functional unit for comparison.
• Life Cycle Inventory (LCI): Involves data collection on all energy and material inputs and outputs.
• Life Cycle Impact Assessment (LCIA): Classifies and characterizes inventory data into environmental impact categories (e.g., global warming potential).
• Life Cycle Interpretation: Analyzes results to draw conclusions and provide recommendations [81].

For ILs and SCFs, a cradle-to-gate or cradle-to-grave scope is typically defined, with the functional unit often expressed as per kg of product manufactured or per unit of analytical result obtained.

Key Green Chemistry Metrics for Solvent Evaluation

Several metrics have been developed to provide a rapid, quantitative assessment of a method's environmental friendliness [80]. These include:

• National Environmental Method Index (NEMI): A pictogram indicating whether a method meets criteria for persistence, bioaccumulation, toxicity, and corrosivity.
• Analytical Eco-Scale: A semi-quantitative score comparing the ideal analysis with the performed analysis, penalizing the use of hazardous reagents and high energy consumption.
• Green Analytical Procedure Index (GAPI): A multi-criteria metric that visualizes the environmental impact of each step of an analytical procedure.
• Analytical GREEnness (AGREE) Metric: A comprehensive tool that uses the 12 principles of Green Analytical Chemistry to provide a final score [80].

Table 1: Key Green Chemistry Metric Tools for Solvent and Method Evaluation

Metric Tool	Key Criteria Assessed	Output Format	Applicability to ILs/SCFs
NEMI	Persistence, Bioaccumulation, Toxicity, Corrosivity	Pictogram	Screening-level assessment of solvent hazard.
Analytical Eco-Scale	Reagent toxicity, Energy consumption, Waste generation	Numerical Score (100 = ideal)	Comparing overall method greenness.
GAPI	All stages of analytical procedure (sampling, extraction, etc.)	Pictogram with 5 pentagrams	Detailed visual impact of each process step.
AGREE	12 Principles of Green Analytical Chemistry	Numerical Score (0-1) & Circular Diagram	Most comprehensive evaluation of analytical method greenness.

Application of LCA to Ionic Liquids and Supercritical Fluids

Life Cycle Assessment of Ionic Liquids

Despite being non-volatile and often described as "green," ILs can incur significant environmental impacts during their synthesis. A seminal LCA study comparing the IL 1-butyl-3-methylimidazolium tetrafluoroborate ([Bmim][BFâ‚„]) with molecular solvents for cyclohexane manufacture and a Diels-Alder reaction found that the IL-based processes were "highly likely to have a larger life cycle environmental impact" [82]. The primary environmental hotspots include the energy-intensive production of the ionic liquid precursor and the use of halogenated solvents during its purification.

Experimental Protocol 1: LCA for an Ionic Liquid-Based Extraction Process

• Goal and Scope: To compare the environmental impact of using [Bmim][BFâ‚„] versus conventional hexane for the extraction of an organic compound from a solid matrix. The functional unit is defined as the processing of 1 kg of solid matrix to achieve 95% analyte recovery.
• Life Cycle Inventory (LCI):
  • System Boundaries: Define a cradle-to-gate system including raw material acquisition, IL synthesis, transportation, energy use during extraction, and waste treatment. Exclude equipment manufacturing.
  • Data Collection:
    • IL Synthesis: Collect data on amounts of 1-methylimidazole, 1-chlorobutane, and sodium tetrafluoroborate; solvent use (e.g., ethyl acetate) for purification; energy for reaction and purification steps.
    • Extraction Process: Record electricity consumption of the extraction apparatus (e.g., stirring, heating) and the mass of IL used.
    • Upstream Data: Use databases like ecoinvent for background processes (e.g., electricity grid mix, chemical production).
• Life Cycle Impact Assessment (LCIA): Select impact categories such as Global Warming Potential (GWP), Cumulative Energy Demand (CED), and Human Toxicity. Calculate characterization factors for all inputs and outputs.
• Interpretation: Perform contribution analysis to identify hotspots (e.g., IL synthesis). Conduct sensitivity analysis on key parameters, such as IL recycling efficiency. A study showed that IL recyclability is a critical factor for improving environmental performance [82].

Life Cycle Assessment of Supercritical Fluids

Supercritical carbon dioxide (scCOâ‚‚) is a popular SCF due to its non-toxicity, non-flammability, and tunable solvation power. However, LCA studies reveal that the environmental profile of scCOâ‚‚ processes is highly dependent on operational parameters, particularly energy consumption. A critical review of 70 LCA studies on SCF processes found that energy is the main environmental hotspot, especially in applications like supercritical water gasification and transesterification [15] [83]. The global warming impact for SCF extraction processes can range widely from 0.2 to 153 kg COâ‚‚-equivalent per kg of input, heavily influenced by the electricity source and process scale [15].

Experimental Protocol 2: LCA for a Supercritical Fluid Extraction (SFE) Process

• Goal and Scope: To evaluate the environmental footprint of scCOâ‚‚ extraction of essential oils from plant material versus steam distillation. The functional unit is 1 kg of extracted essential oil.
• Life Cycle Inventory (LCI):
  • System Boundaries: Cradle-to-gate, including COâ‚‚ production, compression, pumping, heating, extraction, and post-processing.
  • Data Collection:
    • scCOâ‚‚ Process: Record mass of plant material and COâ‚‚, electricity for compressor, pump, and heating mantle, and COâ‚‚ losses.
    • Conventional Process: For steam distillation, record natural gas for steam generation, electricity for pumps, and cooling water.
• Life Cycle Impact Assessment (LCIA): Use an impact method like ReCiPe to calculate impacts on GWP, water consumption, and fossil resource scarcity.
• Interpretation: Benchmark results against conventional extraction. The review notes that 27 LCA studies reported lower impacts for SCF processes, while 18 reported higher impacts, particularly in extraction [15]. Sensitivity analysis should focus on the electricity mix and the potential for process integration to reduce energy demand.

Comparative LCA Findings

The environmental performance of ILs and SCFs is not inherently superior to all conventional solvents. The outcomes of LCA studies are mixed and context-specific. While SCF processes can reduce solvent-related emissions and yield higher-quality outputs, their energy intensity can lead to higher impacts in categories like climate change [15] [84]. Similarly, the complex synthesis of many ILs can outweigh the benefits gained during their application phase [82]. Therefore, a case-by-case evaluation using LCA is essential.

Table 2: Summary of LCA Findings for Ionic Liquids and Supercritical Fluids from Reviewed Literature

Solvent Class	Reported Environmental Impact Range (GWP, kg COâ‚‚-eq)	Main Environmental Hotspot	Key Influencing Factors	Comparative Performance (from reviewed studies)
Ionic Liquids	Varies widely by type and application	Energy and resource use during synthesis; use of hazardous reagents [82].	Precursor chemistry, purification steps, solvent recycling rate [82] [81].	Often higher impact than conventional molecular solvents in lab-scale assessments [82].
Supercritical Fluids (Extraction)	0.2 - 153 kg COâ‚‚-eq per kg input [15]	Energy for fluid compression and heating [15] [83].	Electricity mix, operating pressure/temperature, scale, feed concentration [15].	27 studies report lower impacts, 18 report higher impacts vs. conventional methods [15].

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Materials for Investigating ILs and SCFs in Green Processes

Reagent/Material	Function/Application	Notes on Greenness & Utility
1-Butyl-3-methylimidazolium salts ([Bmim][X])	Model ionic liquid for reaction and extraction media.	Tunable properties with anion [X]⁻ (e.g., [BF₄]⁻, [PF₆]⁻, [Cl]⁻). High synthesis footprint necessitates recycling [82] [57].
Supercritical CO₂ (scCO₂)	Green solvent for extraction, reaction, and cleaning.	Non-toxic, non-flammable. Critical point (31°C, 73.8 bar) accessible. Energy for compression is primary environmental concern [28] [79].
Deep Eutectic Solvents (DES)	Biodegradable and low-cost alternative to some ILs.	Formed from hydrogen-bond donors and acceptors (e.g., choline chloride + urea). Often derived from renewable resources [80] [50].
Ethyl Lactate	Bio-based solvent for extraction and synthesis.	Derived from renewable biomass (e.g., corn). Biodegradable with excellent solvency power [50].
Supported IL Phases (SILPs)	Heterogeneous catalysis and separation.	ILs immobilized on solid supports (e.g., silica), combining IL properties with ease of separation and reduced solvent usage [57].

Workflow and Signaling Pathways

The following diagram illustrates the integrated workflow for applying LCA and green metrics to the development of processes using alternative solvents, highlighting the critical decision points for optimizing environmental performance.

Integrated LCA and Green Metrics Workflow for Solvent Selection

The following diagram outlines the experimental protocol for conducting a supercritical fluid extraction, a common application where LCA is critically important for assessing sustainability.

Supercritical Fluid Extraction Experimental Protocol

Ionic liquids and supercritical fluids present significant opportunities for developing more sustainable chemical processes. However, their "green" credentials cannot be assumed and must be quantitatively validated through rigorous application of life cycle assessment and green chemistry metrics. The protocols and data summarized in this application note provide a foundational framework for researchers to critically evaluate the environmental profiles of these alternative solvents, identifying key hotspots such as energy-intensive synthesis of ILs and compression requirements for SCFs. By integrating these assessment tools from the earliest stages of process design, scientists and drug development professionals can make informed decisions that genuinely advance sustainability goals, driving innovation toward solvents and processes that are not only high-performing but also demonstrably kinder to the environment. Future work must focus on optimizing energy efficiency, improving solvent recycling protocols, and developing more comprehensive and consistent LCA methodologies.

Analyzing Extraction Efficiency and Product Purity in Pharmaceutical Applications

The pursuit of efficient and pure pharmaceutical compounds drives the exploration of advanced extraction technologies. Within this context, ionic liquids (ILs) and supercritical fluids, particularly supercritical carbon dioxide (SC-CO2), have emerged as powerful alternative solvents that align with the principles of green chemistry [58] [85]. These solvents offer unique advantages for the extraction, purification, and processing of active pharmaceutical ingredients (APIs) and bioactive compounds from natural sources. Supercritical fluid extraction (SFE) utilizing SC-CO2 provides an environmentally benign method with high selectivity and minimal solvent residue [37] [63]. Concurrently, ionic liquids, with their tunable properties and negligible vapor pressure, present innovative opportunities for separation processes, including aqueous two-phase systems (ATPS) [86]. This application note details standardized protocols for employing these solvents to maximize extraction efficiency and product purity in pharmaceutical development, providing researchers with practical methodologies for implementation.

Application Notes: Key Solvent Systems & Efficiency Data

Supercritical Fluid Extraction (SFE) with CO2

Supercritical CO2 is the most widely used supercritical fluid in pharmaceutical applications due to its moderate critical parameters (Tc = 31.1°C, Pc = 73.8 bar), non-toxicity, and non-flammability [63] [4]. Its key advantage lies in its tunable solvent power, which can be precisely controlled by adjusting pressure and temperature to selectively extract target compounds [37] [85]. SFE is particularly valuable for extracting thermally labile bioactive compounds because it operates at relatively low temperatures, preventing thermal degradation [37]. The technique effectively eliminates the need for hazardous organic solvents, producing residue-free extracts suitable for pharmaceutical applications [37] [28]. Furthermore, SFE contributes to waste valorisation by converting plant byproducts into value-added extracts [37].

Table 1: Key Parameters Influencing SFE Efficiency and Purity

Parameter	Impact on Extraction Efficiency	Impact on Product Purity
Pressure	Increases solute solubility by increasing fluid density [63]	Enhances selectivity for heavier compounds; enables fractionation [37]
Temperature	Complex effect: increases vapor pressure but decreases density [63]	Higher temperatures can co-extract undesirable compounds [63]
CO2 Flow Rate	Optimizes mass transfer and reduces extraction time [85]	Inadequate flow can reduce purity; optimal flow improves separation [85]
Co-solvent (e.g., Ethanol)	Dramatically improves solubility of polar compounds [37]	Can reduce selectivity if not properly optimized; requires removal [37]
Extraction Time	Must be sufficient to reach equilibrium and exhaustive extraction [63]	Prolonged time may lead to co-extraction of impurities [63]

Ionic Liquids in Aqueous Two-Phase Systems (IL-ATPS)

Ionic liquids offer exceptional tunability through careful selection of cation-anion pairs, allowing researchers to design extraction systems with specific properties [86] [58]. IL-based ATPS have demonstrated remarkable efficiency in the separation and purification of a wide range of pharmaceuticals, from small molecules to large biomolecules [86]. These systems are highly scalable, enabling applications from milliliter-scale drug development to commercial manufacturing [86]. The mechanism for purification in ATPS is driven by the differential affinity of the target compound and contaminants for the two liquid phases [86]. The process involves three major steps: molecular partitioning, physical coalescence, and isolation of the phase of interest [86]. While polymer-based ATPS are limited to macromolecules, IL-ATPS are particularly effective for separating small molecules (< 900 Daltons), which are common in pharmaceutical applications [86].

Table 2: Ionic Liquid Applications in Pharmaceutical Separations

Ionic Liquid System	Target Pharmaceutical	Reported Efficiency/Advantage
Imidazole-terminal PEG	Penicillin	Up to 96% extraction efficiency [86]
Polymer-Salt ATPS	Macromolecules (Proteins, Antibodies)	High yield and scalability from bench to industrial scale [86]
Functionalized PEG with glutaric acid	Immunoglobulins	Improved extraction yields from 28% to 93% [86]
IL-ATPS (General)	Organic compounds, small molecules	Higher yield separations and efficient solvent recycling [86]

Combined SFE and Ionic Liquid Systems

The combination of ionic liquids and supercritical fluids creates synergistic systems that leverage the advantages of both solvents [28]. A significant discovery is that the solubility of SC-CO2 in several ionic liquids is very high, while the solubility of ionic liquids in SC-CO2 is negligibly low [28]. This unique property enables the extraction of organic solutes from ionic liquids using SC-CO2 without any contamination by the ionic liquid [28]. This has led to the development of integrated processes where chemical reactions are carried out in the ionic liquid medium, followed by product extraction using SC-CO2 [28]. Recent advancements have expanded the role of SC-CO2 to function as both an extraction medium and a miscibility controller, thereby enhancing reaction and separation rates [28].

Experimental Protocols

Protocol 1: SFE of Bioactive Compounds from Plant Material

This protocol describes the standardized operation of a supercritical fluid extraction system for the isolation of bioactive compounds from plant matrices, such as herbs, spices, or plant byproducts [37] [63].

Materials and Equipment:

• Supercritical fluid extraction system equipped with a CO2 cylinder, pump, co-solvent addition unit, pressure-controlled extraction vessel, heating jacket, back-pressure regulator, and separator [63]
• Liquid carbon dioxide (food or pharmaceutical grade)
• Co-solvent (e.g., pharmaceutical grade ethanol)
• Plant material (dried and ground to 250-500 μm particle size)
• Analytical balance

Procedure:

• Sample Preparation: Weigh 50-100 g of ground plant material. For improved efficiency, mix the plant material with an inert material like glass beads to prevent channeling during extraction [63].
• System Preparation: Load the sample into the extraction vessel. Ensure the system is clean and all connections are secure. Set the back-pressure regulator to maintain the desired system pressure [37].
• Extraction Conditions:
  • Temperature: Set to 40-80°C based on the target compounds' thermal stability [37] [63].
  • Pressure: Adjust to 100-400 bar. Higher pressures increase solvent power for heavier compounds [63] [85].
  • CO2 Flow Rate: Maintain at 1-10 g/min depending on the vessel size and desired extraction time [85].
  • Co-solvent: If extracting polar compounds (e.g., polyphenols), add 1-15% (v/v) ethanol to the CO2 stream [37].
  • Extraction Time: Typically 1-4 hours, determined by exhaustion of the extractable material [63].
• Extract Collection: Reduce pressure in the separator stage to precipitate the extract. Collect the extract in a cooled vessel. Weigh the extract and analyze for target compounds and potential solvent residues [37].
• System Shutdown: Depressurize the system slowly. Clean the vessel and lines with an appropriate solvent if necessary [63].

Protocol 2: IL-ATPS for Pharmaceutical Separation

This protocol outlines the use of ionic liquid-based aqueous two-phase systems for the purification of pharmaceutical compounds, such as small molecule drugs or biomolecules [86].

Materials and Equipment:

• Ionic liquid (e.g., imidazolium-based ILs like [C4mim][BF4])
• Salt (e.g., K2HPO4, K3PO4) or polymer (e.g., PEG) for phase formation
• Pharmaceutical solution (e.g., fermentation broth, reaction mixture)
• Centrifuge
• Water bath or temperature-controlled mixer
• High aspect ratio separation vessel [86]

Procedure:

• System Preparation: Prepare an aqueous solution of the ionic liquid (e.g., 20-40% w/w) in a separation vessel. Add the pharmaceutical solution to the IL solution [86].
• Phase Formation: Add a concentrated salt or polymer solution to the mixture with gentle stirring to induce phase separation. The final composition should be selected based on the phase diagram of the specific IL-salt/polymer system [86].
• Equilibration: Allow the system to equilibrate at constant temperature (e.g., 25°C) for 15-30 minutes to achieve complete partitioning of the target compound [86].
• Phase Separation: Two options are available:
  • Gravity Separation: Let the system stand until two clear phases form. This may take 30 minutes to several hours depending on viscosity [86].
  • Centrifugation: Centrifuge at 2000-3000 × g for 5-15 minutes to accelerate phase separation [86].
• Product Recovery: Carefully separate the two phases using a pipette or syringe, avoiding the interface where contaminants concentrate. Recover the target compound from the phase of interest using appropriate techniques (e.g., crystallization, back-extraction) [86].
• IL Recycling: Recover the ionic liquid for reuse by evaporating water, precipitating salts, or using membrane processes [87].

Workflow Visualization

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Materials for Pharmaceutical Extraction Studies

Reagent/Material	Function/Application	Notes for Pharmaceutical Use
Supercritical CO2	Primary solvent for SFE; non-polar character [37] [63]	Pharmaceutical grade; critical temperature 31.1°C, pressure 73.8 bar [63]
Ethanol (Pharmaceutical Grade)	Co-solvent for SFE; increases polarity of SC-CO2 [37]	GRAS status; typically used at 1-15% (v/v) [37]
Imidazolium-Based ILs (e.g., [Câ‚„mim][BFâ‚„])	Tunable solvents for ATPS; replace volatile organic compounds [86] [58]	Select cation/anion based on target compound hydrophobicity [86]
Polyethylene Glycol (PEG)	Polymer phase in ATPS; biocompatible and biodegradable [86]	Molecular weight affects partitioning; functionalization possible [86]
Inorganic Salts (K₂HPO₄, K₃PO₄)	Salt phase in ATPS; induces phase separation with ILs or polymers [86]	Cost-effective; high concentration may cause biomolecule denaturation [86]
Functionalized PEG	Affinity-tagged polymers for improved selectivity in ATPS [86]	Enhanced extraction yields for specific targets (e.g., immunoglobulins) [86]

The strategic application of supercritical fluids and ionic liquids provides pharmaceutical scientists with powerful tools to enhance extraction efficiency and product purity while aligning with green chemistry principles. Supercritical CO2 extraction offers unparalleled control through tunable solvent properties, minimal residual solvent, and compatibility with thermolabile compounds [37] [63]. Ionic liquids, particularly in ATPS configurations, enable highly selective separations of diverse pharmaceutical compounds through customizable solvent properties [86] [58]. The integration of these technologies creates synergistic systems that leverage the advantages of both approaches [28]. The protocols and data presented herein provide a foundation for implementing these advanced extraction methodologies in pharmaceutical research and development, potentially leading to improved drug substances with reduced environmental impact.

Economic Viability and Market Trends in the Ionic Liquids Sector

The ionic liquids market is experiencing robust growth, transitioning from academic exploration to broad commercial adoption across industrial sectors. These solvents are increasingly integral to sustainable chemical processes, energy storage, and pharmaceutical applications [13] [88].

Global Market Size and Growth Trajectory

Table 1: Global Ionic Liquids Market Size and Growth Projections

Metric	Value	Time Period/Year	Source
Market Size (2024)	USD 61.24 Million	2024	[13]
Market Size (2025)	USD 66.34 Million	2025	[13]
Market Size (2034)	USD 136.18 Million	2034	[13]
CAGR	8.32%	2025-2034	[13]
Alternative CAGR	6.9%	2025-2032	[88]
2031 Projection	USD 121.9 Million	2031	[88]

Growth is propelled by ionic liquids' role as sustainable, high-performance materials. Key drivers include their negligible vapor pressure, high thermal stability, tunable solubility, and non-flammability, which make them ideal for green chemistry and safer industrial processes [13] [89].

Market Segmentation and Dominant Applications

Table 2: Ionic Liquids Market Share by Key Segments (2024)

Segment Type	Dominant Segment	Market Share (2024)	High-Growth Segment	Projected CAGR
Type	Room Temperature Ionic Liquids (RTILs)	~55%	High-Temperature Ionic Liquids	Highest [13]
Application	Chemical Synthesis & Catalysis	28%	Gas Separation & COâ‚‚ Capture	Notable [13]
Form	Liquid	65%	Solid / Gel	Highest [13]
End-User	Chemicals & Petrochemicals	30%	Environmental & Waste Treatment	~7% [13]

Regional Market Dynamics

North America held a dominant market position in 2024, accounting for approximately 35% of the global share [13]. The Asia-Pacific region, however, is expected to grow at the fastest CAGR from 2025 to 2034, driven by rapid industrialization and investments in clean technologies [13]. Global trade dynamics are also significant, with Germany being a major exporter and India a significant importer of specialty chemicals, including ionic liquids [13].

Application Notes and Protocols

Ionic liquids' versatility allows for tailored formulations to meet specific application needs. Below are detailed protocols for two high-growth areas: biomass valorization and carbon capture.

Application Note 101: Biomass Valorization Using Pressurized Liquid Extraction (PLE) with Ionic Liquids

Objective: To efficiently extract bioactive compounds (e.g., polyphenols, anthocyanins) from agro-industrial food waste using Ionic Liquid-based Pressurized Liquid Extraction (IL-PLE) [90].

Background: PLE uses solvents at elevated temperatures and pressures to remain liquid, enhancing extraction kinetics and yield. Ionic liquids serve as green, tunable solvents in this process, improving the solubility and stability of target compounds [90].

Protocol 101A: IL-PLE of Bioactive Compounds from Blueberry Processing Waste

Research Reagent Solutions: Table 3: Essential Reagents for IL-PLE of Bioactive Compounds

Reagent/Material	Function/Description	Example/Note
Ionic Liquid Solvent	Primary extraction solvent; tunable to target specific compounds.	e.g., Imidazolium-based ILs ([DA-2PS][XCly]â‚‚) [13].
Agro-Industrial Waste	Source matrix for bioactive compounds.	Dried, milled blueberry pomace (skin, seeds) [90].
Diatomaceous Earth	Inert dispersant to prevent sample compaction in extraction cell.	-
Co-Solvent	Modifies IL polarity to optimize compound solubility.	Food-grade ethanol/water mixture [90].
Nitrogen Gas	Inert gas for purging the system post-extraction.	-

Experimental Workflow:

Detailed Methodology:

• Sample Preparation:

  • Drying: Subject blueberry pomace (skins, seeds) to freeze-drying to preserve thermolabile compounds.
  • Comminution: Mill the dried pomace and sieve to a uniform particle size (e.g., 0.5-1.0 mm). Avoid excessive grinding to prevent compaction [90].
  • Mixing: Homogenize the sample with an inert dispersant like diatomaceous earth (approx. 1:1 ratio) to improve solvent flow [90].

• IL-PLE Solvent System:

  • Prepare a water-ethanol mixture with a tailored ionic liquid (e.g., imidazolium-based). The IL concentration and solvent ratio should be optimized for the target bioactive compounds [90].

• PLE Extraction Procedure:

  • Cell Loading: Accurately weigh the prepared sample mixture into the stainless-steel extraction cell.
  • System Stabilization: Place the cell in the oven chamber. Set the temperature (e.g., 80-150°C), pressure (e.g., 1000-2000 psi), and solvent flow rate. Higher temperatures decrease solvent viscosity and break matrix-compound bonds but risk degrading thermolabile compounds above 150°C [90].
  • Static Extraction: Pressurize the system and maintain conditions for 5-15 minutes to allow solvent diffusion and compound dissolution.
  • Dynamic Elution: Open the outlet valve to allow the extract to flow through the cell at a controlled rate (e.g., 1-3 mL/min) into a collection vessel.
  • System Purge: After extraction, purge the system with nitrogen or carbon dioxide to recover the entire extract [90].

• Downstream Processing:

  • Analysis: Analyze the extract for target bioactive compounds (e.g., 16 anthocyanins identified from blueberry waste) using HPLC or GC-MS [90].
  • Solvent Recovery: Recover and recycle the ionic liquid for process economic and environmental viability.

Application Note 102: COâ‚‚ Capture Using Task-Specific Ionic Liquids

Objective: To deploy task-specific ionic liquids for efficient post-combustion carbon dioxide (COâ‚‚) capture from industrial flue gases [13].

Background: Ionic liquids are excellent candidates for COâ‚‚ capture due to their low vapor pressure, high thermal stability, and ability to be functionalized with amine or other groups that chemically bind with COâ‚‚, leading to high absorption capacities and lower energy requirements for regeneration compared to conventional amines [13] [91].

Protocol 102A: Gas Scrubbing with Functionalized Ionic Liquids

Research Reagent Solutions: Table 4: Essential Reagents for COâ‚‚ Capture with Ionic Liquids

Reagent/Material	Function/Description	Example/Note
Task-Specific IL	Absorption liquid with high affinity for COâ‚‚.	e.g., Amino-acid-functionalized or imidazolium-based ILs [13].
Simulated Flue Gas	Model system for experimentation.	10-15% COâ‚‚ in Nâ‚‚ balance.
Gas Analyzer	Measures COâ‚‚ concentration in inlet/outlet streams.	NDIR COâ‚‚ Analyzer.

Experimental Workflow:

Detailed Methodology:

• Ionic Liquid Preparation:

  • Select a task-specific ionic liquid, such as an amino-acid-functionalized IL, for chemical absorption.
  • Pre-dry the IL under vacuum at elevated temperature (e.g., 60-80°C) to remove moisture, which can affect COâ‚‚ capacity and IL stability.

• Absorption Phase:

  • Column Packing: Load the dried ionic liquid into a absorption column equipped with structured packing or trays to maximize gas-liquid contact surface area.
  • Gas Contact: Introduce a simulated flue gas mixture (e.g., 15% COâ‚‚, balance Nâ‚‚) at the bottom of the column at a controlled flow rate.
  • Counter-Current Flow: The flue gas rises, contacting the descending ionic liquid. COâ‚‚ is absorbed through physical dissolution or chemical reaction with the functional groups of the IL.
  • Efficiency Monitoring: Monitor the COâ‚‚ concentration in the treated gas stream exiting the column top using a gas analyzer until breakthrough occurs, indicating IL saturation.

• Regeneration Phase:

  • Desorption: Transfer the COâ‚‚-rich ionic liquid to a regeneration (stripping) column.
  • Energy Input: Apply heat (e.g., 100-120°C) and/or apply a vacuum to break the chemical bonds between the IL and COâ‚‚. The low volatility of ILs allows for this without significant solvent loss.
  • Product Capture: Capture the released, high-purity COâ‚‚ stream for utilization or storage.
  • IL Recycle: Return the regenerated, lean ionic liquid to the absorption column for reuse. The stability of ILs allows for multiple absorption-desorption cycles with minimal degradation.

Enzymatic esterification is a cornerstone of green chemistry, enabling the sustainable synthesis of esters for pharmaceuticals, flavors, and biofuels. The choice of reaction medium profoundly influences enzyme activity, stability, selectivity, and process efficiency. Traditional organic solvents often pose environmental and health challenges. This case study explores two classes of alternative solvents—ionic liquids (ILs) and supercritical fluids (SCFs)—within the broader context of sustainable solvent research. We provide a quantitative comparison and detailed experimental protocols to guide researchers in implementing these advanced biocatalytic systems.

Quantitative Comparison of Reaction Media

The following table summarizes key performance metrics for enzymatic esterification in ionic liquids, supercritical fluids, and ultrasound-assisted systems, as reported in the literature.

Table 1: Performance comparison of enzymatic esterification in different media

Reaction Medium	Model Reaction	Enzyme	Key Optimal Conditions	Reported Yield	Key Advantages
Ionic Liquids	Ethyl lactate synthesis	Candida antarctica lipase B	40°C, 24h, 2% initial water content [92]	95% [92]	High enzyme stability, reusable catalyst, tunable solvent properties [92] [93]
Ionic Liquids	Hexyl dihydrocaffeate synthesis	C. antarctica lipase B (Novozym 435)	39.4°C, 77.5h, 2.1:1 hexanol/acid ratio [93]	84.4% [93]	Enhanced solubility of phenolic acids, high conversion [93]
Supercritical CO₂	Fatty acid butyl ester synthesis	Immobilized Mucor miehei lipase	40°C, 20 MPa pressure [94]	~90% (Model predicted) [94]	Rapid reaction rates, easy product separation, non-toxic [94] [95]
Ultrasound-Assisted	Isoamyl acetate synthesis	C. antarctica lipase B (Lipozyme 435)	50°C, 32 mW power, 20% amplitude [96]	~92% (of equilibrium) in 2h [96]	Dramatically reduced reaction time, enhanced mass transfer [96]

Detailed Experimental Protocols

Protocol 1: Enzymatic Esterification in Ionic Liquids

This protocol outlines the synthesis of ethyl lactate in Cyphos 104 IL, based on a study that achieved a 95% yield [92].

Reagents and Equipment

• Ionic Liquid: Cyphos 104 (0.8 mmol)
• Substrates: Lactic acid (2 mmol), Ethanol (14 mmol, 7x excess)
• Biocatalyst: Immobilized Candida antarctica lipase B (25 mg)
• Equipment: Round-bottom flask (10 mL), magnetic stirrer, temperature-controlled incubator, water activity meter, gas chromatograph (GC) for analysis.

Step-by-Step Procedure

• Water Activity Control: Pre-equilibrate the ionic liquid and the enzyme to a water activity of approximately 0.2. This can be achieved by placing them in a closed container over a saturated salt solution.
• Reaction Mixture Setup: In a 10 mL round-bottom flask, combine 0.8 mmol of Cyphos 104, 2 mmol of lactic acid, 14 mmol of ethanol, and 25 mg of the immobilized lipase.
• Incubation: Seal the flask and place it in an incubator. Stir the reaction mixture continuously at 40°C for 24 hours.
• Termination and Analysis: After 24 hours, separate the enzyme by filtration. Analyze the reaction mixture using GC to determine the conversion yield of ethyl lactate.

Notes

• A small amount of initial water (~2%) is crucial for maintaining enzyme conformation and activity [92].
• The enzyme can typically be recovered by filtration and reused for multiple cycles with minimal loss of activity in the IL medium [92] [97].

Protocol 2: Enzymatic Esterification in Supercritical Carbon Dioxide

This protocol describes the esterification of free fatty acids (FFA) from hydrolyzed soy deodorizer distillate with butanol in SC-COâ‚‚, optimized using Response Surface Methodology [94].

Reagents and Equipment

• Substrate: Hydrolyzed soy deodorizer distillate (FFA source), Butanol
• Biocatalyst: Immobilized Mucor miehei lipase
• Equipment: High-pressure enzymatic reactor system, COâ‚‚ cylinder with pump, temperature and pressure controls, back-pressure regulator, sample collection port.

Step-by-Step Procedure

• Reactor Loading: Load a fixed amount of the immobilized lipase into the high-pressure reactor.
• Substrate Introduction: Mix the hydrolyzed soy deodorizer distillate with butanol at the optimal molar ratio and introduce it into the reactor.
• Pressurization and Heating: Pressurize the reactor with COâ‚‚ to the target pressure (e.g., 20 MPa) and heat to the target temperature (e.g., 40°C).
• Reaction: Maintain the system under supercritical conditions with continuous stirring for the desired reaction time.
• Product Recovery: After the reaction, slowly depressurize the system. SC-COâ‚‚ will separate, leaving the products and unreacted substrates in the reactor. The esterified product can be collected for further analysis.

Notes

• The mutual effects of temperature and alcohol concentration are highly pronounced in SC-COâ‚‚ [94].
• The water generated as a byproduct dissolves in SC-COâ‚‚, shifting the equilibrium towards ester formation and eliminating the need for additional water-removing agents [94].

Workflow for Solvent System Selection

The following diagram illustrates a logical decision-making workflow for selecting an appropriate medium for enzymatic esterification, based on the research objectives and constraints.

Solvent Selection Workflow

The Scientist's Toolkit: Key Research Reagents

Table 2: Essential materials and reagents for enzymatic esterification studies

Reagent/Material	Function/Application	Specific Example(s)
Immobilized Lipases	Biocatalyst for esterification; immobilization enables easy reuse.	Candida antarctica Lipase B (Novozym 435, Lipozyme 435) [92] [96] [93]; Mucor miehei lipase [94]
Phosphonium Ionic Liquids	Green solvent medium for reactions; enhances enzyme stability.	Cyphos 104 [92]
Imidazolium Ionic Liquids	Green solvent medium; tunable properties for different substrates.	[bmim]PF₆ [97]
Supercritical Carbon Dioxide	Non-toxic, tunable reaction medium; simplifies downstream separation.	SC-COâ‚‚ for esterification and extraction [94] [95]
Response Surface Methodology	Statistical tool for optimizing multiple reaction parameters efficiently.	Used to optimize temperature, pressure, and substrate ratios in SC-COâ‚‚ [94] [93]

This comparative analysis demonstrates that advanced solvent systems can significantly outperform conventional organic solvents in enzymatic esterification.

• Ionic Liquids excel as solvents for high-value synthesis, providing an environment that enhances enzyme stability and allows for extensive catalyst reuse, which is critical for cost-sensitive applications [92] [97]. Their tunable nature also makes them ideal for substrates with poor solubility in organic solvents, such as phenolic acids [93].
• Supercritical Fluids, particularly SC-COâ‚‚, offer a superior platform for process intensification. Their excellent mass transfer properties lead to faster reaction rates, and the ease of product separation via depressurization simplifies downstream processing [94] [95] [98]. The ability to tune solvent properties with pressure and temperature provides a powerful lever for controlling reactions.
• Ultrasound Assistance is a powerful tool for process intensification, capable of drastically reducing reaction times by improving mass transfer and activating enzymes [96]. It can be integrated with various solvent systems.

In conclusion, the choice between ionic liquids, supercritical fluids, or hybrid approaches should be guided by the specific research and development goals. ILs are ideal for maximizing catalyst lifespan in value-added chemical synthesis, while SCFs are better suited for scalable processes where separation efficiency and reaction kinetics are paramount. These media represent powerful tools for developing cleaner, more efficient synthetic pathways in the pharmaceutical and chemical industries.

Conclusion

Ionic liquids and supercritical fluids represent a paradigm shift in solvent technology for the pharmaceutical industry, offering a powerful and tunable toolkit to address critical challenges in drug synthesis, extraction, and delivery. Their unique and often complementary properties—such as the non-volatility and structural tunability of ILs and the high diffusivity and environmental friendliness of SCFs—enable enhanced reaction rates, improved solubility of APIs, and cleaner separation processes. While significant progress has been made, evidenced by growing market trends and successful proof-of-concept studies, the path to widespread clinical adoption requires continued research. Future efforts must focus on comprehensive long-term toxicity studies, the development of cost-effective and biodegradable ILs, the optimization of energy-intensive SCF processes, and rigorous clinical trials to validate the safety and efficacy of these innovative systems in human therapeutics. The continued integration of ILs and SCFs holds the promise of ushering in a new era of sustainable and efficient pharmaceutical manufacturing.

References

• 1. - Wikipedia Ionic liquid [https://en.wikipedia.org/wiki/Ionic_liquid]
• 2. Editorial: Properties and Applications of Ionic in Energy and... Liquids [https://pmc.ncbi.nlm.nih.gov/articles/PMC7769932/]
• 3. Knowing Ionic : A Guide for Scientists And Researchers Liquids [https://mindthegraph.com/blog/ionic-liquids/]
• 4. - Wikipedia Supercritical fluid [https://en.wikipedia.org/wiki/Supercritical_fluid]
• 5. : Supercritical and Fluids | IntechOpen Properties Applications [https://www.intechopen.com/chapters/82202]
• 6. Example | Supercritical and Uses | Shimadzu Fluid Properties [https://www.shimadzu.com/an/service-support/technical-support/liquid-chromatography/advanced_analysis/properties-of-supercritical-fluids.html]
• 7. : Their Supercritical and Fluids | NIST Properties Applications [https://www.nist.gov/publications/supercritical-fluids-their-properties-and-applications]
• 8. & Ionic Liquids Properties Applications [https://www.sigmaaldrich.cn/CN/en/technical-documents/technical-article/chemistry-and-synthesis/reaction-design-and-optimization/ionic-liquids-properties-applications]
• 9. Combining ionic liquids and supercritical fluids for green technology | Research groups | Imperial College London [https://www.imperial.ac.uk/vibrational-spectroscopy-and-chemical-imaging/research/supercritical-fluids-ionic-liquids-and-intermolecular-interactions/ionic-liquids/]
• 10. : Their Supercritical and Fluids | SpringerLink Properties Applications [https://link.springer.com/chapter/10.1007/978-94-011-3929-8_1]
• 11. for Battery Applications Market Size Report, 2034 Ionic Liquids [https://www.gminsights.com/industry-analysis/ionic-liquids-for-battery-applications-market]
• 12. and the future of soft materials | Royal Society Ionic liquids [https://royalsociety.org/science-events-and-lectures/2025/03/ionic-liquids/]
• 13. Market Size to Hit USD 136.18 Million by 2034 Ionic Liquids [https://www.precedenceresearch.com/ionic-liquids-market]
• 14. Uncovering ion transport mechanisms in ionic using liquids ... data [https://pubs.rsc.org/en/content/articlehtml/2025/dd/d4dd00378k]
• 15. Environmental impacts of supercritical fluids processes: A critical review of life cycle assessment studies - ScienceDirect [https://www.sciencedirect.com/science/article/pii/S0195925525003038]
• 16. Exploring the Biological Activities of Ionic and Their Potential... Liquids [https://pmc.ncbi.nlm.nih.gov/articles/PMC12031513/]
• 17. Chromatography Supercritical Fluid [https://www.news-medical.net/life-sciences/Supercritical-fluid-chromatography.aspx]
• 18. Are supercritical fluids solvents for the future? - ScienceDirect [https://www.sciencedirect.com/science/article/abs/pii/S0255270118315721]
• 19. (PDF) Ionic : liquids ability and Solvation polarity [https://www.academia.edu/144288744/Ionic_liquids_Solvation_ability_and_polarity]
• 20. Ionic Liquids and Supercritical Co2 | SpringerLink [https://link.springer.com/chapter/10.1007/978-94-010-0127-4_23]
• 21. No Solute Left behind: Supercritical vs Liquid Solvents Fluids [https://extraktlab.com/supercritical-fluids-vs-liquid-solvents/]
• 22. Ionic Liquids — Tutorials 2025.1 documentation [https://www.scm.com/doc/Tutorials/COSMO-RS/Ionic_Liquids.html]
• 23. - Wikipedia Supercritical carbon dioxide [https://en.wikipedia.org/wiki/Supercritical_carbon_dioxide]
• 24. Electrodeposition from supercritical fluids - Physical Chemistry... [https://pubs.rsc.org/en/content/articlehtml/2014/cp/c3cp54955k]
• 25. Comparison of supercritical and CO2 and methanol-modified... CHF 3 [https://pubmed.ncbi.nlm.nih.gov/8823912/]
• 26. Role of supercritical ( carbon ) in fabrication of... dioxide scCO 2 [https://pubmed.ncbi.nlm.nih.gov/34512177/]
• 27. Analysis of Mechanisms for PVP-Active-Agent Formulation as in Supercritical Antisolvent Spray Process | SpringerLink [https://link.springer.com/chapter/10.1007/978-3-319-32370-1_24]
• 28. in Supercritical - fluids portal Eindhoven... ionic liquids Research [https://research.tue.nl/en/publications/supercritical-fluids-in-ionic-liquids]
• 29. Supercritical fluids, ionic liquids and intermolecular interactions | Research groups | Imperial College London [https://www.imperial.ac.uk/vibrational-spectroscopy-and-chemical-imaging/research/supercritical-fluids-ionic-liquids-and-intermolecular-interactions/]
• 30. Determination of 5-fluorouracil anticancer drug solubility in supercritical CO2using semi-empirical and machine learning models | Scientific Reports [https://www.nature.com/articles/s41598-025-87383-z]
• 31. A comparative study of biocatalysis in non-conventional solvents: Ionic liquids, supercritical fluids and organic media - Green Chemistry (RSC Publishing) [https://pubs.rsc.org/en/content/articlelanding/2004/gc/b405614k/unauth]
• 32. 10 Chemical Industry Trends Shaping the Future in 2025 [https://www.hellonesh.io/blog/10-chemical-industry-trends-shaping-the-future-in-2025]
• 33. The Role of Ionic Liquids in the Pharmaceutical Field: An Overview of... [https://pmc.ncbi.nlm.nih.gov/articles/PMC7663996/]
• 34. Ionic Liquids Assisted Topical Drug Delivery for Permeation... [https://link.springer.com/article/10.1208/s12249-022-02313-w]
• 35. Nanotechnology Shows Promise for API and Delivery Synthesis [https://www.pharmtech.com/view/nanotechnology-shows-promise-api-synthesis-and-delivery]
• 36. : Benefits and Applications Supercritical Fluids Extraction [https://extraktlab.com/supercritical-fluids-extraction/]
• 37. Techniques for Obtaining Biologically Active... Supercritical Extraction [https://pmc.ncbi.nlm.nih.gov/articles/PMC11171758/]
• 38. Superlong supercooling solvents (SSSs): Alternative green solvents to ionic liquids and deep eutectic solvents for lithium-ion batteries recycling - ScienceDirect [https://www.sciencedirect.com/science/article/abs/pii/S016773222302216X]
• 39. : Process & Supercritical Fluid Extraction Principles [https://www.vaia.com/en-us/explanations/engineering/chemical-engineering/supercritical-fluid-extraction/]
• 40. OF SOLUBILITY ... | PharmaTutor ENHANCEMENT POORLY WATER [https://www.pharmatutor.org/articles/solubility-enhancement-of-poorly-water-soluble-drug-by-spherical-crystallization-technique]
• 41. Enhancement Techniques: A Comprehensive Review of... Solubility [https://www.ijpsjournal.com/article/Solubility+Enhancement+Techniques+A+Comprehensive+Review+of+Approaches+for+Poorly+Soluble+Drugs]
• 42. (PDF) A review of ionic towards liquids supercritical fluid applications [https://www.academia.edu/6181383/A_review_of_ionic_liquids_towards_supercritical_fluid_applications]
• 43. technology for solubilization of Supercritical ... fluid poorly water [https://pmc.ncbi.nlm.nih.gov/articles/PMC8915588/]
• 44. Application of machine learning approach to estimate the solubility of some solid drugs in supercritical CO2 - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC11822099/]
• 45. Nanoparticles of Poorly - Water Prepared by... Soluble Drugs [https://link.springer.com/article/10.1007/s11095-005-8635-4]
• 46. Design Principles and Applications of Ionic for Transdermal... Liquids [https://pmc.ncbi.nlm.nih.gov/articles/PMC11578336/]
• 47. Frontiers | An insight into pharmaceutical challenges with ionic ... liquids [https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2024.1454247/full]
• 48. Using Supercritical Fluid Technology as a Green Alternative During the Preparation of Drug Delivery Systems [https://www.mdpi.com/1999-4923/11/12/629]
• 49. Supercritical Fluids: An Innovative Strategy for Drug Development - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC11351119/]
• 50. Green Analytical Approaches and Eco-Friendly Solvents : Advancing... [https://www.orientjchem.org/staging/vol41no2/green-analytical-approaches-and-eco-friendly-solvents-advancing-industrial-applications-and-environmental-sustainability-a-comprehensive-review/]
• 51. sciencedirect.com/science/article/abs/pii/S0896844607002033 [https://www.sciencedirect.com/science/article/abs/pii/S0896844607002033]
• 52. Frontiers | Recent advancements toward the incremsent of drug ... [https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2024.1467289/full]
• 53. (PDF) Modular synthesis framework for combined ... [https://www.academia.edu/16559902/Modular_synthesis_framework_for_combined_separation_reaction_systems]
• 54. - TU Delft Research Portal Reactive Separations [https://research.tudelft.nl/en/publications/reactive-separations]
• 55. Purification of ionic liquids by supercritical CO2 monitored by infrared spectroscopy - ScienceDirect [https://www.sciencedirect.com/science/article/abs/pii/S0896844610002834]
• 56. Technology: Investigating the Use of Supercritical ... Fluid Supercritical [https://diversedaily.com/supercritical-fluid-technology-investigating-the-use-of-supercritical-fluids-in-extraction-reaction-and-material-processing/]
• 57. in polymer technology - Green Chemistry... Ionic liquids [https://pubs.rsc.org/en/content/articlehtml/2025/gc/d4gc05445h]
• 58. The Influence of Ionic Liquids on the Effectiveness of Analytical Methods Used in the Monitoring of Human and Veterinary Pharmaceuticals in Biological and Environmental Samples—Trends and Perspectives - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC7024248/]
• 59. (PDF) Ionic and liquids carbon dioxide: green and... supercritical [https://www.academia.edu/113346339/Ionic_liquids_and_supercritical_carbon_dioxide_green_and_alternative_reaction_media_for_chemical_processes]
• 60. Models for Mass Extraction | SpringerLink Transfer Supercritical Fluid [https://link.springer.com/chapter/10.1007/978-3-319-10611-3_3]
• 61. Kinetics and polarity effects in the synthesis of the ionic liquid, 1-hexyl-3-methyl-imidazolium bromide, using compressed CO2 - ScienceDirect [https://www.sciencedirect.com/science/article/abs/pii/S0896844614003386]
• 62. Unlocking the potential of supported liquid phase catalysts with supercritical fluids: low temperature continuous flow catalysis with integrated product separation - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC4650014/]
• 63. Technologies to Extract Bioactive... Solvent Supercritical Fluid [https://pmc.ncbi.nlm.nih.gov/articles/PMC6152233/]
• 64. Solubility of oxygen in the ionic liquid [bmim][PF6]: Experimental and molecular simulation results - ScienceDirect [https://www.sciencedirect.com/science/article/abs/pii/S0021961405000613]
• 65. Molecular mechanisms of ionic liquid cytotoxicity probed by an... [https://www.nature.com/articles/srep19889?error=cookies_not_supported&code=8ab0880a-bdbd-47e4-a2c9-c5af5231bb0d]
• 66. in Technical Documentation: Medical... | Docsie.io Blog Biocompatibility [https://www.docsie.io/blog/glossary/biocompatibility/]
• 67. Testing Solutions For Medical Devices Market Size... Biocompatibility [https://www.strategicrevenueinsights.com/industry/biocompatibility-testing-solutions-for-medical-devices-market]
• 68. 5 learnings from FDA’s new Biocompatibility guidance | Congenius [https://congenius.ch/5-learnings-from-fdas-new-biocompatibility-guidance/]
• 69. Frontiers | Recent advances in AI-based toxicity prediction for drug... [https://www.frontiersin.org/journals/chemistry/articles/10.3389/fchem.2025.1632046/full]
• 70. Streamlining Toxicity Predictions with In Silico Profiling - Life Science... [https://www.instem.com/streamlining-toxicity-predictions-with-in-silico-profiling/]
• 71. Video: Experimental for Using Drosophila As an Invertebrate... Protocol [https://www.jove.com/v/57450/experimental-protocol-for-using-drosophila-as-an-invertebrate-model]
• 72. Measurement and correlation of supercritical CO2 and ionic liquid systems for design of advanced unit operations | Frontiers of Chemical Science and Engineering [https://link.springer.com/article/10.1007/s11705-009-0151-3]
• 73. (PDF) Process intensification by combining ionic and... liquids [https://www.academia.edu/30162738/Process_intensification_by_combining_ionic_liquids_and_supercritical_carbon_dioxide_applied_to_the_design_of_Levodopa_production]
• 74. Formulation: Process Choice and Supercritical - Fluid -Bohrium Scale up [https://www.bohrium.com/paper-details/supercritical-fluid-formulation-process-choice-and-scale-up/812373438411833345-4160]
• 75. Volatile organic compound - Wikipedia [https://en.wikipedia.org/wiki/Volatile_organic_compound]
• 76. Volatile Organic Compounds' Impact on Indoor Air Quality | US EPA [https://www.epa.gov/indoor-air-quality-iaq/volatile-organic-compounds-impact-indoor-air-quality]
• 77. Advances and applications of supercritical carbon dioxide microemulsions with or without ionic liquids - ScienceDirect [https://www.sciencedirect.com/science/article/abs/pii/S0896844625000907]
• 78. History repeats itself again: Will the mistakes of the past for ILs be... [https://pubs.rsc.org/en/content/articlehtml/2023/gc/d2gc03198a]
• 79. Supercritical fluids as green solvents - ScienceDirect [https://www.sciencedirect.com/science/article/abs/pii/B9780128219386000281]
• 80. Analysis and Sample... | springerprofessional.de Green Chemical [https://www.springerprofessional.de/green-chemical-analysis-and-sample-preparations/23184686]
• 81. Rules and benefits of Life in Cycle ... Assessment green chemical [https://pubs.rsc.org/en/content/articlehtml/2015/gc/c4gc01153h]
• 82. Life cycle assessment of an ionic liquid versus molecular solvents and their applications - PubMed [https://pubmed.ncbi.nlm.nih.gov/18441827/]
• 83. Environmental impacts of supercritical fluids processes: A critical review of life cycle assessment studies - Archive ouverte HAL [https://hal.science/hal-05228336v1]
• 84. Supercritical fluids: green solvents for green chemistry? - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC4650016/]
• 85. Supercritical Fluid Extraction: A Green and Sustainable Approach for the Isolation of High-Value Compounds from Natural Sources [https://www.ajgreenchem.com/article_221328.html]
• 86. Aqueous Two-Phase Systems From a Ionic ... Liquid Pharmaceutical [https://pmc.ncbi.nlm.nih.gov/articles/PMC6428778/]
• 87. Recovery and purification of ionic from solutions: a review... liquids [https://pubs.rsc.org/en/content/articlehtml/2018/ra/c8ra06384b]
• 88. - Global Forecast Ionic -2030 Liquids Market 2025 [https://www.researchandmarkets.com/reports/6090220/ionic-liquids-market-global-forecast]
• 89. Size & Share Ionic – Growth Liquid ... Market Analysis Trends [https://www.linkedin.com/pulse/ionic-liquid-market-size-share-analysis-growth-trends-prabhavale-wfghf]
• 90. New Trends in Supercritical Fluid Technology and Pressurized Liquids for the Extraction and Recovery of Bioactive Compounds from Agro-Industrial and Marine Food Waste - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC10254675/]
• 91. Size, Share & Growth Forecast Report Ionic Liquids Market 2025 [https://www.theinsightpartners.com/reports/ionic-liquids-market]
• 92. of lactic acid under microwave Enzymatic in... esterification conditions [https://real.mtak.hu/191790/]
• 93. Optimization of enzymatic of dihydrocaffeic acid with... esterification [https://link.springer.com/article/10.1186/s13065-017-0276-2]
• 94. Enzymatic esterification of free fatty acids of hydrolyzed soy deodorizer distillate in supercritical carbon dioxide - ScienceDirect [https://www.sciencedirect.com/science/article/abs/pii/S0896844604000464]
• 95. Enzymatic reactions in subcritical and supercritical fluids - ScienceDirect [https://www.sciencedirect.com/science/article/abs/pii/S089684461730699X]
• 96. A parameter study of ultrasound assisted enzymatic esterification | Scientific Reports [https://www.nature.com/articles/s41598-022-05551-x]
• 97. in Enzymatic integrated with... esterification ionic liquids [https://pubs.rsc.org/en/content/articlelanding/2003/gc/b211342m]
• 98. Effects of pressure and temperature on enzymatic reactions in supercritical fluids - ScienceDirect [https://www.sciencedirect.com/science/article/abs/pii/S0734975007000201]